<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">68603</article-id><article-id pub-id-type="doi">10.7554/eLife.68603</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Ferroptotic stress promotes the accumulation of pro-inflammatory proximal tubular cells in maladaptive renal repair</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-157293"><name><surname>Ide</surname><given-names>Shintaro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9301-211X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-244510"><name><surname>Kobayashi</surname><given-names>Yoshihiko</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-176385"><name><surname>Ide</surname><given-names>Kana</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2845-8481</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-157295"><name><surname>Strausser</surname><given-names>Sarah A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244419"><name><surname>Abe</surname><given-names>Koki</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231517"><name><surname>Herbek</surname><given-names>Savannah</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-117794"><name><surname>O'Brien</surname><given-names>Lori L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0741-181X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-157298"><name><surname>Crowley</surname><given-names>Steven D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1838-0561</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231518"><name><surname>Barisoni</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231519"><name><surname>Tata</surname><given-names>Aleksandra</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-93480"><name><surname>Tata</surname><given-names>Purushothama Rao</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4837-0337</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-144684"><name><surname>Souma</surname><given-names>Tomokazu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3285-8613</contrib-id><email>tomokazu.souma@duke.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Division of Nephrology, Department of Medicine, Duke University School of Medicine</institution><addr-line><named-content content-type="city">Durham</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Department of Cell Biology, Duke University School of Medicine</institution><addr-line><named-content content-type="city">Durham</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill</institution><addr-line><named-content content-type="city">Chapel Hill</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Pathology, Duke University School of Medicine</institution><addr-line><named-content content-type="city">Durham</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Regeneration Next, Duke University</institution><addr-line><named-content content-type="city">Durham</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Duke Cancer Institute, Duke University School of Medicine</institution><addr-line><named-content content-type="city">Durham</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution><country>United States</country></aff></contrib><contrib contrib-type="editor"><name><surname>Germino</surname><given-names>Gregory G</given-names></name><role>Reviewing Editor</role><aff><institution>National Institutes of Health</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>19</day><month>07</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e68603</elocation-id><history><date date-type="received" iso-8601-date="2021-03-20"><day>20</day><month>03</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-07-17"><day>17</day><month>07</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-03-23"><day>23</day><month>03</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.03.23.436661"/></event></pub-history><permissions><copyright-statement>© 2021, Ide et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Ide et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-68603-v2.pdf"/><abstract><p>Overwhelming lipid peroxidation induces ferroptotic stress and ferroptosis, a non-apoptotic form of regulated cell death that has been implicated in maladaptive renal repair in mice and humans. Using single-cell transcriptomic and mouse genetic approaches, we show that proximal tubular (PT) cells develop a molecularly distinct, pro-inflammatory state following injury. While these inflammatory PT cells transiently appear after mild injury and return to their original state without inducing fibrosis, after severe injury they accumulate and contribute to persistent inflammation. This transient inflammatory PT state significantly downregulates glutathione metabolism genes, making the cells vulnerable to ferroptotic stress. Genetic induction of high ferroptotic stress in these cells after mild injury leads to the accumulation of the inflammatory PT cells, enhancing inflammation and fibrosis. Our study broadens the roles of ferroptotic stress from being a trigger of regulated cell death to include the promotion and accumulation of proinflammatory cells that underlie maladaptive repair.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>single-cell RNA sequencing</kwd><kwd>ferroptosis</kwd><kwd>kidney injury</kwd><kwd>repair</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01 DK123097</award-id><principal-award-recipient><name><surname>Souma</surname><given-names>Tomokazu</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>P30 DK114857</award-id><principal-award-recipient><name><surname>Souma</surname><given-names>Tomokazu</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001463</institution-id><institution>American Society of Nephrology</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Souma</surname><given-names>Tomokazu</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>20POST35210465</award-id><principal-award-recipient><name><surname>Ide</surname><given-names>Shintaro</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007263</institution-id><institution>Astellas Foundation for Research on Metabolic Disorders</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ide</surname><given-names>Kana</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kobayashi</surname><given-names>Yoshihiko</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Ferroptotic stress enhances the accumulation of damage-associated inflammatory proximal tubular cell state, thereby promoting maladaptive renal repair and the AKI-to-CKD transition.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Acute kidney injury (AKI) afflicts 1.2 million hospitalized patients annually in the US; 20–50% of AKI survivors progress to chronic kidney disease (CKD), increasing their risk for dialysis-dependency, cardiovascular events, and mortality (<xref ref-type="bibr" rid="bib10">Chawla et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">Lewington et al., 2013</xref>; <xref ref-type="bibr" rid="bib68">Strausser et al., 2018</xref>). Other than general supportive care, there are no targeted therapies to treat AKI or to prevent AKI to CKD transition. A better understanding of the molecular events underpinning the AKI to CKD transition is needed to develop therapeutic strategies to interrupt this devastating disease process.</p><p>Clinical and preclinical studies have identified damage to proximal tubular (PT) epithelial cells after severe AKI as a critical mechanism driving transition to CKD (<xref ref-type="bibr" rid="bib68">Strausser et al., 2018</xref>; <xref ref-type="bibr" rid="bib9">Chawla et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib13">Cippà et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Ferenbach and Bonventre, 2015</xref>; <xref ref-type="bibr" rid="bib29">Humphreys, 2018</xref>). PT cells are most severely affected by acute ischemic and toxic injuries due to their high metabolic and energy-intensive transporter activities required to maintain normal homeostasis of body fluids (<xref ref-type="bibr" rid="bib21">Ferenbach and Bonventre, 2015</xref>; <xref ref-type="bibr" rid="bib29">Humphreys, 2018</xref>; <xref ref-type="bibr" rid="bib25">Gewin, 2018</xref>). In the renal repair process, damaged PT cells adopt heterogeneous molecular states (<xref ref-type="bibr" rid="bib36">Kirita et al., 2020</xref>). They reactivate genes normally active during renal development (<xref ref-type="bibr" rid="bib65">Rudman-Melnick et al., 2020</xref>; <xref ref-type="bibr" rid="bib34">Kang et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Kumar et al., 2015</xref>), alter their dependency on metabolic fuels (<xref ref-type="bibr" rid="bib44">Legouis et al., 2020</xref>), change their morphology, and proliferate to replenish the areas of denuded epithelium in the proximal tubule (<xref ref-type="bibr" rid="bib21">Ferenbach and Bonventre, 2015</xref>; <xref ref-type="bibr" rid="bib76">Witzgall et al., 1994</xref>). When the initial damage to kidneys is mild, PT cells subsequently return to their original state by redifferentiation, with resolution of inflammation and fibrosis (<xref ref-type="bibr" rid="bib21">Ferenbach and Bonventre, 2015</xref>; <xref ref-type="bibr" rid="bib36">Kirita et al., 2020</xref>; <xref ref-type="bibr" rid="bib65">Rudman-Melnick et al., 2020</xref>; <xref ref-type="bibr" rid="bib44">Legouis et al., 2020</xref>; <xref ref-type="bibr" rid="bib76">Witzgall et al., 1994</xref>; <xref ref-type="bibr" rid="bib4">Berger et al., 2014</xref>; <xref ref-type="bibr" rid="bib41">Kusaba et al., 2014</xref>). However, if damage is more extensive, prolonged, or recurrent, the damaged cells fail to redifferentiate, leading to persistent inflammation, fibrosis, and eventual cell death. The molecular pathways that govern proximal tubular heterogeneity and cell fate during failed renal repair after severe injury are poorly understood. This knowledge gap prevents the development of therapies based on underlying disease mechanisms.</p><p>One of the critical pathways involved in AKI pathogenesis and proximal tubular cell death is ferroptosis, a distinct non-apoptotic form of regulated cell death (<xref ref-type="bibr" rid="bib67">Stockwell et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Dixon et al., 2012</xref>; <xref ref-type="bibr" rid="bib77">Yang et al., 2014</xref>; <xref ref-type="bibr" rid="bib33">Kagan et al., 2017</xref>; <xref ref-type="bibr" rid="bib19">Doll et al., 2017</xref>; <xref ref-type="bibr" rid="bib2">Alim et al., 2019</xref>; <xref ref-type="bibr" rid="bib80">Zhao et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">Linkermann et al., 2014</xref>). An imbalance between the generation of lipid peroxides and their detoxification induces overwhelming accumulation of lipid peroxides (ferroptotic stress), triggering ferroptosis (<xref ref-type="bibr" rid="bib67">Stockwell et al., 2017</xref>; <xref ref-type="bibr" rid="bib2">Alim et al., 2019</xref>). The glutathione/glutathione peroxidase 4 (GPX4) axis is the central defense pathway to prevent ferroptotic stress and ferroptosis (<xref ref-type="bibr" rid="bib67">Stockwell et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Dixon et al., 2012</xref>; <xref ref-type="bibr" rid="bib77">Yang et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Friedmann Angeli et al., 2014</xref>). Global genetic deletion of <italic>Gpx4</italic> in mice causes renal tubular epithelial death and acute kidney injury, identifying renal tubular epithelial cells as one of the cell types most vulnerable to ferroptotic stress (<xref ref-type="bibr" rid="bib22">Friedmann Angeli et al., 2014</xref>). Moreover, reduced glutathione and NADPH availability further render ischemia-reperfusion injured kidneys vulnerable to ferroptotic stress (<xref ref-type="bibr" rid="bib68">Strausser et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Nezu et al., 2017</xref>). Accumulating evidence suggests that pharmacological inhibition of ferroptotic cell death ameliorates AKI severity and excess ferroptotic stress has been linked to failed renal repair in patients, suggesting a new therapeutic target (<xref ref-type="bibr" rid="bib80">Zhao et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">Linkermann et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Friedmann Angeli et al., 2014</xref>; <xref ref-type="bibr" rid="bib74">Wenzel et al., 2017</xref>). Interestingly, recent evidence suggests that molecular regulators of necroptosis, another form of regulated cell death, contribute to disease pathogenesis by additional pathways independent of their well-documented roles in triggering cell death (<xref ref-type="bibr" rid="bib16">Daniels et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Moriwaki and Chan, 2016</xref>; <xref ref-type="bibr" rid="bib55">Moriwaki et al., 2014</xref>). However, it is still not clear whether ferroptotic stress has additional roles in the pathogenesis of AKI and its sequelae beyond the induction of ferroptotic cell death and loss of functional tubular cells.</p><p>Here, using complementary single-cell transcriptomic and mouse genetic approaches, we identify the role of a molecularly distinct, damage-associated, PT cell state that is dynamically and differentially regulated during successful versus failed repair. Furthermore, we provide mechanistic evidence that ferroptotic stress in PT cells enhances this damage-associated state, in addition to triggering cell death, thereby promoting failed renal repair and the AKI-to-CKD transition.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Tubular epithelial cells exhibit heterogeneous molecular states after severe injury</title><p>To identify cellular mechanisms that promote maladaptive repair after severe kidney injury, we first developed and optimized mouse models for ‘successful’ versus ‘failed’ renal repair after ischemia-reperfusion-induced injury (IRI). This was achieved by extending renal ischemic times from 20 min for successful recovery to 30 min for failed recovery (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). After mild injury, histologic examination showed that inflammation and macrophage accumulation resolved within 21 days (ischemic time 20 min; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1, D and E</xref>). By contrast, after severe injury there was progressive epithelial damage and fibrosis, and the accumulation of F4/80+ macrophages persisted around the damaged epithelial cells for at least 6 months (ischemic time 30 min; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1, D and E</xref>; and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E</xref>).</p><p>We used this failure-to-repair model (unilateral IRI, ischemic time 30 min) to generate a single-cell transcriptome map of failed renal repair (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Kidneys were harvested at 6 hr and 1, 7, and 21 days after IRI. High-quality transcriptome data from a total of 18,258 cells from injured kidneys (IRI) and homeostatic uninjured kidneys (Homeo) were obtained (<xref ref-type="fig" rid="fig1">Figure 1</xref>, B and C). Using a Seurat integration algorithm that normalizes data and removes potential batch effects (<xref ref-type="bibr" rid="bib70">Stuart et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Hafemeister and Satija, 2019</xref>), we integrated the transcriptome data from each condition and performed unsupervised clustering analysis of the integrated dataset. Uniform manifold approximation and projection (UMAP) resolved 21 separate clusters, representing distinct cell types (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref> and <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A</xref>). The cellular identity of each cluster was determined based on known cell-type-specific markers (<xref ref-type="bibr" rid="bib60">Park et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Ransick et al., 2019</xref>). We successfully identified known cell-type-specific damage-induced genes such as <italic>Havcr1</italic> (kidney injury molecule-1, KIM1), <italic>Krt8</italic> (keratin 8), <italic>Krt20</italic> (keratin 20), and <italic>Lcn2</italic> (neutrophil gelatinase-associated lipocalin, NGAL) selectively in ischemia-reperfusion-injured (IRI) kidneys, but not in homeostatic uninjured control kidneys (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>), (<xref ref-type="bibr" rid="bib48">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib30">Ichimura et al., 2008</xref>; <xref ref-type="bibr" rid="bib59">Paragas et al., 2011</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Single-cell RNA sequencing (scRNA-seq) identifies dynamic cellular state transitions of tubular epithelial cells after severe IRI.</title><p>(<bold>A</bold>) Drop-seq strategy. uIRI, unilateral IRI. A schematic illustration of epithelial cell states is shown. (<bold>B</bold>) and (<bold>C</bold>) Integrated single-cell transcriptome map. Unsupervised clustering identified 21 distinct clusters in the UMAP plot. Arrowheads indicate damage-associated tubular epithelial cells. The dotted area (PT cell clusters; PT and DA-PT) was used for the downstream analyses in (<bold>D</bold>)–(<bold>G</bold>). (<bold>D</bold>) UMAP plots showing the expression of indicated genes in PT cell clusters (PT and DA-PT in (<bold>B</bold>)). Differentiated/mature PT cell markers: <italic>Lrp2</italic> (megalin), <italic>Slc34a1</italic> (sodium-dependent phosphate transporter 2a, NaPi2a), <italic>Acsm2</italic> (acyl-coenzyme A synthetase), and <italic>Hnf4a</italic> (hepatocyte nuclear factor 4α); and damage-induced genes: <italic>Vcam1</italic> (vascular adhesion molecule 1), <italic>Cdh6</italic> (cadherin 6), <italic>Havcr1</italic> (kidney injury molecule-1, KIM1), <italic>Sox9</italic> (Sry-box 9). Arrowheads; DA-PT. (<bold>E</bold>) Immunostaining for SOX9 and VCAM1 using post-severe IRI kidneys on day 21. Scale bar: 20 μm. (<bold>F</bold>) Pseudotime trajectory analysis of proximal tubular cells (PT and DA-PT clusters) that underwent IRI. A region occupied with cells from 6 hr after post-IRI was set as a starting state. (<bold>G</bold>) RNA velocity analysis of PT clusters (PT and DA-PT) from post-IRI kidneys on day 7. Cells in PT clusters from IRI day 7 dataset was extracted for the analysis. The arrows indicate predicted lineage trajectories. PT, proximal tubule; DA-PT, damage-associated PT; TL, thin limb; TAL, thick ascending limb; DA-TAL, damage-associated TAL; DCT, distal convoluted tubule; DA-DCT, damage-associated DCT; CNT, connecting tubule; CD, collecting duct (P, principal cells, IC, intercalated cells); Mes, mesangial cells; Endo, endothelial cells; SMC, smooth muscle cells; Fib, fibroblasts; Mac, macrophages; Mono, monocytes; DC, dendritic cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Characterization of severe and mild unilateral IRI models.</title><p>(<bold>A</bold>) Experimental workflow for the mild and severe IRI models. Left kidneys from wild-type C57BL/6J mice were subjected to mild (20 min) and severe (30 min) ischemia. Contralateral kidneys (CLK) were used as controls. uIRI, unilateral IRI. Kidneys were harvested on day 21 post-IRI. (<bold>B</bold>) Severe IRI results in renal atrophy. Relative size of post-IRI kidney compared to contralateral kidney (CLK) was quantified. N = 4–5. (<bold>C</bold>) Hematoxylin-eosin staining of IRI kidneys on day 21 (D21). Note that severe-IRI resulted in tubular dilatation, flattening of tubular epithelial cells, cast formation, and inflammatory cell infiltration. (<bold>D</bold>) Immunofluorescence for KIM1, NGAL, F4/80, and αSMA. Severe IRI resulted in persistent expression of proximal and distal tubular injury markers. Kidney injury molecule 1, KIM1 (encoded by <italic>Havcr1</italic>) is a marker for proximal tubular injury. Neutrophil gelatinase-associated lipocalin, NGAL (encoded by <italic>Lcn2</italic>) is a marker for distal tubular injury. Note that post-severe IRI kidneys exhibit accumulation of F4/80<sup>+</sup> cells (mostly macrophages) and αSMA<sup>+</sup> myofibroblasts in renal interstitium, both are classical features of failed renal repair. (<bold>E</bold>) Real-time PCR analyses of indicated gene expression. <italic>Acta2</italic> gene encodes αSMA. N = 4–5. Scale bars: 100 μm in stitched images of (<bold>C</bold>); 20 μm in higher magnifications of (<bold>C</bold>); 50 μm in (<bold>D</bold>). *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001. Unpaired Student’s t-test for (<bold>B</bold>) and one-way ANOVA with post hoc multiple comparisons test for (<bold>E</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Severe IRI leads to cystic and atrophic kidneys 6 months after severe IRI.</title><p>(<bold>A</bold>) Experimental workflow for mild and severe IRI models with long-term observation. Kidneys were harvested on 6 months post-IRI. (<bold>B</bold>) Severe IRI (30 min ischemia) results in marked renal atrophy on 6 months post-IRI. Relative size of post-IRI kidney compared to contralateral kidney (CLK) was quantified. N = 5. Unpaired Student’s t-test. (<bold>C</bold>) and (<bold>D</bold>) Hematoxylin-eosin staining of IRI kidneys. Note that severe-IRI resulted in flattened and necrotic tubular epithelial cells with massive infiltration of inflammatory cells, which occupied the renal parenchyma. * indicates clusters of inflammatory cells, occupying renal parenchyma. (<bold>E</bold>) Immunofluorescence for KIM1, NGAL, F4/80, and αSMA. Severe IRI resulted in persistent expression of proximal and distal tubular injury markers (KIM1 and NGAL, respectively). Note that post-severe IRI kidneys exhibit accumulation of F4/80<sup>+</sup> myeloid cells (mostly macrophages) and αSMA<sup>+</sup> myofibroblasts in renal interstitium. Small cystic structures (#) were encircled by myofibroblasts. Scale bars: 20 μm in (<bold>C</bold>), 200 μm in (<bold>D</bold>) and 50 μm in (<bold>E</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>scRNA-seq identifies major cell types in homeostatic and post-IRI kidneys.</title><p>(<bold>A</bold>) Pearson correlation plot showing the linear relationship between the number of genes (nGene) and unique molecular identifiers (nUMI). Experimental conditions and cell types are color-coded. (<bold>B</bold>) Dot plot shows the gene expression patterns of cluster-enriched canonical markers. Note that damage-associated tubular epithelial cells (DA-PT, DA-TAL, and DA-DCT) have reduced expression of canonical cellular markers. (<bold>C</bold>) Tubular injury marker gene expressions are selectively observed in damaged kidneys (IRI) but not in homeostatic control kidneys. ‘C’ indicates cells from the control homeostatic kidneys. ‘I’ indicates cells from IRI kidneys from all time points. Proximal tubule-specific injury markers (<italic>Havcr1</italic>, <italic>Krt20</italic>), distal tubule-specific injury markers (<italic>Lcn2</italic>), and pan-tubular injury marker (<italic>Krt8</italic>) are shown. Both homeostatic and activated cells show high canonical cell type marker gene expressions, such as <italic>Slc34a1</italic> in PT, but damage-associated clusters (DA-PT, DA-TAL, DA-DCT) show reduced homeostatic gene expressions and increased damage-induced gene expressions (See <xref ref-type="fig" rid="fig1">Figure 1A</xref>). (<bold>D</bold>) Our single-cell preparation resulted in high yields of podocytes (1.24%) and endothelial cells (14.66%). Abbrev: PT, proximal tubule; TL, thin limb; TAL, thick ascending limb; DCT, distal convoluted tubule (DCT1 and DCT2); CNT, connecting tubule; CD, collecting duct (P, principal cells, IC, intercalated cells); Mes, mesangial cells; Endo, endothelial cells; SMC, smooth muscle cells; Fib, fibroblasts; Mac, macrophages; Mono, monocytes; DC, dendritic cells; DA-PT, damage-associated PT; DA-TAL, damage-associated TAL; DA-DCT, damage-associated DCT.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>UMAP plots show the expression pattern of anchor genes in homeostatic and post-IRI kidneys.</title><p>(<bold>A</bold>) UMAP plots show the identified cell clusters (resolution was set as 1.0). (<bold>B</bold>) UMAP plots show the expression pattern of indicated canonical marker genes (anchor genes) of each cluster. We manually combined three clusters of differentiated/mature proximal tubular cells (PT, S1/S2 and PT, S2/S3) into one cluster (PT) to generate a more coarse-grained cell-type annotation and data visualization in other figures. We also combined three clusters of endothelial cells (Endo-1, Endo-2, and Endo-3) into one cluster (Endo) for data visualization in other figures. S1, S1 segment; S2, S2 segment 2; S3, S3 segment of proximal tubule.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig1-figsupp4-v2.tif"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 5.</label><caption><title>Damage-associated PT cells show an inflammatory transcriptional signature.</title><p>(<bold>A</bold>) UMAP of PT clusters (PT, differentiated proximal tubular cell cluster; DA-PT, damage-associated proximal tubular cell cluster). See <xref ref-type="fig" rid="fig1">Figure 1B</xref>. (<bold>B</bold>) Volcano plot showing a distinct transcriptional profile of damage-associated PT cells (PT cells in DA-PT cluster). A Wilcoxon rank-sum test was used for the statistical analysis comparing cells in PT cluster from IRI kidneys and cells in DA-PT cluster from IRI kidneys. Blue and gray data points indicate transcripts that fall below the set threshold for fold change (Log<sub>2</sub> fold change, a threshold value of 0.25) and p value (a cutoff value of <italic>10e-</italic>5). Note that cells in the DA-PT cluster show reduced expression of homeostatic marker genes (<italic>Acsm2</italic>, <italic>Slc34a1</italic>, and <italic>Lrp2</italic>), oxidative stress defense genes (<italic>Hmox</italic>, <italic>Miox</italic>, <italic>and Gpx3</italic>), and a gene encodes transcription factor for PT maturation in renal development (<italic>Hnf4a</italic>). The cells in the DA-PT cluster also show enrichment of developmental genes (<italic>Sox4</italic>, <italic>Sox9</italic>, <italic>Cited2</italic>, and C<italic>dh6</italic>), damage-induced genes (<italic>Havcr1</italic> and <italic>Vcam1</italic>) and inflammatory cytokines and chemokines (<italic>Spp1</italic>, <italic>Ccl2</italic>, <italic>Cxcl1</italic>, and <italic>Cxcl2</italic>). (<bold>C</bold>) Dot plots show the expression of <italic>Sox9</italic> gene is highly enriched in damage-associated PT (DA-PT) cell population. (<bold>D</bold>) and (<bold>E</bold>) Gene ontology enrichment analyses identify that DA-PT cluster is enriched for immune response gene ontology. The cells in the DA-PT cluster from IRI kidneys (all time points) were compared with the cells in the PT cluster or cells in all other nephron segments and collecting duct (IRI kidneys, all time points) in (<bold>D</bold>) and (<bold>E</bold>), respectively. (<bold>F</bold>) Gene Ontology enrichment analyses identify the PT cluster is enriched for glutathione-mediated anti-oxidative stress responses. The cells in the PT cluster from IRI kidneys (all time points) were compared with the cells from all other nephron segments and collecting duct from IRI kidneys (all time points).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig1-figsupp5-v2.tif"/></fig><fig id="fig1s6" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 6.</label><caption><title>Severe IRI reduces expressions of proximal tubular differentiation markers.</title><p>(<bold>A</bold>) UMAP plots showing the expression of indicated genes. Note that damage-associated PT cell state (cells in DA-PT cluster) are enriched with damage-induced genes (<italic>Havcr1</italic>, <italic>Krt20</italic>, <italic>Vcam1</italic>, and <italic>Vim</italic>) and exhibit less differentiated signature (upregulation of <italic>Cdh6</italic> and downregulation of <italic>Hnf4a</italic>). Arrow, PT cells; arrowheads; DA-PT cells. (<bold>B</bold>) and (<bold>C</bold>) Comparative analyses of kidneys underwent severe IRI (ischemic time 30 min) and mild IRI (ischemic time 20 min). Kidneys were harvested on day 21 post-IRI. Severe IRI reduces LTL<sup>high</sup> proximal tubular cells. Lotus tetragonolobus lectin (LTL) binds fully differentiated proximal tubular cells. LTL<sup>high</sup> areas from kidneys on day 21 were quantified. Wild-type C57BL/6J mice were used. Scale bars: 50 μm. N = 4–7. (<bold>D</bold>) Real-time PCR analyses of <italic>Slc34a1</italic>. mRNA expression of <italic>Slc34a1</italic> was reduced after severe IRI (ischemic time 30 min on day 21). Whole kidney lysates from post-IRI kidneys on day 21 were used. Contralateral kidneys (CLK) were used as controls. N = 4–5. **p &lt; 0.01; ****p &lt; 0.0001, one-way ANOVA with post hoc multiple comparisons test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig1-figsupp6-v2.tif"/></fig><fig id="fig1s7" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 7.</label><caption><title>Comparative analyses of damage-associated PT cells and neonatal proximal tubular cells.</title><p>(<bold>A</bold>) and (<bold>B</bold>) Characterization of mouse neonatal kidney single-cell RNA-seq data. UMAP plots show mouse neonatal kidney cells from GSM2473317 (4693 cells; post-natal day 1) in (<bold>A</bold>). Dot plots show the gene expression patterns of cluster-enriched canonical markers in (<bold>B</bold>). (<bold>C</bold>) UMAP rendering of Top 100 genes characterizing mature and immature early proximal tubular (PT) cells. We obtained the top 100 genes representing mature PT and immature early PT cells by performing differential gene expression analysis using the ‘FindMarkers’ command in Seurat. As expected, the mature PT Top 100 genes are enriched in mature PT cluster. The early PT Top 100 genes are enriched in immature early PT and nephron progenitor clusters. (<bold>D</bold>) UMAP rendering of mature and early PT genes on adult PT clusters from our dataset (PT and DA-PT). Note that the early PT Top 100 genes are highly enriched in damage-associated PT (DA-PT) population, indicating they are in a less differentiated state. (<bold>E</bold>) UMAP plots showing gene expressions of early PT genes (<italic>Cd24a</italic>, <italic>Jag1</italic>, and <italic>Aldh1a2</italic>) are enriched in DA-PT cluster.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig1-figsupp7-v2.tif"/></fig><fig id="fig1s8" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 8.</label><caption><title>Trajectory analyses predict lineage hierarchy from differentiated mature PT cells to damage-associated PT cells.</title><p>(<bold>A</bold>) UMAP plots showing mature and damage-associated PT cells (PT and DA-PT clusters) underwent IRI. (<bold>B</bold>) Pseudotime trajectory analysis using Monocle 3. A region occupied with <italic>Slc34a1</italic><sup>high</sup> cells was set as a starting state. Note that predicted trajectory starting from PT to DA-PT state. See <xref ref-type="fig" rid="fig1">Figure 1F</xref> for the analysis with a different starting ‘root’ setting. The earliest time point of injury was used as a starting root in <xref ref-type="fig" rid="fig1">Figure 1F</xref>. Both analyses resulted in a similar predicted trajectory. (<bold>C</bold>) UMAP plots showing proximal tubular cells from PT and DA-PT clusters on IRI day 7 (D7) . Cells from post-IRI kidneys on day seven are shown and used for RNA velocity analysis to investigate potential cellular plasticity at this stage (single data point). See <xref ref-type="fig" rid="fig1">Figure 1G</xref> for RNA velocities (trajectory). UMAP plots in the right panels show the indicated genes; homeostatic genes (<italic>Lrp2</italic>, <italic>Acsm2</italic>, and <italic>Slc34a1</italic>), damage-induced genes (<italic>Vcam1</italic>, <italic>Cdh6</italic>, and <italic>Sox9</italic>), and cellular proliferation (<italic>Mki67</italic> and <italic>Top2a</italic>). Fig. S8A and S8B are supporting data for <xref ref-type="fig" rid="fig1">Figure 1F</xref>. Fig. S8C is supporting data for <xref ref-type="fig" rid="fig1">Figure 1G</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig1-figsupp8-v2.tif"/></fig></fig-group><p>Based on the cell clustering and gene expression patterns, we noticed that there are at least three epithelial cell states (homeostatic normal, activated, and dedifferentiated cells) in our dataset (See <xref ref-type="fig" rid="fig1">Figure 1A</xref>, right panel). Homeostatic normal cells express high expression of ‘anchor’ genes involved in normal cell function and identity (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3, B and C</xref>). Most of the tubular epithelial cells from IRI kidneys robustly expressed damage-induced genes (ex. <italic>Havcr1</italic>, <italic>Krt8</italic>, <italic>Krt20</italic>, <italic>Lcn2</italic>), indicating they are in activated states (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>). These activated cells and homeostatic cells were grouped in the same cluster because they both highly express anchor genes characteristic for normal tubular epithelial states and functions (<xref ref-type="fig" rid="fig1">Figure 1</xref>, B and C; Fig, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>). However, we also identified additional damage-associated tubular epithelial clusters (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, arrowheads; DA-PT, DA-TAL, and DA-DCT) that had lost or reduced expression of ‘normal’ mature epithelial cell marker genes but highly expressed damage-induced genes (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3, B and C</xref>, <xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p><p>Among these damage-associated epithelial cell clusters, we found a damage-associated proximal tubular cell state (See DA-PT cluster), which shows reduced homeostatic gene expression (ex. <italic>Lrp2</italic>, <italic>Slc34a1</italic>, <italic>Hnf4a</italic>, and <italic>Acsm2</italic>) and enrichment for genes associated with both renal development and kidney injury in human and mouse (ex. <italic>Cdh6</italic>, <italic>Sox9</italic>, <italic>Sox4</italic>, <italic>Cited2</italic>, <italic>Vcam1</italic>, <italic>Vim</italic>, and <italic>Havcr1</italic>; <xref ref-type="fig" rid="fig1">Figure 1D</xref>, and <xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5B</xref> and <xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6A</xref>), (<xref ref-type="bibr" rid="bib14">Combes et al., 2019a</xref>; <xref ref-type="bibr" rid="bib20">Famulski et al., 2012</xref>; <xref ref-type="bibr" rid="bib1">Adam et al., 2017</xref>). Moreover, gene ontology enrichment analyses of this cellular population revealed proinflammatory molecular signatures and enriched expression of chemokines and cytokines such as <italic>Cxcl2, Cxcl1, Ccl2</italic>, and <italic>Spp1</italic> (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5B,D and E</xref>). Reduced expression of <italic>Hnf4a</italic>, which is a transcription factor essential for the maturation of PT cells (<xref ref-type="bibr" rid="bib53">Marable et al., 2018</xref>; <xref ref-type="bibr" rid="bib54">Marable et al., 2020</xref>), and other homeostatic genes and upregulation of <italic>Cdh6</italic>, which is selectively expressed in immature proximal tubule progenitors in development and is essential for renal epithelialization (<xref ref-type="bibr" rid="bib54">Marable et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">Cho et al., 1998</xref>; <xref ref-type="bibr" rid="bib51">Mah et al., 2000</xref>), suggest that the cells in this cluster (DA-PT) are in a less differentiated cell state (<xref ref-type="fig" rid="fig1">Figure 1D</xref> and <xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6A</xref>), (<xref ref-type="bibr" rid="bib54">Marable et al., 2020</xref>). Then, we compared the transcriptional signature of this damage-associated PT cell state with previously published neonatal kidney single-cell RNA seq data (GSE94333, <xref ref-type="fig" rid="fig1s7">Figure 1—figure supplement 7, A and B</xref>), (<xref ref-type="bibr" rid="bib1">Adam et al., 2017</xref>). The top 100 genes enriched in immature early PT cells in neonatal kidneys were mainly expressed in this damage-associated PT cell state (DA-PT, <xref ref-type="fig" rid="fig1s7">Figure 1—figure supplement 7, C and D</xref>). These analyses support our notion that the cells in the DA-PT cluster are in a dedifferentiated inflammatory state.</p><p>Among the damage-induced genes expressed in this dedifferentiated inflammatory PT cell state, we focused on the enrichment of <italic>Sox9</italic> and <italic>Vcam1</italic> (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, See DA-PT cluster, arrowheads). Recent single-nucleus transcriptomic profiling of mouse IRI-kidneys identified vascular cell adhesion molecule 1 (VCAM1) as a marker of non-repairing proximal tubular cell state (<xref ref-type="bibr" rid="bib36">Kirita et al., 2020</xref>), and <italic>Vcam1</italic> induction has been observed in multiple forms of human kidney diseases, including allograft rejection (<xref ref-type="bibr" rid="bib27">Hauser et al., 1997</xref>). SRY-box9 (SOX9) is an essential transcription factor for successful renal repair after acute ischemic and toxic insults (<xref ref-type="bibr" rid="bib34">Kang et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Kumar et al., 2015</xref>) and is involved in the development of multiple organs, including mouse and human kidneys (<xref ref-type="bibr" rid="bib62">Reginensi et al., 2011</xref>). SOX9 contributes to tissue repair processes by conferring stemness, plasticity, and regenerative capacity (<xref ref-type="bibr" rid="bib34">Kang et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Kumar et al., 2015</xref>; <xref ref-type="bibr" rid="bib64">Roche et al., 2015</xref>; <xref ref-type="bibr" rid="bib32">Kadaja et al., 2014</xref>; <xref ref-type="bibr" rid="bib24">Furuyama et al., 2011</xref>; <xref ref-type="bibr" rid="bib71">Tata et al., 2018</xref>). Our single-cell RNA-sequencing (scRNA-seq) data revealed that <italic>Sox9</italic> was most robustly induced in damage-associated PT cells compared to other tubular epithelial cells (DA-PT, <xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5C</xref>). To validate this finding, we performed immunofluorescence for SOX9 and VCAM1 in histological sections of kidneys with failed repair. SOX9 nuclear accumulation was observed in VCAM1<sup>+</sup> proximal tubular cells (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). High expression of <italic>Sox9</italic> and <italic>Vcam1</italic> suggests a potential role of this damage-associated PT cell state both in adaptive and maladaptive renal repair in a context-dependent manner, such as ranging severity of injury.</p><p>To understand the lineage hierarchy of PT cell states, we analyzed PT cells from differentiated and damage-associated PT cell clusters (PT and DA-PT in <xref ref-type="fig" rid="fig1">Figure 1B</xref>) using two algorithm tools (Monocle 3 and Velocyto) that allow the computational prediction of cell differentiation trajectories (<xref ref-type="bibr" rid="bib8">Cao et al., 2019</xref>; <xref ref-type="bibr" rid="bib42">La Manno et al., 2018</xref>). By placing each cell from the entire dataset in pseudotime we observed a predicted differentiation trajectory originating from PT to DA-PT (<xref ref-type="fig" rid="fig1">Figure 1F</xref> and <xref ref-type="fig" rid="fig1s8">Figure 1—figure supplement 8, A and B</xref>). We then performed RNA velocity analysis, which predicts the cell state trajectory based on the ratio between unspliced and spliced mRNA expressions, for these two PT cell states from the post-IRI dataset on day 7. Our RNA velocity analysis showed two trajectories running in opposite directions from the middle of the cluster, a position where genes associated with tubular maturation and damage are both not highly expressed (<xref ref-type="fig" rid="fig1">Figure 1G</xref> and <xref ref-type="fig" rid="fig1s8">Figure 1—figure supplement 8C</xref>). One projects toward the area with high levels of damage-induced genes (dedifferentiation path to damage-associated PT cell state) and the other toward the area with high levels of maturation-associated genes (redifferentiation path to differentiated PT cell state). Our computational analyses suggest the potential existence of cellular plasticity at this stage (Day 7 post-IRI; <xref ref-type="fig" rid="fig1">Figure 1G</xref> and <xref ref-type="fig" rid="fig1s8">Figure 1—figure supplement 8C</xref>).</p></sec><sec id="s2-2"><title>Proximal tubular cells dynamically alter their cellular states after acute kidney injury</title><p>To determine the temporal dynamics of damage-associated PT cell state in adaptive and maladaptive repair and validate the computational analyses, we performed expression analyses of multiple marker genes for this PT cell state in successful and failed renal repair processes. Quantitative RT-PCR analyses for <italic>Sox9</italic>, <italic>Cdh6</italic>, and <italic>Vcam1</italic> genes confirmed the transient induction of these genes and resolution after mild ischemic injury (20 min ischemia, Fig, 2B), but persistently elevated expression after severe ischemic injury (30 min) through 21 days after injury (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Using immunofluorescence and in situ hybridization, we observed more VCAM1<sup>+</sup> and <italic>Cdh6</italic><sup>+</sup> tubular epithelial cells in IRI kidneys after 30 min than 20 min ischemia (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). The number of SOX9-positive cells was similarly increased between kidneys with mild and severe IRI on day 7 compared to baseline (<xref ref-type="fig" rid="fig2">Figure 2</xref>, D and E). Confocal imaging showed that most of the SOX9-positive cells co-express VCAM1 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1, B and C</xref>). Notably, SOX9 expression was reduced to baseline level in the kidneys that underwent mild injury while it persisted up to 6 months after severe IRI (<xref ref-type="fig" rid="fig2">Figure 2</xref>, D and E). We observed clusters of SOX9<sup>+</sup>VCAM1<sup>+</sup> cells in the remaining parenchyma at 6 months post-severe IRI, but not in the post mild-IRI kidneys (<xref ref-type="fig" rid="fig2">Figure 2F</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1, B and C</xref>). In accordance with the hypothesis that severe IRI injury is associated with increased signature of damage-associated PT cell state, there was a reduction of homeostatic gene expressions (<italic>Acsm2</italic> and <italic>Slc34a1</italic>) and the number of fully differentiated PT cells, which have high lotus tetragonolobus lectin (LTL)-binding (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6, B-D</xref>), (<xref ref-type="bibr" rid="bib54">Marable et al., 2020</xref>). This finding is in line with a clinical correlation between low expression of <italic>ACSM2B</italic>, the human ortholog of <italic>Acsm2</italic>, and reduced renal function in patients with CKD (<xref ref-type="bibr" rid="bib43">Ledo et al., 2015</xref>). Collectively, these data support the emergence and accumulation of damage-associated PT cells after severe injury but their return to a homeostatic state after mild injury.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Damage-associated PT cells emerge transiently after mild injury but persist after severe injury.</title><p>(<bold>A</bold>) Experimental workflow for the mild and severe IRI models. Left kidneys from wild-type (WT) C57BL/6J (B6) mice were subjected to mild (20 min) and severe (30 min) ischemia (unilateral IRI, uIRI). Contralateral kidneys (CLK) were used as controls. (<bold>B</bold>) Real-time PCR analyses of indicated gene expression. Whole kidney lysates were used. N = 4–5. (<bold>C</bold>) Expression analyses of VCAM1 and <italic>Cdh6</italic> using post-IRI kidneys on day 21. Immunostaining for VCAM1 revealed clusters of VCAM1<sup>high</sup> tubular epithelial cells. In situ hybridization (ISH) was used to detect <italic>Cdh6</italic> gene expression on kidney sections. (<bold>D</bold>) Immunostaining for SOX9 in mild (20 min) and severe (30 min) IRI kidneys collected at indicated time points (day 7, day 21, and 6 months after IRI). (<bold>E</bold>) Quantification of SOX9<sup>+</sup> cells over the DAPI<sup>+</sup> area. Note that SOX9<sup>+</sup> cells persist after severe IRI up to 6 months after IRI (30 for 30 min ischemia). In contrast, they disappear after a transient appearance in post-mild IRI kidneys (20 for 20 min ischemia). N = 4–8. (<bold>F</bold>) Immunostaining for SOX9 and VCAM1 (6 months post-severe IRI kidneys, dotted area in <bold>D</bold>). Scale bars, 20 μm in (<bold>C</bold>, <italic>Cdh6</italic>), and 50 μm (<bold>C</bold>, VCAM1, <bold>D and F</bold>). *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001, one-way ANOVA with post hoc multiple comparisons test. n.s., not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Comparative analyses of mild and severe IRI identify distinct temporal dynamics of damage-associated PT cells.</title><p>(<bold>A</bold>) Experimental workflow. Wild type C57BL/6J mice were used. Mild IRI (20 min ischemia) and severe IRI (30 min ischemia). Kidneys were harvested on day 7, day 21 and 6 months post-IRI. (<bold>B</bold>) Immunostaining for SOX9 and VCAM1. Note that double-positive cells (indicative for damage-associated PT cell state) emerge after mild and severe IRI similarly on day 7, but they are differentially regulated subsequently. SOX9<sup>+</sup>VCAM1<sup>+</sup> cells disappear after mild IRI (20 min ischemia) on day 21, but they persist at least for 6 months after severe IRI (30 min ischemia). Scale bars: 50 μm. * indicates cystic lesions. (<bold>C</bold>) Quantification of double-positive cells over DAPI<sup>+</sup> area in (<bold>B</bold>). N = 3–8. ***p &lt; 0.001, ****p &lt; 0.0001, one-way ANOVA with post hoc multiple comparisons test. n.s., not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig2-figsupp1-v2.tif"/></fig></fig-group><p>To further characterize the dynamic changes and plasticity of proximal tubular cell state, we employed a <italic>CreERT2</italic> allele of <italic>Sox9</italic>, a highly enriched gene in the damage-associated PT cell state (DA-PT, <xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5C</xref>), combined with <italic>Rosa26<sup>tdTomat</sup></italic><sup>o</sup> reporter to carry out lineage tracing (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). In this mouse line (<italic>Sox9<sup>IRES-CreERT2</sup>; Rosa26<sup>tdTomato</sup></italic>), tamoxifen administration permanently labels the <italic>Sox9</italic>-lineage cells with the tdTomato fluorescent reporter and provides the spatial information of the cells with a history of <italic>Sox9</italic> expression. On day 21, we found that severe ischemia (30 min) induces more robust accumulation of <italic>Sox9</italic>-lineage-labeled cells than mild ischemic injury (20 min) in the cortex and outer medulla of the IRI-kidneys (<xref ref-type="fig" rid="fig3">Figure 3</xref>, B and C). Approximately 25% percent of <italic>Sox9</italic>-lineage cells that underwent severe IRI were positive for VCAM1 on day 21, suggesting that part of <italic>Sox9</italic>-lineage cells did not fully redifferentiate after severe injury (<xref ref-type="fig" rid="fig3">Figure 3</xref>, D and E; 30 min). In contrast, only a few <italic>Sox9</italic>-lineage cells that underwent mild injury were VCAM1 positive at this time, indicating successful redifferentiation (<xref ref-type="fig" rid="fig3">Figure 3</xref>, D and E; 20 min). These results are consistent with the temporal dynamics of SOX9 and VCAM1 immunostaining results (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Taken together, our data suggest that loss of plasticity and impaired redifferentiation of damage-associated PT cells underlie the failed renal repair/regeneration process (<xref ref-type="fig" rid="fig3">Figure 3F</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Lineage-tracing identifies the cellular plasticity of damage-associated PT cells.</title><p>(<bold>A</bold>) Schematic of fate-mapping strategy using <italic>Sox9<sup>IRES-CreERT2</sup>; Rosa26<sup>tdTomato</sup></italic> mice. Tamoxifen was administered three times on alternate days. Contralateral kidneys (CLK) were used as controls. (<bold>B</bold>) Distribution of tdTomato-expressing cells (<italic>Sox9</italic>-lineage cells) in contralateral (CLK), mild (20 min) and severe (30 min) IRI kidneys on day 21 (D21). (<bold>C</bold>) Quantification of tdTomato<sup>+</sup> area relative to DAPI<sup>+</sup> area in (<bold>B</bold>). DAPI was used for nuclear staining. N = 4–5. (<bold>D</bold>) Immunostaining for VCAM1 in <italic>Sox9</italic>-lineage-tagged kidneys (post-IRI, day 21). <italic>Sox9</italic>-lineage cells express native tdTomato red fluorescence (TdT). Insets: individual fluorescence channels. (<bold>E</bold>) Quantification of double-positive cells in total tdTomato<sup>+</sup> cells in (<bold>D</bold>). N = 3–4. Note that more <italic>Sox9</italic>-lineage cells express VCAM1 after severe IRI (30 min) compared to mild IRI (20 min) on day 21. One-way ANOVA with post hoc multiple comparisons test and unpaired Student’s t-test were used for (<bold>C</bold>) and (<bold>E</bold>), respectively. Scale bars, 200 μm in (<bold>B</bold>); and 50 μm in (<bold>D</bold>). *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001. (<bold>F</bold>) Schematic illustration of PT cell state dynamics. Differentiated/mature PT cells are activated, transit into a molecularly distinct PT cell state (damage-associated PT cells in DA-PT cluster), and redifferentiate into their original state after mild injury (left). Severe injury prevents the redifferentiation of damage-associated PT cells into normal PT cell state, leading to the accumulation and persistence of damage-associated PT cells (right).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig3-v2.tif"/></fig></sec><sec id="s2-3"><title>Damage-associated PT cells create a proinflammatory milieu with renal myeloid cells</title><p>While an initial inflammatory response is critical for tissue repair, uncontrolled persistent inflammation underlies organ fibrosis (<xref ref-type="bibr" rid="bib21">Ferenbach and Bonventre, 2015</xref>; <xref ref-type="bibr" rid="bib29">Humphreys, 2018</xref>; <xref ref-type="bibr" rid="bib25">Gewin, 2018</xref>). We hypothesized that the accumulation of damage-associated PT cells, which show proinflammatory transcriptional signature (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5B,D and E</xref>), creates an uncontrolled inflammatory milieu by interacting with resident and infiltrating myeloid cells such as macrophages and monocytes (<xref ref-type="bibr" rid="bib31">Ide et al., 2020</xref>). To determine the intercellular interactions between damage-associated PT cells and myeloid cells, we used NicheNet, a computational algorithm tool that infers ligand-receptor interactions and downstream target genes (<xref ref-type="fig" rid="fig4">Figure 4</xref>, A-D), (<xref ref-type="bibr" rid="bib6">Browaeys et al., 2020</xref>). We applied NicheNet to predict ligand-receptor pairs in which ligands from damage-associated PT cells interact with receptors in monocyte or macrophages (<xref ref-type="fig" rid="fig4">Figure 4</xref>, A and C), (<xref ref-type="bibr" rid="bib6">Browaeys et al., 2020</xref>). Among the top five predicted ligands expressed in damage-associated PT cells, we confirmed the enrichment of <italic>Icam1</italic>, <italic>Pdgfb</italic>, and <italic>Apoe</italic> expression in this cell state (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, arrowheads). <italic>Icam1</italic> and <italic>Pdgfb</italic> have been implicated in human AKI (<xref ref-type="bibr" rid="bib20">Famulski et al., 2012</xref>), and <italic>Apoe</italic> genetic variation has been linked with CKD progression (<xref ref-type="bibr" rid="bib28">Hsu et al., 2005</xref>). As inferred by NicheNet, mRNA expression of <italic>Icam1</italic>, <italic>Pdgfb</italic>, and <italic>Apoe</italic> were markedly increased in the kidneys showing the accumulation of damage-associated PT cells compared to post-IRI kidneys without the accumulation (<xref ref-type="fig" rid="fig4">Figure 4F</xref>; 30 min <italic>vs.</italic> 20 min ischemia). These data delineate a complex inflammatory circuit within the damaged kidneys involving intercellular communication between damage-associated PT cells and myeloid cells that contribute to maladaptive renal repair.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Damage-associated PT cells create a proinflammatory milieu with myeloid cells.</title><p>(<bold>A</bold>) Schematic model of intercellular communications between damage-associated PT cells and macrophages. NicheNet was used to predict intercellular interactions using our integrated single-cell map of failed renal repair. (<bold>B</bold>) Predicted ligands from damage-associated PT cells and receptors in macrophages. (<bold>C</bold>) Schematic model of intercellular communications between damage-associated PT cells and monocytes. (<bold>D</bold>) Predicted ligands from damage-associated PT cells and receptors in monocytes. (<bold>E</bold>) UMAP plots showing the expression of indicated genes. Our integrated single-cell map of mouse failed renal repair is shown (See <xref ref-type="fig" rid="fig1">Figure 1</xref>, <bold>B and C</bold>). Arrowheads indicate damage-associated PT cells (DA-PT cluster). Arrows indicate differentiated PT cells (PT cluster). (<bold>F</bold>) Real-time PCR analyses of indicated gene expression. Post-IRI kidneys on day 21 that underwent mild (20 min) or severe (30 min) ischemia were used. N = 4–5. *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001, one-way ANOVA with post hoc multiple comparisons test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig4-v2.tif"/></fig></sec><sec id="s2-4"><title>Damage-associated PT cells exhibit high ferroptotic stress after severe IRI</title><p>Next, we investigated the molecular mechanisms that are critical for cells to traverse between differentiated PT cells and damage-associated PT cells. To this end, we analyzed the transcriptional signature of PT cells in the differentiated/mature cluster to identify critical pathways to maintain this cellular state. We found that genes associated with glutathione metabolic processes and anti-oxidative stress response pathways are overrepresented in the differentiated mouse PT cell cluster (<xref ref-type="fig" rid="fig5">Figure 5A</xref>; <xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5F</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). We also found that these pathways are enriched in normal differentiated human PT cells (<xref ref-type="fig" rid="fig5">Figure 5A</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2, A and B</xref>; GSE131882). Mirroring these findings, oxidative stress-induced signaling pathways related to failed renal repair, such as cellular senescence and DNA damage responses (<xref ref-type="bibr" rid="bib37">Kishi et al., 2019</xref>; <xref ref-type="bibr" rid="bib7">Canaud et al., 2019</xref>), were highly enriched in damage-associated PT cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). Taken together, we propose that glutathione-mediated anti-oxidative stress responses are critical for maintaining the cellular identity of fully differentiated PT cells, and dysregulation of these pathways underlies the failure of damage-associated PT cells to redifferentiate into normal PT cell state.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Damage-associated PT cells undergo high ferroptotic stress after severe IRI.</title><p>(<bold>A</bold>) UMAP rendering of glutathione metabolic process in mouse and human kidneys. (<bold>B</bold>) A scheme showing glutathione-glutathione peroxidase 4 (GPX4) anti-ferroptotic defense pathway. <italic>Slc7a11</italic> and <italic>Slc3a2</italic> (system x<sub>c</sub><sup>-</sup>); <italic>Gclc</italic> and <italic>Gclm</italic> (glutamate-cysteine ligase); <italic>Gss</italic> (glutathione synthetase); <italic>Gsr</italic> (glutathione reductase): and <italic>Gpx4</italic>. MDA (malondialdehyde, a lipid peroxidation product) and ACSL4 (acyl-CoA synthetase long-chain family member 4) are markers for ferroptotic stress. (<bold>C</bold>) Dot plots show the expression of genes for glutathione-GPX4 axis, <italic>Sox9,</italic> and <italic>Acsl4</italic>. (<bold>D</bold>) Immunostaining for SOX9 and MDA (6 hr post-IRI), and (<bold>E</bold>) quantification of double-positive cells in total SOX9<sup>+</sup> cells. N = 4. (<bold>F</bold>) Immunostaining for SOX9 and ACSL4 (1 day post-IRI), and (<bold>G</bold>) quantification of double-positive cells in total SOX9<sup>+</sup> cells. N = 4. Insets: individual fluorescence channels of the dotted box area. Note that severe ischemia (30 min) induces more ferroptotic stress markers (MDA and ACSL4) in SOX9<sup>+</sup> cells in damaged kidneys than mild ischemia (20 min). Wild-type C57BL/6J mice were used for (<bold>D</bold>) to (<bold>G</bold>). Scale bars, 20 μm in (<bold>D</bold>) and (<bold>F</bold>). *p &lt; 0.05. unpaired Student’s t-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Gene ontology analyses identify enrichment of anti-oxidative stress defense genes in differentiated/mature PT cells.</title><p>UMAP rendering of signaling pathways. Upper panels show the pathways enriched in differentiated PT cells (PT cluster). Lower panels show the pathways enriched in damage-associated PT cells (DA-PT cluster). Arrows indicate differentiated PT cell cluster (PT). Arrowheads indicate DA-PT cell cluster.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Characterization of human normal kidney single-nucleus RNA-seq data.</title><p>(<bold>A</bold>) UMAP plots showing human normal kidney cells from GSE131882 (7,631 cells). Two normal kidney datasets were integrated and analyzed. (<bold>B</bold>) Dot plot showing the gene expression patterns of cluster-enriched canonical markers. (<bold>C</bold>) UMAP rendering of signaling pathways. Note that the signaling pathways for anti-oxidative stress, which are enriched in differentiated PT cells in mouse kidneys, are also enriched in normal differentiated PT cells in humans. Blue arrowheads: PT cells, green arrowheads, VCAM1<sup>+</sup> PT cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig5-figsupp2-v2.tif"/></fig></fig-group><p>Among the cellular stress pathways related to dysregulation of glutathione metabolism, ferroptotic stress and ferroptosis have been implicated in failed repair of human AKI and pathogenesis in mouse models of AKI, (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), (<xref ref-type="bibr" rid="bib67">Stockwell et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Dixon et al., 2012</xref>; <xref ref-type="bibr" rid="bib77">Yang et al., 2014</xref>; <xref ref-type="bibr" rid="bib47">Linkermann et al., 2014</xref>; <xref ref-type="bibr" rid="bib74">Wenzel et al., 2017</xref>; <xref ref-type="bibr" rid="bib57">Müller et al., 2017</xref>). To investigate whether ferroptotic stress underlies the emergence and accumulation of damage-associated PT cells in addition to its known role in inducing cell death during maladaptive repair, we first tested the expression of the canonical anti-ferroptosis defense pathway, glutathione/GPX4 axis (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). In agreement with the underrepresentation of glutathione metabolic process in damage-associated PT cells, the genes encoding the glutathione/GPX4 defense pathway were markedly downregulated in this PT cell state (DA-PT) compared to differentiated PT cells (PT), suggesting that damage-associated PT cells are potentially vulnerable to ferroptotic stress (<xref ref-type="fig" rid="fig5">Figure 5C</xref>).</p><p>We then analyzed the expression of ferroptotic stress biomarkers such as malondialdehyde (MDA, a lipid peroxidation product) and acyl-CoA synthetase long-chain family member 4 (ACSL4), which also regulate cellular sensitivity to ferroptosis (<xref ref-type="bibr" rid="bib33">Kagan et al., 2017</xref>; <xref ref-type="bibr" rid="bib19">Doll et al., 2017</xref>; <xref ref-type="bibr" rid="bib57">Müller et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Kenny et al., 2019</xref>; <xref ref-type="bibr" rid="bib79">Yuan et al., 2016</xref>; <xref ref-type="bibr" rid="bib46">Li et al., 2019</xref>). A recent pharmacological inhibitor study showed that ACSL4 is a reliable maker for ferroptotic stress in murine model of ischemic AKI (<xref ref-type="bibr" rid="bib80">Zhao et al., 2020</xref>). We identified significant upregulation of <italic>Acsl4</italic> in damage-associated PT cells in dot-plots (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). The co-expression of markers for damage-associated PT cells and ferroptotic stress was confirmed by immunofluorescence for SOX9, MDA, and ACSL4 (<xref ref-type="fig" rid="fig5">Figure 5</xref>, D-G). We found that severe ischemia (30 min) induces more expression of ferroptotic stress markers in SOX9<italic><sup>+</sup></italic> cells than mild ischemic injury (20 min) (<xref ref-type="fig" rid="fig5">Figure 5</xref>, E and G). These data demonstrate that SOX9<sup>+</sup> damage-associated PT cells undergo high ferroptotic stress after severe ischemic injury.</p><p>To address whether the emergence of damage-associated PT cells is specific to IRI injury or appears in other cases of acute kidney injury, we investigated the co-expression of SOX9 and VCAM1 in models of toxic renal injury (aristolochic acid nephropathy, AAN) and obstructive renal injury (unilateral ureteral obstruction, UUO), which lead to severe fibrosis. By immunofluorescence analyses of SOX9 and VCAM1 co-expression, we found the emergence of damage-associated PT cells in both models (<xref ref-type="fig" rid="fig6">Figure 6</xref>, A and C). Furthermore, the SOX9-positive tubular epithelial cells in these models showed co-expression of ACSL4, suggesting that ferroptotic stress of damage-associated PT cells is a conserved response to kidney injury across various etiologies (<xref ref-type="fig" rid="fig6">Figure 6</xref>, B and C).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Damage-associated PT cells emerge after injury in mouse and human kidneys.</title><p>(<bold>A</bold>) Immunostaining for SOX9 and VCAM1. Aristolochic acid nephropathy (AAN) and unilateral ureteral obstruction (UUO) models were used. Kidneys from wild-type C57BL/6J mice were harvested on day 26 (D26) for AAN and day 10 (D10) for UUO. Insets: individual fluorescence channels of the dotted box area. (<bold>B</bold>) Immunostaining for SOX9 and ACSL4. bIRI, bilateral IRI model. Kidneys were harvested on day 3 (D3) for bIRI, day 5 (D5) for AAN, and day 10 (D10) for UUO. Insets: individual fluorescence channels of the dotted box area. (<bold>C</bold>) Quantification of double-positive cells in total SOX9<sup>+</sup> cells from panel (<bold>A</bold>) and (<bold>B</bold>). Scale bars, 20 μm. N = 3–4. **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001, one-way ANOVA with post hoc multiple comparisons test. (<bold>D</bold>) UMAP of the human proximal tubular cells from AKI kidneys. (<bold>E</bold>) Dot plots showing the expression of indicated genes. Note that PT cells in state 3 (DA-PT-like) show increased gene expressions of markers for mouse damage-associated PT cells (<italic>SOX9</italic>, <italic>VCAM1</italic>, <italic>CDH6</italic>) and reduced expression of homeostatic genes (<italic>ALDOB, MIOX, and GPX4</italic>). (<bold>F</bold>) Pseudotime trajectory analysis of PT clusters (PT and DA-PT-like cells). A region occupied with <italic>ALDOB</italic><sup>high</sup> cells were set as a starting state. Arrow, predicted trajectory from PT cells to DA-PT-like cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Characterization of human AKI kidney single-cell RNA-seq data.</title><p>(<bold>A</bold>) UMAP plots showing human AKI kidney cells from GSE145927 (43,998 cells). Data from the two non-rejecting AKI tissues were analyzed and integrated. We manually combined two clusters of differentiated proximal tubular cells (PT, state one and PT, state 2) into one cluster (PT) to generate a more coarse-grained cell-type annotation and data visualization. (<bold>B</bold>) Dot plot showing the gene expression patterns of cluster-enriched canonical markers. Note that DA-PT-like cells (PT, state 3) exhibit reduced expression of homeostatic genes (ex. <italic>LRP2</italic>, <italic>SLC34A1</italic>) but are enriched for damage-induced genes (ex. <italic>VCAM1</italic>, <italic>KRT8</italic>) as in the case of mouse damage-associated PT (DA-PT) cells. (<bold>C</bold>) UMAP rendering of signaling pathways. Note that genes for the glutathione-metabolic process are highly expressed in PT and gradually reduced towards DA-PT-like cells as in the predicted trajectory in <xref ref-type="fig" rid="fig6">Figure 6F</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig6-figsupp1-v2.tif"/></fig></fig-group><p>We then investigated whether molecularly similar damage-associated PT cells can be observed in human AKI. We analyzed scRNA-seq data from biopsy samples of two transplanted human kidneys with evidence of AKI and acute tubular injury but no evidence of rejection (GSE145927; <xref ref-type="fig" rid="fig6">Figure 6D</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>), (<xref ref-type="bibr" rid="bib52">Malone et al., 2020</xref>). We found a cell population that is enriched for genes expressed in mouse damage-associated PT cells, including <italic>SOX9</italic>, <italic>VCAM1</italic>, <italic>CDH6, and VIM</italic>. This cellular population also showed decreased expression of homeostatic PT genes (<italic>ALDOB</italic>, <italic>MIOX</italic>, and <italic>GPX4</italic>) (<xref ref-type="fig" rid="fig6">Figure 6</xref>, State 3; D, and E). Trajectory inference using Monocle 3 suggests that damage-associated PT cells emerge from mature differentiated PT cells with high expression of homeostatic genes in human kidneys (PT to DA-PT-like in <xref ref-type="fig" rid="fig6">Figure 6F</xref>). Interestingly, the glutathione metabolic gene signature is high in mature PT cells and decreases along the trajectory to DA-PT-like cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>). These data suggest that the emergence of damage-associated PT cells is a mechanism of acute kidney injury and repair that is shared by humans and mice.</p></sec><sec id="s2-5"><title>Genetic induction of ferroptotic stress results in accumulation of inflammatory PT cells after mild injury</title><p>Our data suggest that severe injury, which induces more oxidative and ferroptotic stress than mild injury, causes the accumulation of inflammatory damage-associated PT cells and worsens long-term renal outcomes. We hypothesized that ferroptotic stress plays a crucial role in driving the accumulation of inflammatory PT cells and promoting maladaptive repair in addition to triggering cell death (ferroptosis). To test this hypothesis, we generated a mouse model that selectively and conditionally deletes <italic>Gpx4</italic> in <italic>Sox9</italic>-lineage cells (<italic>Sox9<sup>IRES-CreERT2</sup>; Gpx4<sup>flox/flox</sup></italic>, hereafter conditional knockout [cKO]; <xref ref-type="fig" rid="fig7">Figure 7A</xref>). Genetic deletion of <italic>Gpx4</italic> robustly induces ferroptotic stress and triggers ferroptosis (<xref ref-type="bibr" rid="bib77">Yang et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Friedmann Angeli et al., 2014</xref>). In this mouse line, exons 4–7 of the <italic>Gpx4</italic> allele, which include the catalytically active selenocysteine site of the GPX4 protein, is deleted in a tamoxifen-inducible manner selectively in <italic>Sox9</italic>-lineage cells. We subjected the cKO mice and littermate control mice to mild renal ischemic stress (ischemic time 22 min). This condition induces robust <italic>Sox9-CreERT2</italic> expression but does not induce the failed renal repair phenotype in control mice (<italic>Gpx4</italic> <sup>flox/flox</sup>). We induced <italic>Gpx4</italic> deletion at the time of injury by tamoxifen injection (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). The littermate control mice were subjected to the same renal ischemic stress and tamoxifen. We confirmed successful deletion of GPX4 protein by immunofluorescence (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1, B and C</xref>) and found that expression of the ferroptotic stress marker ACSL4 was increased on day 21 post-IRI in cKO kidneys compared to littermate kidneys that underwent the same ischemic stress (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1, D and E</xref>). Contralateral uninjured kidneys from cKO mice only showed a minimum deletion of GPX4 as the <italic>Sox9-CreERT2</italic> activity is not induced in non-injured proximal tubular cells (See <xref ref-type="fig" rid="fig3">Figure 3B</xref> for CLK), (<xref ref-type="bibr" rid="bib40">Kumar et al., 2015</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Genetic induction of ferroptotic stress to <italic>Sox9</italic>-lineage cells augments kidney injury.</title><p>(<bold>A</bold>) Experimental workflow for <italic>Gpx4</italic> deletion in <italic>Sox9</italic>-lineage cells. uIRI, unilateral IRI (ischemic time 22 min). Kidneys were harvested on day 21 post-IRI. cKO mice and their littermate controls were subjected to the same ischemic stress and tamoxifen treatment. <italic>Gpx4</italic> is deleted in <italic>Sox9-</italic>lineage cells after IRI with tamoxifen administration. (<bold>B</bold>) The deletion of <italic>Gpx4</italic> results in renal atrophy. Relative size of post-IRI kidneys compared to contralateral kidneys (CLK) was quantified. Control, littermate control. N = 7. (<bold>C</bold>) and (<bold>D</bold>) Immunostaining for tubular injury markers (KIM1 and KRT8). IRI kidneys from cKO and control littermates are shown. CLK did not show KIM1 or KRT8 staining. Quantification of KIM1 or KRT8-positive area over the DAPI<sup>+</sup> area is shown in (<bold>D</bold>). N = 5–7. (<bold>E</bold>) and (<bold>F</bold>) Immunostaining for F4/80 and αSMA. IRI kidneys from cKO and control littermates are shown. Quantification of F4/80 or αSMA-positive area over the DAPI<sup>+</sup> area is shown in (<bold>F</bold>). N = 5–7. Insets: individual fluorescence channels of the dotted box area. (<bold>G</bold>) and (<bold>H</bold>) TUNEL staining for evaluating cell death. Quantification of TUNEL-positive nuclei is shown in (<bold>H</bold>). N = 4. Arrowheads, TUNEL<sup>+</sup> nuclei. Abbrev: hpf, high power field. Unpaired t-test for (<bold>D</bold>) and (<bold>F</bold>). One-way ANOVA with post hoc multiple comparison test for (<bold>H</bold>). Scale bars, 100 μm in (<bold>C</bold>) and (<bold>E</bold>); 20 μm in (<bold>G</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Genetic deletion of <italic>Gpx4</italic> leads to augmented ferroptotic stress after mild IRI.</title><p>(<bold>A</bold>) Experimental workflow for genetic deletion of <italic>Gpx4</italic> in <italic>Sox9</italic>-lineage cells. cKO mice and their littermate controls were subjected to the same ischemic stress (ischemic time, 22 min) and tamoxifen treatment. Kidneys were harvested on day 21 post-IRI. Note that <italic>Sox9</italic> is only induced in proximal tubular cells after IRI (<italic>Sox9</italic> gene is silenced in this tubular segment after the completion of renal development); therefore, <italic>Gpx4</italic> deletion occurs after injury in IRI kidneys with tamoxifen injection. The initial dose of tamoxifen was administered immediately before the surgical intervention. Left kidneys were subjected to mild (22 min) ischemia. Only littermate controls were used for phenotypic comparisons. (<bold>B</bold>) and (<bold>C</bold>) Immunostaining for GPX4 and quantification. GPX4 immunostaining confirms the deletion of GPX4 in IRI-kidneys from cKO mice (see IRI, cKO). Inlets show the higher magnification and single-color images of dotted areas. N = 5–7. (<bold>D</bold>) and (<bold>E</bold>) Immunostaining for ACSL4 and quantification. Inlets show the higher magnification and single-color images of dotted areas. N = 3–5. **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, one-way ANOVA with post hoc multiple comparisons test. Scale bars: 50 μm in (<bold>B</bold>) and (<bold>D</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig7-figsupp1-v2.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Genetic deletion of <italic>Gpx4</italic> leads to severe kidney injury after mild IRI.</title><p>(<bold>A</bold>) Experimental workflow for genetic deletion of <italic>Gpx4</italic> in <italic>Sox9</italic>-lineage cells. cKO mice and their littermate controls were subjected to the same ischemic stress (ischemic time, 22 min) and tamoxifen treatment. Kidneys were harvested on day 21 post-IRI. (<bold>B</bold>) Hematoxylin-eosin staining of IRI kidneys. Control; littermate controls. Representative images from IRI kidneys are shown. (<bold>C</bold>) Higher magnification images. Note that <italic>Gpx4</italic> deletion after mild IRI resulted in severe tubular dilatation, flattening of tubular epithelial cells, cast formation, and inflammatory cell infiltration. (<bold>D</bold>) Quantification of kidney injury score. N = 4–5. ****p &lt; 0.0001, one-way ANOVA with post hoc multiple comparisons test. Scale bars: 50 μm in (<bold>B</bold>); 20 μm in (<bold>C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig7-figsupp2-v2.tif"/></fig><fig id="fig7s3" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 3.</label><caption><title>Genetic deletion of <italic>Gpx4</italic> leads to the accumulation of damage-associated PT cells.</title><p>(<bold>A</bold>) and (<bold>B</bold>) Immunostaining for KIM1, KRT8, F4/80, and αSMA. Post-IRI kidneys on day 21 were analyzed. Note that <italic>Gpx4</italic> deletion increased tubular injury markers (KIM1 and KRT8) and led to the accumulation of myeloid cells (F4/80) and myofibroblasts (αSMA) in post-IRI kidneys from cKO mice on day 21 (ischemic time, 22 min). (<bold>C</bold>) Real-time PCR analyses of indicated genes. N = 6–7. *p &lt; 0.05; **p &lt; 0.01, one-way ANOVA with post-hoc multiple comparisons test. (<bold>D</bold>) Immunostaining for VCAM1, EMCN (endomucin), and F4/80 using post-IRI kidney on day 21. Note that VCAM1<sup>+</sup>EMCN<sup>–</sup>F4/80<sup>–</sup> cells (damage-associated PT cell state) accumulated in <italic>Gpx4</italic>-deleted kidneys after mild IRI on day 21. (<bold>E</bold>) In situ hybridization for <italic>Cdh6</italic> expression using post-IRI kidney on day 21. <italic>Cdh6</italic> is induced in tubular epithelial cells in <italic>Gpx4</italic>-deleted kidneys after mild IRI on day 21. Arrowheads: <italic>Cdh6</italic>+ tubular epithelial cells. These data indicate that damage-associated PT (DA-PT) cells accumulate even after mild IRI when the <italic>Gpx4</italic> gene is deleted. Note that littermate control kidneys underwent the same ischemic time (22 min) recovered without accumulating myofibroblasts, macrophages, and damage-associated PT cells, indicative of successful recovery. <italic>Gpx4</italic>-deleted kidneys underwent mild IRI (22 min ischemia) mimicked the failed renal repair phenotype observed after severe ischemic injury. Scale bars: 50 μm in (<bold>A</bold>), (<bold>B</bold>), and (<bold>D</bold>) and 20 μm in (<bold>E</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig7-figsupp3-v2.tif"/></fig><fig id="fig7s4" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 4.</label><caption><title>Genetic deletion of <italic>Gpx4</italic> leads to cell death of tubular epithelial cells.</title><p>(<bold>A</bold>) Experimental workflow for genetic deletion of <italic>Gpx4</italic> in <italic>Sox9</italic>-lineage cells. cKO mice and their littermate controls were subjected to the same ischemic stress (ischemic time, 22 min) and tamoxifen treatment. Kidneys were harvested on day 21 post-IRI. (<bold>B</bold>) TUNEL staining for evaluating cell death. The dotted areas are shown in <xref ref-type="fig" rid="fig7">Figure 7G</xref>. See quantification for <xref ref-type="fig" rid="fig7">Figure 7H</xref>. Scale bar, 50 μm. N=4. Arrows, TUNEL<sup>+</sup> nuclei.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig7-figsupp4-v2.tif"/></fig></fig-group><p>The post-ischemic cKO kidneys were atrophic and showed severe tubular injury on histological evaluation on day 21 and exhibited marked accumulation of KIM1<sup>+</sup>KRT8<sup>+</sup> injured tubular cells (<xref ref-type="fig" rid="fig7">Figure 7</xref>, B-D and <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). By contrast, control littermate kidneys that underwent the same ischemic stress exhibited resolution of histological changes and fewer KIM1<sup>+</sup>KRT8<sup>+</sup> cells (<xref ref-type="fig" rid="fig7">Figure 7</xref>, C and D, and <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). Contralateral kidneys from both genotypes showed neither increased KIM1 nor KRT8 expression (<xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3, A and C</xref>). The post-ischemic cKO kidneys also exhibited massive accumulation of F4/80<sup>+</sup> macrophages, αSMA<sup>+</sup> myofibroblasts, and increased collagen synthesis (<xref ref-type="fig" rid="fig7">Figure 7</xref>, E-F; <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3, B and C</xref>). Then, we assessed the number of cell death by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay, which detects ferroptotic cell death in <italic>Gpx4</italic>-deleted tissues (<xref ref-type="bibr" rid="bib22">Friedmann Angeli et al., 2014</xref>). Consistent with the known role of GPX4 to prevent ferroptosis, genetic deletion of <italic>Gpx4</italic> led to the increased TUNEL<sup>+</sup> tubular epithelial cells in cKO kidneys (<xref ref-type="fig" rid="fig7">Figure 7</xref>, G and H; See <xref ref-type="fig" rid="fig7s4">Figure 7—figure supplement 4</xref> for CLK). Collectively, these data indicate that genetic induction of ferroptotic stress in <italic>Sox9</italic>-lineage cells is sufficient to prevent normal renal repair after mild ischemic injury and to mimic the failed renal repair phenotype observed after severe ischemic injury.</p><p>We then investigated if the number of damage-associated PT cells was increased in the <italic>Gpx4</italic> cKO kidneys after mild ischemic injury. While VCAM1 is strongly induced in damage-associated PT cells and serves as a reliable marker, it is also expressed weakly in F4/80<sup>+</sup> macrophages and endomucin (EMCN)<sup>+</sup> endothelial cells after kidney injury (<xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6A</xref>; see UMAP). For the precise quantification of damage-associated PT cells, we co-stained the kidneys with VCAM1, EMCN, and F4/80, and scored VCAM1<sup>+</sup>F4/80<sup>–</sup>EMCN<sup>–</sup> cells as damage-associated PT cells (<xref ref-type="fig" rid="fig8">Figure 8</xref>, B and C; and <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3D</xref>). Supporting our hypothesis, we observed increased numbers of VCAM1<sup>+</sup>EMCN<sup>–</sup>F4/80<sup>–</sup> cells in post-ischemic cKO kidneys on day 21, while the value was at a baseline level in control littermate kidneys that underwent the same mild ischemic stress (<xref ref-type="fig" rid="fig8">Figure 8</xref>, B and C). We further employed a genetic fate-mapping strategy in <italic>Gpx4</italic>-deficient <italic>Sox9</italic>-lineage cells by generating a mouse line that harbors <italic>Sox9<sup>IRES-CreERT2</sup>; Gpx4<sup>flox/flox</sup>; Rosa26<sup>tdTomato</sup></italic> alleles. Confocal imaging identified the colocalization of tdTomato (<italic>Sox9</italic>-lineage) and VCAM1 and ACSL4 in the post-IRI cKO kidneys (<xref ref-type="fig" rid="fig8">Figure 8D</xref>). Other molecular markers of damage-associated PT cell state, such as <italic>Cdh6</italic> and <italic>Sox9</italic>, were also increased in cKO kidneys on day 21 post-IRI (<xref ref-type="fig" rid="fig8">Figure 8E</xref>). These VCAM1<sup>+</sup> cells were also positive for SOX9 (<xref ref-type="fig" rid="fig8">Figure 8F</xref>). In situ hybridization confirmed robust <italic>Cdh6</italic> expression in tubular epithelial cells in post-ischemic cKO kidneys (<xref ref-type="fig" rid="fig8">Figure 8G</xref> and <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3E</xref>). These data substantiate our model that ferroptotic stress drives the accumulation of damage-associated PT cells by preventing redifferentiation of these transient inflammatory epithelial cells into normal PT cell state and augments renal inflammation and fibrosis (<xref ref-type="fig" rid="fig8">Figure 8H</xref>).</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Genetic induction of ferroptotic stress induces the accumulation of damage-associated PT cells after mild injury.</title><p>(<bold>A</bold>) Schematic representation of experimental workflow. tdTomato-lineage tracing was employed to detect <italic>Sox9</italic>-lineage cells. cKO mice and their littermate controls were subjected to the same ischemic stress (ischemic time, 22 min) and tamoxifen treatment. Kidneys were harvested on day 21 post-IRI. (<bold>B</bold>) and (<bold>C</bold>) Immunostaining for VCAM1, EMCN (endomucin), and F4/80. IRI kidneys from cKO and control littermates (control) are shown. Quantification of VCAM1<sup>+</sup>EMCN<sup>–</sup>F4/80<sup>–</sup> area over the DAPI<sup>+</sup> area is shown in (<bold>C</bold>). N = 6. (<bold>D</bold>) Immunostaining for VCAM1, ACSL4, and native tdTomato (TdT) fluorescence. Insets: individual fluorescence channels. (<bold>E</bold>) Real-time PCR analyses of indicated gene expression. Whole kidney lysates were used. N = 6–7. *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001, one-way ANOVA with post hoc multiple comparisons test for (<bold>C</bold>) and (<bold>E</bold>). (<bold>F</bold>) Immunostaining for SOX9 and VCAM1. Arrowheads indicate double-positive cells (damage-associated PT cells). (<bold>G</bold>) ISH for <italic>Cdh6</italic> expression. Red arrowheads indicate <italic>Cdh6</italic>-positive renal tubular cells. Scale bars, 100 μm in (<bold>B</bold>); 20 μm in (<bold>D</bold>); 50 μm in (<bold>F</bold>); and 10 μm in (<bold>G</bold>). (<bold>H</bold>) Schematic illustration of PT cell state dynamics. Differentiated/mature PT cells are activated, transit into a damage-associated inflammatory PT cell state (DA-PT), and redifferentiate to their original state after mild injury. Ferroptotic stress prevents the redifferentiation of damage-associated PT cells into normal PT cell state, leading to the accumulation of the pathologic PT cells that actively produce inflammatory signals.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig8-v2.tif"/></fig></sec><sec id="s2-6"><title>Pharmacological inhibition of ferroptotic stress prevents the accumulation of inflammatory PT cells and ferroptosis after ischemia-reperfusion injury</title><p>We next investigated whether pharmacological inhibition of ferroptosis blunts the dynamic changes seen in proximal tubular cells. We administered liproxstatin-1, an in vivo active ferroptosis inhibitor that scavenges lipid peroxides (<xref ref-type="bibr" rid="bib22">Friedmann Angeli et al., 2014</xref>), to our cKO mice that underwent mild renal ischemia (<xref ref-type="fig" rid="fig9">Figure 9A</xref>). The same volume of vehicle solution (1% dimethyl sulfoxide in phosphate-buffered saline) was administered to cKO and littermate controls (<italic>Gpx4<sup>flox/flox</sup></italic>), and these animals underwent the same procedure of unilateral IRI. While vehicle-treated IRI-kidneys of control genotype did not show renal atrophy, cKO IRI-kidneys with daily vehicle injections exhibited renal atrophy (<xref ref-type="fig" rid="fig9">Figure 9B</xref>). We further confirmed effective genetic targeting in our cKO IRI-kidneys from the vehicle and liproxstatin-1-treated groups by using tdTomato-lineage tracing and GPX4 immunohistochemistry (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1, B and C</xref>). Daily administration of liproxstatin-1 potently mitigated the renal atrophy and reduced expression of renal tubular injury markers in cKO IRI-kidneys (KIM1 and KRT8; <xref ref-type="fig" rid="fig9">Figure 9</xref>, B-D; <xref ref-type="fig" rid="fig9s2">Figure 9—figure supplement 2</xref>). Notably, liproxstatin-1 prevented the accumulation of SOX9+VCAM1+ proximal tubular cells (<xref ref-type="fig" rid="fig9">Figure 9</xref>, E and F). Quantitative RT-PCR analyses confirmed that the expression of <italic>Sox9</italic>, <italic>Vcam1</italic>, and <italic>Cdh6</italic> (DA-PT markers) were all reduced by liproxstatin-1 to the same level as in contralateral uninjured kidneys (<xref ref-type="fig" rid="fig9">Figure 9G</xref>). Moreover, TUNEL staining showed a significant reduction of TUNEL+ cells in the liproxstatin-1-treated IRI-cKO kidneys compared to the vehicle-treated IRI-cKO kidneys (<xref ref-type="fig" rid="fig9">Figure 9</xref>, H and I). Collectively, liproxstatin-1 potently ameliorated the pathologic changes of proximal tubular cells and overall damage of <italic>Gpx4</italic>-deficient kidneys that underwent IRI (<xref ref-type="fig" rid="fig9">Figure 9J</xref>).</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Pharmacological inhibition of ferroptotic stress blunts the accumulation of damage-associated PT cells and cell death.</title><p>(<bold>A</bold>) Schematic representation of experimental workflow. All mice (cKO and control littermates) were subjected to the same ischemic stress (ischemic time, 22 min, unilateral IRI) and tamoxifen treatment. The same volume of vehicle was administered to the control groups (control vehicle and cKO vehicle). Kidneys were harvested on day 21 post-IRI. (<bold>B</bold>) Liproxstatin-1 prevents renal atrophy. Relative size of post-IRI kidneys compared to contralateral kidneys (CLK) was quantified. Control, littermate control. N = 4–5. (<bold>C and D</bold>) Immunostaining for KIM1 and KRT8. IRI kidneys from cKO are shown. Quantification of immunostained area over the DAPI<sup>+</sup> area is shown in (<bold>D</bold>). N = 4–5. (<bold>E and F</bold>) Immunostaining for SOX9 and VCAM1. Quantification of VCAM1<sup>+</sup>EMCN<sup>–</sup>F4/80<sup>–</sup> area over the DAPI<sup>+</sup> area is shown in (<bold>F</bold>). Arrowheads indicate damage-associated PT cells. (<bold>G</bold>) Real-time PCR analyses of indicated gene expression. Whole kidney lysates were used. N = 4–5. (<bold>H</bold>) and (<bold>I</bold>) TUNEL staining for evaluating cell death. Quantification of TUNEL-positive nuclei is shown in (<bold>I</bold>). N = 4–5. Red arrowheads indicate TUNEL+ tubular epithelial cells. Scale bars, 50 μm in (<bold>C</bold>) and (<bold>E</bold>); and 20 μm in (<bold>H</bold>). *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001, unpaired t-test for (<bold>D</bold>), (<bold>F</bold>). and (<bold>I</bold>); One-way ANOVA with post hoc multiple comparisons test for (<bold>G</bold>). (<bold>J</bold>) Liproxstatin-1 improves renal repair after IRI.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig9-v2.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>Liproxstatin-1 potently reduced ferroptotic stress in the absence of GPX4.</title><p>(<bold>A</bold>) Experimental workflow for liproxstatin-1 (Lip-1) treatment to <italic>Gpx4</italic> cKO mice. cKO mice and their littermate controls were subjected to the same ischemic stress (ischemic time, 22 min) and tamoxifen treatment. The same volume of vehicle was administered to cKO mice and littermate Cre-negative mice. Kidneys were harvested on day 21 post-IRI. (<bold>B</bold>) Distribution of tdTomato-expressing cells (<italic>Sox9</italic>-lineage cells) in contralateral (CLK) and IRI kidneys on day 21. Note that liproxstatin-1-treated kidneys and vehicle-treated kidneys show comparable targeting (n=three for vehicle, and n=two for liproxstatin-1). (<bold>C</bold>) Immunostaining for GPX4 and quantification. GPX4 immunostaining confirms the deletion of GPX4 in IRI-kidneys from cKO mice both vehicle and liproxstatin-1-treated group. N = 4–5. (<bold>D</bold>) Immunostaining for ACSL4 and quantification using kidneys from cKO mice (day 21 post-IRI). Liproxstatin-1 treatment reduced the expression of ACSL4 in IRI kidneys in the absence of GPX4. p&lt;0.05, unpaired t-test. Scale bars, 100 μm in (<bold>B</bold>) and 50 μm in (<bold>C</bold>) and (<bold>D</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig9-figsupp1-v2.tif"/></fig><fig id="fig9s2" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 2.</label><caption><title>Liproxstatin-1 potently mitigated ferroptotic stress-induced pathologic changes in the absence of GPX4.</title><p>(<bold>A</bold>) Experimental workflow for liproxstatin-1 (Lip-1) treatment to <italic>Gpx4</italic> cKO mice. cKO mice and their littermate controls were subjected to the same ischemic stress (ischemic time, 22 min) and tamoxifen treatment. The same volume of vehicle was administered to cKO mice and littermate Cre-negative mice. Kidneys were harvested on day 21 post-IRI. IRI, ischemia-reperfusion-injured kidneys. CLK, contralateral kidneys. (<bold>B</bold>) and (<bold>C</bold>) Immunostaining for KIM1 and LTL in <italic>Sox9</italic>-lineage-tagged kidneys. <italic>Sox9</italic>-lineage cells express native tdTomato red fluorescence (TdT). Note that liproxstatin-1 treatment potently reduced the expression of KIM1 and restored the expression of LTL in tdTomato-positive cells in ischemia-reperfusion-injured cKO kidneys. Insets: individual fluorescence channels. Note that Inlets show the higher magnification and single-color images of dotted areas. (<bold>D</bold>) TUNEL staining for evaluating cell death. The dotted areas are shown in <xref ref-type="fig" rid="fig9">Figure 9H</xref>. See quantification for <xref ref-type="fig" rid="fig9">Figure 9I</xref>. N=4–5. Arrows, TUNEL<sup>+</sup> nuclei. Scale bars, 50 μm in (<bold>B</bold>) – (<bold>D</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-fig9-figsupp2-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>By using complementary scRNA-seq and mouse genetic approaches in several experimental models of renal injury and repair, our study revealed novel mechanisms regulating proximal tubular cell states that underlie renal repair and regeneration. By detailed characterization of damage-associated PT cells in our single-cell map of failed repair, we identified that this PT state significantly downregulates the canonical anti-ferroptosis defense pathway, making them potentially vulnerable to ferroptotic stress. Genetic induction of ferroptotic stress after mild injury was sufficient to prevent the redifferentiation of damage-associated PT cells into the normal PT cell state, leading to the accumulation and persistence of inflammatory PT cells that promote maladaptive repair. Our data collectively advances our understanding of the ferroptotic cell death pathway by identifying a novel role of ferroptotic stress in promoting and accumulating pathologic cellular state beyond its known role to trigger non-apoptotic regulated cell death (ferroptosis). GPX4 is a key coordinator of proximal tubular cell fate for renal repair and regeneration by preventing both cell death and cell death-independent pathologic changes after IRI.</p><p>Unbiased clustering of cells clearly separates damage-associated PT cells from homeostatic and activated differentiated PT cells, indicating that damage-associated PT cells represent a unique cellular status. We also found a molecularly similar PT cell state in kidneys of patients with acute kidney injury. Similar to our current findings, we and others have identified the emergence of molecularly distinct epithelial cells during the process of lung injury and repair (<xref ref-type="bibr" rid="bib38">Kobayashi et al., 2020</xref>; <xref ref-type="bibr" rid="bib12">Choi et al., 2020</xref>; <xref ref-type="bibr" rid="bib69">Strunz et al., 2020</xref>). These novel transient cells are termed as pre-alveolar type-1 transitional cell state (PATS), alveolar differentiation intermediate, and damage-associated transient progenitors. They originate from alveolar type two epithelial cells and differentiate into type one alveolar epithelial cells (<xref ref-type="bibr" rid="bib38">Kobayashi et al., 2020</xref>; <xref ref-type="bibr" rid="bib12">Choi et al., 2020</xref>; <xref ref-type="bibr" rid="bib69">Strunz et al., 2020</xref>). PATS and PATS-like cells in humans accumulate during failed lung repair and fibrosis (<xref ref-type="bibr" rid="bib38">Kobayashi et al., 2020</xref>), as in the case of maladaptive repair of kidneys. Molecular mechanisms underlying the accumulation of these transitional cell state include hypoxia, inflammation, and DNA damage. All these pathways promote maladaptive renal repair by altering PT cell states (<xref ref-type="bibr" rid="bib68">Strausser et al., 2018</xref>; <xref ref-type="bibr" rid="bib48">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib21">Ferenbach and Bonventre, 2015</xref>; <xref ref-type="bibr" rid="bib37">Kishi et al., 2019</xref>). These data suggest that the emergence of molecularly distinct epithelial cell states and their persistence/accumulation is a general mechanism of maladaptive repair in multiple organs across mice and humans.</p><p>The complexity of proximal tubular cell states in renal injury and repair processes has been recently identified at single-cell resolution (<xref ref-type="bibr" rid="bib36">Kirita et al., 2020</xref>; <xref ref-type="bibr" rid="bib65">Rudman-Melnick et al., 2020</xref>). A recent study investigated PT cellular heterogeneity using single-nucleus RNA sequencing in a mouse model of bilateral renal IRI. The paper revealed multiple novel PT cellular states, ranging from severely injured cells, cells repairing from injury, and cells undergoing failed repair (<xref ref-type="bibr" rid="bib36">Kirita et al., 2020</xref>). Interestingly, the damage-associated PT cells reported here shares some of the transcriptional signatures with so-called failed repair proximal tubular cells (FR-PTC), such as <italic>Vcam1, Cp, Akap12, and Dcdc2a</italic> among the Top 20 transcriptional signature of FR-PTC. In contrast, we also found some differences between the damage-associated PT cells and FR-PTC. The most highly expressed genes in FR-PTC (ex. <italic>Kcnip4, Dock10, Pdgfd, Erbb4, and Psd3</italic>) were not expressed in damage-associated PT cells and vice versa. Moreover, damage-associated PT cells act like a transient cell state. They redifferentiate to the homeostatic PT cell state after mild injury while they accumulate after severe injury. Damage-associated PT cells may represent a broad transient cell state, including FR-PTC.</p><p>Another study profiled juvenile (4-week-old) mouse kidneys that underwent 30 min unilateral IRI (<xref ref-type="bibr" rid="bib65">Rudman-Melnick et al., 2020</xref>). Unlike adult kidneys, the kidneys at this stage showed marked regenerative ability and showed successful repair. The study found transient induction of nephrogenic transcriptional signature (ex. <italic>Sox4</italic>, <italic>Cd24a</italic>, <italic>Npnt</italic>, <italic>Lhx1, Osr2, Foxc1, Hes1, Pou3f3, and Sox9</italic>) in damaged PT cells during the injury–repair process (<xref ref-type="bibr" rid="bib65">Rudman-Melnick et al., 2020</xref>). While our transcriptional analyses of damage-associated PT cells indicate they are in a dedifferentiated state, they do not show a nephrogenic signature at the level of damaged juvenile kidneys (i.e. damage-associated PT cells were positive for <italic>Sox4, Npnt</italic>, and <italic>Cd24a</italic>, and <italic>Sox9</italic>, but negative for <italic>Lhx1, Osr2, Foxc1, Hes1, and Pou3f3</italic>). The differences in reactivation of developmental genes between adult and juvenile kidneys may underlie the age-dependent decline of reparative capacity of mouse and human kidneys. Future studies testing the proximal tubular heterogeneity and spatiotemporal dynamics in additional renal injury models in young and aged animals may offer further insights into molecular mechanisms governing proximal tubular cell plasticity and identify therapeutic targets.</p><p>It has been largely believed that ferroptotic stress reduces functional renal epithelial cells by intercellular propagation of ferroptotic cell death (synchronized cell death) and induces so-called necroinflammation (<xref ref-type="bibr" rid="bib47">Linkermann et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Friedmann Angeli et al., 2014</xref>; <xref ref-type="bibr" rid="bib46">Li et al., 2019</xref>; <xref ref-type="bibr" rid="bib69">Strunz et al., 2020</xref>). Consistent with this notion, we observed the accumulation of TUNEL<sup>+</sup> tubular epithelial cells in cKO kidneys. In addition to inducing ferroptosis in some tubular epithelial cells, to our surprise, our genetic knockout studies showed that excess ferroptotic stress in regenerating PT cells drives the accumulation, but not reduction, of damage-associated PT cells that augment renal inflammation. Specific gene-expression signatures indicate that damage-associated PT cells are not merely severely injured cells on the pathway to cell death but a unique functional cell state. The cells are enriched for expression of renal developmental genes such as <italic>Sox4</italic> and <italic>Sox9</italic>. SOX9 is a previously described transcription factor essential for renal repair (<xref ref-type="bibr" rid="bib34">Kang et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Kumar et al., 2015</xref>), and SOX4 regulates epithelial mesenchymal transition in different disease contexts (<xref ref-type="bibr" rid="bib72">Tiwari et al., 2013</xref>). Moreover, damage-associated PT cells are actively involved in renal inflammation by interacting with myeloid cells through producing cytokines and chemokines. Thus, ferroptotic stress not only promotes the alteration of cell state but makes it irreversible, leading to the pathologic accumulation of cells that actively produce inflammatory and fibrogenic signals.</p><p>In summary, our study broadens the roles of ferroptotic stress from one that is restricted to the induction of regulated cell death (ferroptosis) to include the promotion and accumulation of a pathologic cell state, processes that underlie maladaptive repair. Understanding the molecular mechanisms by which ferroptotic stress controls these processes in vivo would open a new avenue for currently available and prospective anti-ferroptotic reagents to enhance tissue repair/regeneration in multiple organs. Our studies provide a scientific foundation for future mechanistic and translational studies to enhance renal repair and regeneration by modulating anti-ferroptotic stress pathways to prevent AKI to CKD transition in patients.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top">C57BL/6J</td><td valign="top">The Jackson laboratory</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:020940">IMSR_JAX:020940</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Sox9<sup>IRESCreERT2</sup></italic></td><td valign="top">The Jackson laboratory</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:4947114">MGI:4947114</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Rosa26<sup>tdTomato</sup></italic></td><td valign="top">The Jackson laboratory</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:007914">IMSR_JAX:007914</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Gpx4<sup>flox</sup></italic></td><td valign="top">The Jackson laboratory</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX">IMSR_JAX</ext-link>: 027964</td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-SOX9 (Rabbit monoclonal)</td><td valign="top">Abcam <break/>(ab196450)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2665383">AB_2665383</ext-link></td><td valign="top">Clone EPR14335 <break/>IF: 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-SOX9 (Rabbit monoclonal)</td><td valign="top">Abcam <break/>(ab185966)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2728660">AB_2728660</ext-link></td><td valign="top">Clone EPR14335-78 <break/>IF: 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-KIM1 <break/>(goat polyclonal)</td><td valign="top">R and D systems <break/>(AF1817)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2116446">AB_2116446</ext-link></td><td valign="top">IF: 1:400</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-NGAL <break/>(rat monoclonal)</td><td valign="top">Abcam <break/>(ab70287)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2136473">AB_2136473</ext-link></td><td valign="top">IF: 1:400</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-GPX4 (Rabbit monoclonal)</td><td valign="top">Abcam <break/>(ab125066)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10973901">AB_10973901</ext-link></td><td valign="top">Clone EPNCIR144 <break/>IF: 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-F4/80 (Rat monoclonal)</td><td valign="top">Bio-Rad <break/>(MCA497)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2098196">AB_2098196</ext-link></td><td valign="top">Clone C1:A3-1 <break/>IF: 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Endomucin (Rat monoclonal)</td><td valign="top">Abcam <break/>(ab106100)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10859306">AB_10859306</ext-link></td><td valign="top">Clone V.7C7.1 <break/>IF: 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-KRT8 <break/>(Rat monoclonal)</td><td valign="top">DSHB <break/>(TROMA-I)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_531826">AB_531826</ext-link></td><td valign="top">IF: 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-αSMA <break/>(mouse monoclonal)</td><td valign="top">Sigma <break/>(C6198)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_476856">AB_476856</ext-link></td><td valign="top">Clone 1A4 <break/>IF: 1:200</td></tr><tr><td valign="top">Reagent, commercial</td><td valign="top">LTL</td><td valign="top">Vector laboratories <break/>(B-1325 and FL-1321)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2336558">AB_2336558</ext-link></td><td valign="top">IF: 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-MDA <break/>(rabbit polyclonal)</td><td valign="top">Abcam <break/>(Ab6463)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_305484">AB_305484</ext-link></td><td valign="top">IF: 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-ACSL4 <break/>(rabbit monocolonal)</td><td valign="top">Abcam <break/>(Ab204380) <break/>(Ab155282)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2714020">AB_2714020</ext-link></td><td valign="top">Clone: EPR8640 <break/>IF: 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-VCAM1 <break/>(rabbit monocolonal)</td><td valign="top">CST <break/>39036S <break/>39301S</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2799146">AB_2799146</ext-link></td><td valign="top">Clone: D8U5V <break/>IF: 1:100</td></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">RNAScope probe-Mm-Cdh6</td><td valign="top">Advance Cell Diagnosis <break/>(Cat. 519541)</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">RNAscope Intro Pack 2.5 HD Reagent Kit Brown Mm</td><td valign="top">Advance Cell Diagnosis <break/>(Cat. 322371)</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">software, algorithm</td><td valign="top">ImageJ</td><td valign="top">NIH, <break/>Bethesda, MD <break/>(Version 1.52P)</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003070">SCR_003070</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">GraphPad Prism</td><td valign="top"/><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Seurat</td><td valign="top"/><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016341">SCR_016341</ext-link></td><td valign="top"><xref ref-type="bibr" rid="bib70">Stuart et al., 2019</xref> <break/><ext-link ext-link-type="uri" xlink:href="https://satijalab.org/seurat/get_started.html">https://satijalab.org/seurat/get_started.html</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Monocle 3</td><td valign="top"/><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_018685">SCR_018685</ext-link></td><td valign="top"><xref ref-type="bibr" rid="bib8">Cao et al., 2019</xref> <ext-link ext-link-type="uri" xlink:href="https://cole-trapnell-lab.github.io/monocle3/">https://cole-trapnell-lab.github.io/monocle3/</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Velocyto.R</td><td valign="top"/><td valign="top"/><td valign="top"><xref ref-type="bibr" rid="bib42">La Manno et al., 2018</xref> <break/><ext-link ext-link-type="uri" xlink:href="https://github.com/velocyto-team/velocyto.R">https://github.com/velocyto-team/velocyto.R</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">NicheNet</td><td valign="top"/><td valign="top"/><td valign="top"><xref ref-type="bibr" rid="bib6">Browaeys et al., 2020</xref> <break/><ext-link ext-link-type="uri" xlink:href="https://github.com/saeyslab/nichenetr/blob/master/vignettes/seurat_wrapper.md">https://github.com/saeyslab/nichenetr/blob/master/vignettes/seurat_wrapper.md</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">RStudio</td><td valign="top"/><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_000432">SCR_000432</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://www.rstudio.com/">http://www.rstudio.com/</ext-link></td></tr><tr><td valign="top">Commercial reagnet</td><td valign="top">Liberase</td><td valign="top">Roche <break/>(291963)</td><td valign="top"/><td valign="top">0.3 mg/ml</td></tr><tr><td valign="top">Commercial reagnet</td><td valign="top">Hyaluronidase</td><td valign="top">Sigma <break/>(H4272)</td><td valign="top"/><td valign="top">10 μg/mL</td></tr><tr><td valign="top">Commercial reagnet</td><td valign="top">Trypsin</td><td valign="top">Corning <break/>(45000–664)</td><td valign="top"/><td valign="top">0.25%</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Tamoxifen</td><td valign="top">Sigma <break/>(T5648)</td><td valign="top"/><td valign="top">100 mg/kg</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Liproxstatin-1</td><td valign="top">Selleckchem <break/>(S7699)</td><td valign="top"/><td valign="top">10 mg/kg</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Aristolochic acid</td><td valign="top">Sigma <break/>(A9451)</td><td valign="top"/><td valign="top">6 mg/kg</td></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">TUNEL staining</td><td valign="top">Abcam <break/>(Ab206386)</td><td valign="top"/><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>All animal experiments were approved by the Institutional Animal Care and Use Committee at Duke University and performed according to the IACUC-approved protocol (A051-18-02 and A014-21-01) and adhered to the NIH Guide for the Care and Use of Laboratory Animals. The following mouse lines were used for our study; <italic>Sox9<sup>IRES-CreERT2,</sup></italic> (<xref ref-type="bibr" rid="bib24">Furuyama et al., 2011</xref>), <italic>Rosa26<sup>tdTomato</sup></italic> (Jackson lab, stock #007914), (<xref ref-type="bibr" rid="bib50">Madisen et al., 2010</xref>), <italic>Gpx4<sup>flox</sup></italic> (Jackson lab, stock# 027964), (<xref ref-type="bibr" rid="bib78">Yoo et al., 2012</xref>), and C57BL/6J (Jackson lab, stock #000664). Mice were backcrossed into a C57BL/6J background at least three times and maintained in our specific-pathogen-free facility. Timed deletion of the <italic>Gpx4</italic> gene and fate-mapping was achieved using <italic>Sox9<sup>IRES-CreERT2</sup></italic> knock-in mouse line with three doses of intraperitoneal injections of tamoxifen (100 mg/kg body weight, Sigma, St. Louis MO) on alternate days. The first dose of tamoxifen was administered immediately before the surgical intervention. All tested animals were included in data analyses, and outliers were not excluded. To avoid confounding effects of age and strain background, littermate controls were used for all phenotype analyses of genetically modified mouse lines. Animals were allocated randomly into the experimental groups and analyses. The operators were blinded to mouse genotypes when inducing surgical injury models. To determine experimental sample sizes to observe significant differences reproducibly, data from our previous studies were used to estimate the required numbers. The number of biological replicates is represented by N in each figure legend. Experiments were performed on at least three biological replicates.</p></sec><sec id="s4-2"><title>Mouse models of renal injury and repair</title><p>Adult male mice aged between 8 and 16 weeks were used for all the models described below. The mice were euthanized, and kidneys were harvested for analyses. For the unilateral IRI (uIRI) model, ischemia was induced by the retroperitoneal approach on the left kidney for 20 min (mild IRI), 22 min (mild IRI in cKO studies), or 30 min (severe IRI) by an atraumatic vascular clip (Roboz, RS-5435, Gaithersburg, MD), as previously reported (<xref ref-type="bibr" rid="bib58">Nezu et al., 2017</xref>; <xref ref-type="bibr" rid="bib23">Fu et al., 2018</xref>). Mice were anesthetized with isoflurane and provided preemptive analgesics (buprenorphine SR). The body temperature of mice was monitored and maintained on a heat-controlled surgical pad. For the bilateral IRI (bIRI) model, ischemia was induced by the retroperitoneal approach on both kidneys for 22 min. The mice were received intraperitoneal injections of 500 μl of normal saline at the end of surgery. For the unilateral ureteral obstruction (UUO) model, the left ureter was tied at the level of the lower pole of the kidney, and the kidneys were harvested on day 10. For the aristolochic acid nephropathy (AAN) model, we used acute and chronic models, as we previously described (<xref ref-type="bibr" rid="bib63">Ren et al., 2020</xref>). For the acute AAN model, three doses of 6 mg/kg body weight aristolochic acid (Sigma, A9451) in phosphate-buffered saline (PBS) were administered daily intraperitoneally to the male mice. For the chronic AAN model, six doses of 6 mg/kg body weight aristolochic acid in phosphate-buffered saline (PBS) were administered on alternate days over 2 weeks intraperitoneally to the male mice. The same volume of PBS was injected to control animals (<xref ref-type="bibr" rid="bib63">Ren et al., 2020</xref>; <xref ref-type="bibr" rid="bib17">Dickman et al., 2011</xref>). Contralateral kidneys (CLK), sham-treated kidneys, and vehicle-injected kidneys were used as controls depending on the models used. The numbers and dates of treatment are indicated in the individual figure legends and experimental schemes. Operators were blinded to mouse genotypes when inducing surgical injury models.</p></sec><sec id="s4-3"><title>Pharmacological inhibition of ferroptosis</title><p>Mice were randomly assigned to vehicle (1% dimethyl sulfoxide in phosphate-buffered saline) and liproxstatin-1 (10 mg/kg, Selleckchem, S7699, <xref ref-type="bibr" rid="bib22">Friedmann Angeli et al., 2014</xref>) groups. Liproxstatin-1 and vehicle were administered daily by intraperitoneal injections starting from 1 hr before renal ischemia. All the mice were subjected to the same ischemic stress (22 min ischemic time, unilateral IRI model) and tamoxifen treatment. The mice were euthanatized, and kidneys were harvested on day 21 after IRI.</p></sec><sec id="s4-4"><title>Droplet-based scRNA-seq</title><p>Mice were transcardially perfused with ice-cold PBS, and the kidneys were harvested. The kidneys were dissociated with liberase TM (0.3 mg/mL, Roche, Basel, Switzerland, #291963), hyaluronidase (10 μg/mL, Sigma, H4272), DNaseI (20 μg/mL) at 37°C for 40 min, followed by incubation with 0.25% trypsin EDTA at 37°C for 30 min. Trypsin was inactivated using 10% fetal bovine serum in PBS. Cells were then resuspended in PBS supplemented with 0.01% bovine serum albumin. Our protocol yielded high cell viability (&gt;95%) and very few doublets, enabling us to avoid the use of flow cytometry-based cell sorting. After filtration through a 40 μm strainer, cells at a concentration of 100 cells/μl were run through microfluidic channels along with mRNA capture beads and droplet-generating oil, as previously described (<xref ref-type="bibr" rid="bib38">Kobayashi et al., 2020</xref>; <xref ref-type="bibr" rid="bib49">Macosko et al., 2015</xref>). cDNA libraries were generated and sequenced using HiSeq X Ten with 150 bp paired-end sequencing. Each condition contains the cells from three mice to minimize potential biological and technical variability.</p></sec><sec id="s4-5"><title>Data preprocessing, unsupervised clustering, and cell type annotation of Drop-Seq data</title><p>Analysis of the scRNA-seq of mouse kidneys was performed by processing FASTQ files using dropSeqPipe v0.3 and mapped on the GRCm38 genome reference with annotation version 91. Unique molecular identifier (UMI) counts were then further analyzed using an R package Seurat v.3.06 for quality control, dimensionality reduction, and cell clustering (<xref ref-type="bibr" rid="bib70">Stuart et al., 2019</xref>). The scRNA-seq matrices were filtered by custom cutoff (genes expressed in &gt;3 cells and cells expressing more than 500 and less than 3000 detected genes were included) to remove potential empty droplets and doublets. Relationships between the number of UMI/cell and genes/cell were comparable across the condition (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>). After quality control filtration and normalization using SCTransform (<xref ref-type="bibr" rid="bib26">Hafemeister and Satija, 2019</xref>), UMI count matrices from post-IRI kidneys and homeostatic kidneys were integrated using Seurat’s integration and label transfer method, which corrects potential batch effects (<xref ref-type="bibr" rid="bib70">Stuart et al., 2019</xref>). The integrated dataset was used for all the analyses. To remove an additional confounding source of variation, the mitochondrial mapping percentage was regressed out. The number of principal components (PC) for downstream analyses were determined using elbow plot to identify knee point, and we included the first 25 PCs for the downstream analyses. A graph-based clustering approach in Seurat was used to cluster the cells in our integrated dataset. The resolution was set at 1.0 for the mouse integrated dataset. Cluster-defining markers for each cluster were obtained using the Seurat FindAllMarkers command (genes at least expressed in 25% of cells within the cluster, log fold change&gt; 0.25) with the Wilcoxon Rank Sum test (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Based on the marker genes and manual curation of the gene expression pattern of canonical marker genes in UMAP plots (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>), we assigned a cell identity to each cluster. Ambiguous clusters were shown as unknown. We manually combined 3 clusters of differentiated proximal tubular cells (PT, S1/S2 and PT, S2/S3; <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>) into one cluster (PT) to generate a more coarse-grained cell-type annotation and data visualization. We also combined three clusters of endothelial cells (Endo-1, Endo-2, and Endo-3; <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>) into one cluster (Endo) for data visualization.</p></sec><sec id="s4-6"><title>Data preprocessing, unsupervised clustering, and cell type annotation of mouse neonatal kidneys</title><p>The RDS files for mouse neonatal kidneys (postnatal day 1) were obtained from Gene Expression Omnibus (GEO accession number: GSE94333, GSM2473317), (<xref ref-type="bibr" rid="bib1">Adam et al., 2017</xref>). Data were analyzed as in our mouse kidney dataset using Seurat and SCTransform (<xref ref-type="bibr" rid="bib70">Stuart et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Hafemeister and Satija, 2019</xref>). We included the first 17 PCs for the downstream analyses of mouse neonatal kidneys. A graph-based clustering approach in Seurat was used to cluster the cells. The resolution was set at 0.8. Based on the marker genes and manual curation of the gene expression pattern of canonical marker genes in UMAP plots (<xref ref-type="fig" rid="fig1s7">Figure 1—figure supplement 7</xref>), we assigned a cell identity to each cluster. The anchor genes for assigning cell identity were obtained from previous single-cell transcriptome analyses of the developing mouse kidneys (<xref ref-type="bibr" rid="bib1">Adam et al., 2017</xref>; <xref ref-type="bibr" rid="bib15">Combes et al., 2019b</xref>).</p></sec><sec id="s4-7"><title>Data preprocessing, unsupervised clustering, and cell type annotation of human kidneys</title><p>The RDS files for human kidneys were obtained from Gene Expression Omnibus (GEO accession number: GSE131882 and GSE145927), (<xref ref-type="bibr" rid="bib52">Malone et al., 2020</xref>; <xref ref-type="bibr" rid="bib75">Wilson et al., 2019</xref>). Normal human kidney data was originated from two macroscopically normal nephrectomy samples without renal mass (GSE131882; GSM3823939 and GSM3823941), (<xref ref-type="bibr" rid="bib75">Wilson et al., 2019</xref>). Human AKI kidney data was originated from two biopsy-samples of transplant kidneys with evidence of AKI and acute tubular injury but no evidence of rejection (GSE145927; GSM4339775 and GSM4339778), (<xref ref-type="bibr" rid="bib52">Malone et al., 2020</xref>). Data were integrated and analyzed as in the mouse kidney analyses using Seurat’s integration method and SCTransform (<xref ref-type="bibr" rid="bib70">Stuart et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Hafemeister and Satija, 2019</xref>). We included the first 25 PCs for the downstream analyses of human normal and AKI kidneys. A graph-based clustering approach in Seurat was used to cluster the cells. The resolution was set at 0.5 for normal human kidneys and 1.0 for the human AKI kidneys. Based on the marker genes and manual curation of the gene expression pattern of canonical marker genes in UMAP plots (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), we assigned a cell identity to each cluster. The anchor genes for assigning cell identity were obtained from previous single-cell transcriptome analyses of the human kidneys (<xref ref-type="bibr" rid="bib52">Malone et al., 2020</xref>; <xref ref-type="bibr" rid="bib75">Wilson et al., 2019</xref>; <xref ref-type="bibr" rid="bib66">Stewart et al., 2019</xref>).</p></sec><sec id="s4-8"><title>Differential gene expression analyses and Gene ontology (GO) enrichment analyses</title><p>To predict the cellular functions based on enriched gene signature, we performed gene-ontology enrichment analyses. Differentially expressed genes obtained using FindMarkers command in Seurat were used for identifying signaling pathways and gene ontology through Enricher (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> and <xref ref-type="supplementary-material" rid="supp3">3</xref>; <xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5B</xref>), (<xref ref-type="bibr" rid="bib39">Kuleshov et al., 2016</xref>). To visualize the overrepresented signaling pathways, scaled data in the integrated Seurat object were extracted. Then, mean values of the scaled score of gene members in each GO class were calculated and shown in UMAP (<xref ref-type="bibr" rid="bib38">Kobayashi et al., 2020</xref>). The gene member lists of signaling pathways were obtained from AmiGO 2 (<xref ref-type="bibr" rid="bib3">AmiGO Hub et al., 2009</xref>). Log<sub>2</sub> fold changes and <italic>P</italic>-values of each gene extracted using FindMarkers command in Seurat with Wilcoxon rank sum test were shown in a volcano plot using an R package EnhancedVolcano v1.4.0 (<xref ref-type="bibr" rid="bib5">Blighe et al., 2021</xref>; <ext-link ext-link-type="uri" xlink:href="https://github.com/kevinblighe/EnhancedVolcano">https://github.com/kevinblighe/EnhancedVolcano</ext-link>), (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5B</xref>). Top 100 genes in mature and early PT cell clusters were obtained using the ‘FindMarkers’ command in Seurat. These genes were visualized on the UMAP plots using the scaled score as in GO class visualization.</p></sec><sec id="s4-9"><title>RNA velocity analyses</title><p>To infer future states of individual cells, we performed RNA velocity analyses (<xref ref-type="bibr" rid="bib42">La Manno et al., 2018</xref>) using single-time point dataset of post-IRI kidney on day 7. The aligned BAM files were used as input for Velocyto to obtain the counts of unspliced and spliced reads in loom format. Cell barcodes for the clusters of interests (PT and DA-PT) were extracted and utilized for velocyto run command in velocyto.py v0.17.15, as well as for generating RNA velocity plots using velocyto.R v0.6 in combination with an R package SeuratWrappers v0.2.0 (<xref ref-type="bibr" rid="bib70">Stuart et al., 2019</xref>; <ext-link ext-link-type="uri" xlink:href="https://github.com/satijalab/seurat-wrappers">https://github.com/satijalab/seurat-wrappers</ext-link>). Twenty-five nearest neighbors in slope calculation smoothing were used for RunVelocity command.</p></sec><sec id="s4-10"><title>Pseudotime trajectory analyses</title><p>To infer the dynamic cellular process during injury and repair, we performed single-cell trajectory analyses. We first extracted the clusters of interests (PT and DA-PT) from our integrated Seurat object of mouse kidneys and utilized for Monocle 3 (version 0.2.3.0) analyses with default parameters to identify a pseudotime trajectory with SeuratWrappers v0.2.0 (<xref ref-type="bibr" rid="bib8">Cao et al., 2019</xref>; <xref ref-type="bibr" rid="bib73">Trapnell et al., 2014</xref>). We set the starting states in two different approaches. We used the UMAP space area occupied by cells from the earliest time point of IRI kidneys (6 hr post-IRI, <xref ref-type="fig" rid="fig1">Figure 1F</xref>) and the area occupied by the cells with high expression of genes that are highly expressed in differentiated PT cells, such as <italic>Slc34a1</italic> (<xref ref-type="fig" rid="fig1s8">Figure 1—figure supplement 8B</xref>) as the starting state, respectively. Both approaches resulted in similar trajectory inference. For the human AKI dataset, we extracted the clusters of interests (PT and DA-PT-like) from our integrated Seurat object and applied the Monocle 3 algorithm with default parameters. We used the UMAP space area occupied by the cells with high expression of homeostatic genes (<italic>ALDOB</italic>), (<xref ref-type="fig" rid="fig6">Figure 6F</xref>).</p></sec><sec id="s4-11"><title>Intercellular communication analyses using NicheNet</title><p>To predict the intercellular communication process between damage-associated PT (DA-PT) cells and myeloid cells (monocytes and macrophages), we performed NicheNet analyses based on the analytical pipeline (<xref ref-type="bibr" rid="bib6">Browaeys et al., 2020</xref>; <ext-link ext-link-type="uri" xlink:href="https://github.com/saeyslab/nichenetr/blob/master/vignettes/seurat_wrapper.md">https://github.com/saeyslab/nichenetr/blob/master/vignettes/seurat_wrapper.md</ext-link>) using an R package nichenetr (version 1.0.0) with default parameters (<xref ref-type="bibr" rid="bib6">Browaeys et al., 2020</xref>). Based on high enrichment of chemokines and cytokines in DA-PT cells and the observed positive association between the numbers of macrophages and DA-PT cells in severely injured kidneys, we surmised that they have a close molecular interaction. We used NicheNet to predict the ligand-receptor pairs that are most likely to explain the target gene expression in renal myeloid cells after IRI. We defined DA-PT cells as the ‘sender/niche’ cell population and myeloid cells as the ‘receiver/target’ cell population in our integrated Seurat object for these analyses. We defined the differentially expressed genes in monocytes or macrophages in IRI-kidneys compared to homeostatic kidneys as the gene sets of interest that were affected by predicted ligand-receptor interactions.</p></sec><sec id="s4-12"><title>Tissue collection and histology</title><p>Kidneys were prepared as described previously (<xref ref-type="bibr" rid="bib58">Nezu et al., 2017</xref>; <xref ref-type="bibr" rid="bib31">Ide et al., 2020</xref>). For cryosections (7 μm), the tissues were fixed with 4% paraformaldehyde in PBS at 4°C for 4 hr and then processed through a sucrose gradient. Kidneys were embedded in OCT compound for sectioning. For paraffin sections (5 μm), the tissues were fixed with 10% neutral buffered formalin overnight at 4°C and processed at Substrate Services Core and Research Support at Duke. Sections were blocked (animal-free blocker with 0.5% triton x-100) for 30 min and incubated with the primary antibodies overnight at 4°C. Primary antibodies used were as follows: SOX9 (Abcam, Cambridge, UK, ab196450 or ab185966, 1:200), KIM1 (R and D Systems, Minneapolis, MN, AF1817, 1:400), NGAL (Abcam, ab70287, 1:400), F4/80 (Bio-rad, Hercules, CA, MCA497G, 1:200), α-SMA (Sigma, C6198, 1:200), LTL (Vector, Burlingame, CA, B-1325 or FL-1321, 1:200), KRT8 (DSHB, TROMA-I, 1:200), MDA (Abcam, ab6463, 1:200), ACSL4 (Abcam, ab204380 or ab155282, 1:200), EMN (Abcam, 106100, 1:200), VCAM1 (CST, 39036S or 33901S, 1:100), and GPX4 (Abcam, ab125066, 1:200). Alexa Fluor-labeled secondary antibodies were used appropriately for immunofluorescence. ImmPRES HRP reagent kit was used for immunohistochemistry (Vector, MP-7401). Nuclei were stained with DAPI (1:400, Sigma). Heat-induced antigen retrieval was performed using pH 6.0 sodium citrate solution (eBioscience). Experiments for RNAScope in situ hybridization (Advanced Cell Diagnostics, ACD, Newark, CA) was performed as recommended by the manufacturer. Mm-Cdh6 (ACD, 519541) was used. Images were captured using Axio imager and 780 confocal microscopes (Zeiss, Oberkochen, Germany). Paraffin-sections were stained with hematoxylin and eosin (H and E). The kidney injury score was calculated as we previously reported (<xref ref-type="bibr" rid="bib63">Ren et al., 2020</xref>). TUNEL staining was performed following the manufacturer’s instruction (Abcam, ab206386). To ensure the TUNEL signal’s specificity, we used sections treated with DNase I as a positive control and a section treated without terminal deoxynucleotidyl transferase as a negative control, as recommended by the manufacturer. Sections were counterstained with methyl green. More than three randomly selected areas from at least three kidneys were imaged and quantified using ImageJ (<xref ref-type="bibr" rid="bib31">Ide et al., 2020</xref>). The stitched large area was used for quantification to alleviate the selection bias in the acquisition of images. All representative images were from more than three kidneys tested.</p></sec><sec id="s4-13"><title>RNA extraction and real-time quantitative PCR</title><p>Total RNA was extracted from kidneys using the TRIzol reagent (Invitrogen, 15596026). Three μg of total RNA was then reverse transcribed with Maxima H minus cDNA synthesis master mix (Invitrogen, M1662). Equivalent amounts of diluted cDNA from each sample were analyzed with Real-time PCR with the primers listed below using the Powerup SYBR Green reagent (Invitrogen, A25776) on a QuantStudio three real-time PCR systems (Thermo). 18S rRNA expression was used to normalize samples using the ΔΔCT-method.</p></sec><sec id="s4-14"><title>Statistical analysis</title><p>Statistical analyses were conducted using GraphPad Prism software. Two-tailed unpaired Student’s t-test was used for two groups, and one-way analysis of variance (ANOVA) followed by Sidak multiple comparison test was used for more than two groups. All results are represented as means ± SE. A p value less than 0.05 was considered statistically significant.</p><p>Additional protocols are available in the supplementary method.</p><p>Primers used for quantitative PCR.</p><list list-type="simple"><list-item> <p><italic>Sox9</italic>: Fw-<named-content content-type="sequence">GAGCCGGATCTGAAGAGGGA</named-content>, Rv-<named-content content-type="sequence">GCTTGACGTGTGGCTTGTTC</named-content></p> </list-item> <list-item> <p><italic>Vcam1</italic>: Fw-<named-content content-type="sequence">TCTTACCTGTGCGCTGTGAC</named-content>, Rv-<named-content content-type="sequence">ACTGGATCTTCAGGGAATGAGT</named-content></p> </list-item> <list-item> <p><italic>Cdh6</italic>: Fw-<named-content content-type="sequence">CCAATATTCACCAAGGACGTTTA</named-content>, Rv-<named-content content-type="sequence">CGTGACTTGGACCACAAATG</named-content></p> </list-item> <list-item> <p><italic>Acsm2</italic>: Fw-<named-content content-type="sequence">CCAAGATGGCAGAACACTCC</named-content>, Rv-<named-content content-type="sequence">TCAGAAGTACTCAGGCCTGTCC</named-content></p> </list-item> <list-item> <p><italic>Icam1</italic>: Fw-<sc><named-content content-type="sequence">GCTACCATCACCGTGTATTCG</named-content></sc>, Rv-<named-content content-type="sequence">AGGTCCTTGCCTACTTGCTG</named-content></p> </list-item> <list-item> <p><italic>Pdgfb</italic>: Fw-<named-content content-type="sequence">CGAGGGAGGAGGAGCCTA</named-content>, Rv-<named-content content-type="sequence">GTCTTGCACTCGGCGATTA</named-content></p> </list-item> <list-item> <p><italic>Apoe</italic>: Fw-<named-content content-type="sequence">TTGGTCACATTGCTGACAGG</named-content>, Rv-<named-content content-type="sequence">AGCGCAGGTAATCCCAGAA</named-content></p> </list-item> <list-item> <p><italic>Havcr1</italic>: Fw-<named-content content-type="sequence">AAACCAGAGATTCCCACACG</named-content>, Rv-<named-content content-type="sequence">GTCGTGGGTCTTCCTGTAGC</named-content></p> </list-item> <list-item> <p><italic>Lcn2</italic>: Fw-<named-content content-type="sequence">CAAGCAATACTTCAAAATTACCCTGTA</named-content>, Rv-<named-content content-type="sequence">GCAAAGCGGGTGAAACGTT</named-content></p> </list-item> <list-item> <p><italic>Acta2</italic>: Fw-<named-content content-type="sequence">CCCACCCAGAGTGGAGAA</named-content>, Rv-<named-content content-type="sequence">ACATAGCTGGAGCAGCGTCT</named-content></p> </list-item> <list-item> <p><italic>Slc34a1</italic>: Fw-<named-content content-type="sequence">CTCATTCGGATTTGGTGTCA</named-content>, Rv-<sc><named-content content-type="sequence">GGCCTCTACCCTGGACATAGA</named-content></sc></p> </list-item> <list-item> <p><italic>Krt8</italic>: Fw-<named-content content-type="sequence">CTGAGCTTGGCAACATGC</named-content>, Rv-<named-content content-type="sequence">ACGCTTGTTGATCTCATCCTC</named-content></p> </list-item> <list-item> <p><italic>18S rRNA</italic>: Fw-<named-content content-type="sequence">CGGCTACCACATCCAAGGAA</named-content>, Rv-<named-content content-type="sequence">GCTGGAATTACCGCGGCT</named-content></p> </list-item></list><p>Genotyping primers.</p><list list-type="simple"><list-item> <p><italic>Cre</italic>, Fw: <named-content content-type="sequence">GTGCAAGTTGAATAACCGGAAATGG</named-content>,</p></list-item> <list-item><p>Cre, Rv: <named-content content-type="sequence">AGAGTCATCCTTAGCGCCGTAAATCAAT</named-content></p> </list-item> <list-item> <p><italic>Gpx4 <sup>flox</sup></italic>, wt: <named-content content-type="sequence">CTGCAACAGCTCCGAGTTC</named-content></p> </list-item> <list-item> <p><italic>Gpx4 <sup>flox</sup></italic>, common: <named-content content-type="sequence">CGGTGCCAAAGAAAGAAAGT</named-content></p> </list-item> <list-item> <p><italic>Gpx4 <sup>flox</sup></italic>, mut: <named-content content-type="sequence">CCAGTAAGCAGTGGGTTCTC</named-content></p> </list-item> <list-item> <p><italic>Rosa26<sup>tdTomato</sup></italic>, Fw: <named-content content-type="sequence">CTGTTCCTGTACGGCATGG</named-content></p> </list-item> <list-item> <p><italic>Rosa26<sup>tdTomato</sup></italic>, Rv-<named-content content-type="sequence">GGCATTAAAGCAGCGTATCC</named-content></p> </list-item> <list-item> <p><italic>Rosa26<sup>wt</sup></italic>, Fw: <named-content content-type="sequence">AAGGGAGCTGCAGTGGAGTA</named-content></p> </list-item> <list-item> <p><italic>Rosa26<sup>wt</sup></italic>, Rv: <named-content content-type="sequence">CCGAAAATCTGTGGGAAGTC</named-content>.</p></list-item></list></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Drs. Brigid Hogan and Myles Wolf for critical advice and helpful suggestions on the manuscript. We also thank Dr. Helene F Kirshner (Duke Center for Genomic and Computational Biology) for her bioinformatical support on our single-cell transcriptome dataset. The monoclonal antibody against keratin 8 (TROMA-1, developed by Drs. P Brulet and R Kemeler) was obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at the Department of Biology, The University of Iowa. We thank Drs. Tetsuhiro Yokonishi (Duke University), Leslie Gewin and Kensei Taguchi (Vanderbilt University), and members of the Crowley lab for their technical advice. This study was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK123097), a pilot award from the Northwestern University George M O’Brien Kidney Research Core Center (P30 DK114857), the American Society of Nephrology Carl W Gottschalk Career Developmental Grant, and Duke Nephrology Start-up Fund to TS. SI, YK, and KI are supported in part by fellowship grants from the American Heart Association, Japan Society for the Promotion of Science, and the Astellas Foundation for Research on Metabolic Disorders, respectively. Imaging was performed at the Duke Light Microscopy Core Facility supported by the shared instrumentation grant (1S10RR027528-01).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Investigation, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Resources, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Resources, Supervision, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: All animal experiments were approved by the Institutional Animal Care and Use Committee at Duke University and performed according to the IACUC-approved protocols (A051-18-02 and A014-21-01) and adhered to the NIH Guide for the Care and Use of Laboratory.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Cluster-enriched genes in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-68603-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Differentially expressed genes in PT cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-68603-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Gene ontology analyses of PT cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-68603-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-68603-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession codes GSE161201.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Ide</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name><name><surname>Ide</surname><given-names>K</given-names></name><name><surname>Strausser</surname><given-names>SA</given-names></name><name><surname>Herbek</surname><given-names>S</given-names></name><name><surname>O'Brien</surname><given-names>LL</given-names></name><name><surname>Crowley</surname><given-names>SD</given-names></name><name><surname>Barisoni</surname><given-names>L</given-names></name><name><surname>Tata</surname><given-names>A</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name><name><surname>Soum</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Ferroptotic stress promotes the accumulation of pro-inflammatory proximal tubular cells in maladaptive renal repair</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE161201">GSE161201</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Adam</surname><given-names>M</given-names></name><name><surname>Potter</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>The use of cold active proteases can dramatically reduce single cell RNA-seq gene expression artifacts</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE94333">GSE94333</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>PC</given-names></name><name><surname>Humphreys</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>The Single Cell Transcriptomic Landscape of Early Human Diabetic Nephropathy</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131882">GSE131882</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Malone</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Single Cell Transcriptional Analysis of Donor and Recipient Immune Cell Chimerism in the Rejecting Kidney Transplant</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145927">GSE145927</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname> <given-names>M</given-names></name><name><surname>Potter</surname> <given-names>AS</given-names></name><name><surname>Potter</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Psychrophilic proteases dramatically reduce single-cell RNA-seq artifacts: a molecular atlas of kidney development</article-title><source>Development</source><volume>144</volume><fpage>3625</fpage><lpage>3632</lpage><pub-id pub-id-type="doi">10.1242/dev.151142</pub-id><pub-id pub-id-type="pmid">28851704</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alim</surname> <given-names>I</given-names></name><name><surname>Caulfield</surname> <given-names>JT</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Swarup</surname> <given-names>V</given-names></name><name><surname>Geschwind</surname> <given-names>DH</given-names></name><name><surname>Ivanova</surname> <given-names>E</given-names></name><name><surname>Seravalli</surname> <given-names>J</given-names></name><name><surname>Ai</surname> <given-names>Y</given-names></name><name><surname>Sansing</surname> <given-names>LH</given-names></name><name><surname>Ste Marie</surname> <given-names>EJ</given-names></name><name><surname>Hondal</surname> <given-names>RJ</given-names></name><name><surname>Mukherjee</surname> <given-names>S</given-names></name><name><surname>Cave</surname> <given-names>JW</given-names></name><name><surname>Sagdullaev</surname> <given-names>BT</given-names></name><name><surname>Karuppagounder</surname> <given-names>SS</given-names></name><name><surname>Ratan</surname> <given-names>RR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke</article-title><source>Cell</source><volume>177</volume><fpage>1262</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.03.032</pub-id><pub-id pub-id-type="pmid">31056284</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>AmiGO Hub</collab><collab>Web Presence Working Group</collab><name><surname>Carbon</surname> <given-names>S</given-names></name><name><surname>Ireland</surname> <given-names>A</given-names></name><name><surname>Mungall</surname> <given-names>CJ</given-names></name><name><surname>Shu</surname> <given-names>S</given-names></name><name><surname>Marshall</surname> <given-names>B</given-names></name><name><surname>Lewis</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>AmiGO: online access to ontology and annotation data</article-title><source>Bioinformatics</source><volume>25</volume><fpage>288</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btn615</pub-id><pub-id pub-id-type="pmid">19033274</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname> <given-names>K</given-names></name><name><surname>Bangen</surname> <given-names>JM</given-names></name><name><surname>Hammerich</surname> <given-names>L</given-names></name><name><surname>Liedtke</surname> <given-names>C</given-names></name><name><surname>Floege</surname> <given-names>J</given-names></name><name><surname>Smeets</surname> <given-names>B</given-names></name><name><surname>Moeller</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Origin of regenerating tubular cells after acute kidney injury</article-title><source>PNAS</source><volume>111</volume><fpage>1533</fpage><lpage>1538</lpage><pub-id pub-id-type="doi">10.1073/pnas.1316177111</pub-id><pub-id pub-id-type="pmid">24474779</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Blighe</surname> <given-names>K</given-names></name><name><surname>Rana</surname> <given-names>S</given-names></name><name><surname>Lewis</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling</data-title><source>R Package Version 1.10.0</source><ext-link ext-link-type="uri" xlink:href="https://github.com/kevinblighe/EnhancedVolcano">https://github.com/kevinblighe/EnhancedVolcano</ext-link></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browaeys</surname> <given-names>R</given-names></name><name><surname>Saelens</surname> <given-names>W</given-names></name><name><surname>Saeys</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>NicheNet: modeling intercellular communication by linking ligands to target genes</article-title><source>Nature Methods</source><volume>17</volume><fpage>159</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0667-5</pub-id><pub-id pub-id-type="pmid">31819264</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canaud</surname> <given-names>G</given-names></name><name><surname>Brooks</surname> <given-names>CR</given-names></name><name><surname>Kishi</surname> <given-names>S</given-names></name><name><surname>Taguchi</surname> <given-names>K</given-names></name><name><surname>Nishimura</surname> <given-names>K</given-names></name><name><surname>Magassa</surname> <given-names>S</given-names></name><name><surname>Scott</surname> <given-names>A</given-names></name><name><surname>Hsiao</surname> <given-names>LL</given-names></name><name><surname>Ichimura</surname> <given-names>T</given-names></name><name><surname>Terzi</surname> <given-names>F</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Bonventre</surname> <given-names>JV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cyclin G1 and TASCC regulate kidney epithelial cell G2-M arrest and fibrotic maladaptive repair</article-title><source>Science Translational Medicine</source><volume>11</volume><elocation-id>eaav4754</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aav4754</pub-id><pub-id pub-id-type="pmid">30674655</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname> <given-names>J</given-names></name><name><surname>Spielmann</surname> <given-names>M</given-names></name><name><surname>Qiu</surname> <given-names>X</given-names></name><name><surname>Huang</surname> <given-names>X</given-names></name><name><surname>Ibrahim</surname> <given-names>DM</given-names></name><name><surname>Hill</surname> <given-names>AJ</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Mundlos</surname> <given-names>S</given-names></name><name><surname>Christiansen</surname> <given-names>L</given-names></name><name><surname>Steemers</surname> <given-names>FJ</given-names></name><name><surname>Trapnell</surname> <given-names>C</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The single-cell transcriptional landscape of mammalian organogenesis</article-title><source>Nature</source><volume>566</volume><fpage>496</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0969-x</pub-id><pub-id pub-id-type="pmid">30787437</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chawla</surname> <given-names>LS</given-names></name><name><surname>Amdur</surname> <given-names>RL</given-names></name><name><surname>Amodeo</surname> <given-names>S</given-names></name><name><surname>Kimmel</surname> <given-names>PL</given-names></name><name><surname>Palant</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The severity of acute kidney injury predicts progression to chronic kidney disease</article-title><source>Kidney International</source><volume>79</volume><fpage>1361</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1038/ki.2011.42</pub-id><pub-id pub-id-type="pmid">21430640</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chawla</surname> <given-names>LS</given-names></name><name><surname>Eggers</surname> <given-names>PW</given-names></name><name><surname>Star</surname> <given-names>RA</given-names></name><name><surname>Kimmel</surname> <given-names>PL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Acute kidney injury and chronic kidney disease as interconnected syndromes</article-title><source>New England Journal of Medicine</source><volume>371</volume><fpage>58</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1214243</pub-id><pub-id pub-id-type="pmid">24988558</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>EA</given-names></name><name><surname>Patterson</surname> <given-names>LT</given-names></name><name><surname>Brookhiser</surname> <given-names>WT</given-names></name><name><surname>Mah</surname> <given-names>S</given-names></name><name><surname>Kintner</surname> <given-names>C</given-names></name><name><surname>Dressler</surname> <given-names>GR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Differential expression and function of cadherin-6 during renal epithelium development</article-title><source>Development</source><volume>125</volume><fpage>803</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1242/dev.125.5.803</pub-id><pub-id pub-id-type="pmid">9449663</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>J</given-names></name><name><surname>Park</surname> <given-names>JE</given-names></name><name><surname>Tsagkogeorga</surname> <given-names>G</given-names></name><name><surname>Yanagita</surname> <given-names>M</given-names></name><name><surname>Koo</surname> <given-names>BK</given-names></name><name><surname>Han</surname> <given-names>N</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Inflammatory signals induce AT2 Cell-Derived Damage-Associated transient progenitors that mediate alveolar regeneration</article-title><source>Cell Stem Cell</source><volume>27</volume><fpage>366</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.06.020</pub-id><pub-id pub-id-type="pmid">32750316</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cippà</surname> <given-names>PE</given-names></name><name><surname>Sun</surname> <given-names>B</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Naesens</surname> <given-names>M</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transcriptional trajectories of human kidney injury progression</article-title><source>JCI Insight</source><volume>3</volume><elocation-id>123151</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.123151</pub-id><pub-id pub-id-type="pmid">30429361</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combes</surname> <given-names>AN</given-names></name><name><surname>Zappia</surname> <given-names>L</given-names></name><name><surname>Er</surname> <given-names>PX</given-names></name><name><surname>Oshlack</surname> <given-names>A</given-names></name><name><surname>Little</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Single-cell analysis reveals congruence between kidney organoids and human fetal kidney</article-title><source>Genome Medicine</source><volume>11</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-019-0615-0</pub-id><pub-id pub-id-type="pmid">30674341</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combes</surname> <given-names>AN</given-names></name><name><surname>Phipson</surname> <given-names>B</given-names></name><name><surname>Lawlor</surname> <given-names>KT</given-names></name><name><surname>Dorison</surname> <given-names>A</given-names></name><name><surname>Patrick</surname> <given-names>R</given-names></name><name><surname>Zappia</surname> <given-names>L</given-names></name><name><surname>Harvey</surname> <given-names>RP</given-names></name><name><surname>Oshlack</surname> <given-names>A</given-names></name><name><surname>Little</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Single cell analysis of the developing mouse kidney provides deeper insight into marker gene expression and ligand-receptor crosstalk</article-title><source>Development</source><volume>146</volume><elocation-id>dev178673</elocation-id><pub-id pub-id-type="doi">10.1242/dev.182162</pub-id><pub-id pub-id-type="pmid">31118232</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniels</surname> <given-names>BP</given-names></name><name><surname>Snyder</surname> <given-names>AG</given-names></name><name><surname>Olsen</surname> <given-names>TM</given-names></name><name><surname>Orozco</surname> <given-names>S</given-names></name><name><surname>Oguin</surname> <given-names>TH</given-names></name><name><surname>Tait</surname> <given-names>SWG</given-names></name><name><surname>Martinez</surname> <given-names>J</given-names></name><name><surname>Gale</surname> <given-names>M</given-names></name><name><surname>Loo</surname> <given-names>YM</given-names></name><name><surname>Oberst</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RIPK3 restricts viral pathogenesis via cell Death-Independent neuroinflammation</article-title><source>Cell</source><volume>169</volume><fpage>301</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.03.011</pub-id><pub-id pub-id-type="pmid">28366204</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickman</surname> <given-names>KG</given-names></name><name><surname>Sweet</surname> <given-names>DH</given-names></name><name><surname>Bonala</surname> <given-names>R</given-names></name><name><surname>Ray</surname> <given-names>T</given-names></name><name><surname>Wu</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Physiological and molecular characterization of aristolochic acid transport by the kidney</article-title><source>Journal of Pharmacology and Experimental Therapeutics</source><volume>338</volume><fpage>588</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1124/jpet.111.180984</pub-id><pub-id pub-id-type="pmid">21546538</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname> <given-names>SJ</given-names></name><name><surname>Lemberg</surname> <given-names>KM</given-names></name><name><surname>Lamprecht</surname> <given-names>MR</given-names></name><name><surname>Skouta</surname> <given-names>R</given-names></name><name><surname>Zaitsev</surname> <given-names>EM</given-names></name><name><surname>Gleason</surname> <given-names>CE</given-names></name><name><surname>Patel</surname> <given-names>DN</given-names></name><name><surname>Bauer</surname> <given-names>AJ</given-names></name><name><surname>Cantley</surname> <given-names>AM</given-names></name><name><surname>Yang</surname> <given-names>WS</given-names></name><name><surname>Morrison</surname> <given-names>B</given-names></name><name><surname>Stockwell</surname> <given-names>BR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Ferroptosis: an iron-dependent form of nonapoptotic cell death</article-title><source>Cell</source><volume>149</volume><fpage>1060</fpage><lpage>1072</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.03.042</pub-id><pub-id pub-id-type="pmid">22632970</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname> <given-names>S</given-names></name><name><surname>Proneth</surname> <given-names>B</given-names></name><name><surname>Tyurina</surname> <given-names>YY</given-names></name><name><surname>Panzilius</surname> <given-names>E</given-names></name><name><surname>Kobayashi</surname> <given-names>S</given-names></name><name><surname>Ingold</surname> <given-names>I</given-names></name><name><surname>Irmler</surname> <given-names>M</given-names></name><name><surname>Beckers</surname> <given-names>J</given-names></name><name><surname>Aichler</surname> <given-names>M</given-names></name><name><surname>Walch</surname> <given-names>A</given-names></name><name><surname>Prokisch</surname> <given-names>H</given-names></name><name><surname>Trümbach</surname> <given-names>D</given-names></name><name><surname>Mao</surname> <given-names>G</given-names></name><name><surname>Qu</surname> <given-names>F</given-names></name><name><surname>Bayir</surname> <given-names>H</given-names></name><name><surname>Füllekrug</surname> <given-names>J</given-names></name><name><surname>Scheel</surname> <given-names>CH</given-names></name><name><surname>Wurst</surname> <given-names>W</given-names></name><name><surname>Schick</surname> <given-names>JA</given-names></name><name><surname>Kagan</surname> <given-names>VE</given-names></name><name><surname>Angeli</surname> <given-names>JP</given-names></name><name><surname>Conrad</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition</article-title><source>Nature Chemical Biology</source><volume>13</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2239</pub-id><pub-id pub-id-type="pmid">27842070</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Famulski</surname> <given-names>KS</given-names></name><name><surname>de Freitas</surname> <given-names>DG</given-names></name><name><surname>Kreepala</surname> <given-names>C</given-names></name><name><surname>Chang</surname> <given-names>J</given-names></name><name><surname>Sellares</surname> <given-names>J</given-names></name><name><surname>Sis</surname> <given-names>B</given-names></name><name><surname>Einecke</surname> <given-names>G</given-names></name><name><surname>Mengel</surname> <given-names>M</given-names></name><name><surname>Reeve</surname> <given-names>J</given-names></name><name><surname>Halloran</surname> <given-names>PF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Molecular phenotypes of acute kidney injury in kidney transplants</article-title><source>Journal of the American Society of Nephrology</source><volume>23</volume><fpage>948</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1681/ASN.2011090887</pub-id><pub-id pub-id-type="pmid">22343120</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferenbach</surname> <given-names>DA</given-names></name><name><surname>Bonventre</surname> <given-names>JV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD</article-title><source>Nature Reviews Nephrology</source><volume>11</volume><fpage>264</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1038/nrneph.2015.3</pub-id><pub-id pub-id-type="pmid">25643664</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedmann Angeli</surname> <given-names>JP</given-names></name><name><surname>Schneider</surname> <given-names>M</given-names></name><name><surname>Proneth</surname> <given-names>B</given-names></name><name><surname>Tyurina</surname> <given-names>YY</given-names></name><name><surname>Tyurin</surname> <given-names>VA</given-names></name><name><surname>Hammond</surname> <given-names>VJ</given-names></name><name><surname>Herbach</surname> <given-names>N</given-names></name><name><surname>Aichler</surname> <given-names>M</given-names></name><name><surname>Walch</surname> <given-names>A</given-names></name><name><surname>Eggenhofer</surname> <given-names>E</given-names></name><name><surname>Basavarajappa</surname> <given-names>D</given-names></name><name><surname>Rådmark</surname> <given-names>O</given-names></name><name><surname>Kobayashi</surname> <given-names>S</given-names></name><name><surname>Seibt</surname> <given-names>T</given-names></name><name><surname>Beck</surname> <given-names>H</given-names></name><name><surname>Neff</surname> <given-names>F</given-names></name><name><surname>Esposito</surname> <given-names>I</given-names></name><name><surname>Wanke</surname> <given-names>R</given-names></name><name><surname>Förster</surname> <given-names>H</given-names></name><name><surname>Yefremova</surname> <given-names>O</given-names></name><name><surname>Heinrichmeyer</surname> <given-names>M</given-names></name><name><surname>Bornkamm</surname> <given-names>GW</given-names></name><name><surname>Geissler</surname> <given-names>EK</given-names></name><name><surname>Thomas</surname> <given-names>SB</given-names></name><name><surname>Stockwell</surname> <given-names>BR</given-names></name><name><surname>O'Donnell</surname> <given-names>VB</given-names></name><name><surname>Kagan</surname> <given-names>VE</given-names></name><name><surname>Schick</surname> <given-names>JA</given-names></name><name><surname>Conrad</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice</article-title><source>Nature Cell Biology</source><volume>16</volume><fpage>1180</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1038/ncb3064</pub-id><pub-id pub-id-type="pmid">25402683</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>Y</given-names></name><name><surname>Tang</surname> <given-names>C</given-names></name><name><surname>Cai</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>G</given-names></name><name><surname>Zhang</surname> <given-names>D</given-names></name><name><surname>Dong</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Rodent models of AKI-CKD transition</article-title><source>American Journal of Physiology-Renal Physiology</source><volume>315</volume><fpage>F1098</fpage><lpage>F1106</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00199.2018</pub-id><pub-id pub-id-type="pmid">29949392</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuyama</surname> <given-names>K</given-names></name><name><surname>Kawaguchi</surname> <given-names>Y</given-names></name><name><surname>Akiyama</surname> <given-names>H</given-names></name><name><surname>Horiguchi</surname> <given-names>M</given-names></name><name><surname>Kodama</surname> <given-names>S</given-names></name><name><surname>Kuhara</surname> <given-names>T</given-names></name><name><surname>Hosokawa</surname> <given-names>S</given-names></name><name><surname>Elbahrawy</surname> <given-names>A</given-names></name><name><surname>Soeda</surname> <given-names>T</given-names></name><name><surname>Koizumi</surname> <given-names>M</given-names></name><name><surname>Masui</surname> <given-names>T</given-names></name><name><surname>Kawaguchi</surname> <given-names>M</given-names></name><name><surname>Takaori</surname> <given-names>K</given-names></name><name><surname>Doi</surname> <given-names>R</given-names></name><name><surname>Nishi</surname> <given-names>E</given-names></name><name><surname>Kakinoki</surname> <given-names>R</given-names></name><name><surname>Deng</surname> <given-names>JM</given-names></name><name><surname>Behringer</surname> <given-names>RR</given-names></name><name><surname>Nakamura</surname> <given-names>T</given-names></name><name><surname>Uemoto</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine</article-title><source>Nature Genetics</source><volume>43</volume><fpage>34</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/ng.722</pub-id><pub-id pub-id-type="pmid">21113154</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gewin</surname> <given-names>LS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Renal fibrosis: primacy of the proximal tubule</article-title><source>Matrix Biology</source><volume>68-69</volume><fpage>248</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2018.02.006</pub-id><pub-id pub-id-type="pmid">29425694</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafemeister</surname> <given-names>C</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression</article-title><source>Genome Biology</source><volume>20</volume><elocation-id>296</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-019-1874-1</pub-id><pub-id pub-id-type="pmid">31870423</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauser</surname> <given-names>IA</given-names></name><name><surname>Riess</surname> <given-names>R</given-names></name><name><surname>Hausknecht</surname> <given-names>B</given-names></name><name><surname>Thüringer</surname> <given-names>H</given-names></name><name><surname>Sterzel</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Expression of cell adhesion molecules in primary renal disease and renal allograft rejection</article-title><source>Nephrology Dialysis Transplantation</source><volume>12</volume><fpage>1122</fpage><lpage>1131</lpage><pub-id pub-id-type="doi">10.1093/ndt/12.6.1122</pub-id><pub-id pub-id-type="pmid">9198039</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname> <given-names>CC</given-names></name><name><surname>Kao</surname> <given-names>WH</given-names></name><name><surname>Coresh</surname> <given-names>J</given-names></name><name><surname>Pankow</surname> <given-names>JS</given-names></name><name><surname>Marsh-Manzi</surname> <given-names>J</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Bray</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Apolipoprotein E and progression of chronic kidney disease</article-title><source>Jama</source><volume>293</volume><fpage>2892</fpage><lpage>2899</lpage><pub-id pub-id-type="doi">10.1001/jama.293.23.2892</pub-id><pub-id pub-id-type="pmid">15956634</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphreys</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanisms of renal fibrosis</article-title><source>Annual Review of Physiology</source><volume>80</volume><fpage>309</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-022516-034227</pub-id><pub-id pub-id-type="pmid">29068765</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichimura</surname> <given-names>T</given-names></name><name><surname>Asseldonk</surname> <given-names>EJ</given-names></name><name><surname>Humphreys</surname> <given-names>BD</given-names></name><name><surname>Gunaratnam</surname> <given-names>L</given-names></name><name><surname>Duffield</surname> <given-names>JS</given-names></name><name><surname>Bonventre</surname> <given-names>JV</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells</article-title><source>Journal of Clinical Investigation</source><volume>118</volume><fpage>1657</fpage><lpage>1668</lpage><pub-id pub-id-type="doi">10.1172/JCI34487</pub-id><pub-id pub-id-type="pmid">18414680</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ide</surname> <given-names>S</given-names></name><name><surname>Yahara</surname> <given-names>Y</given-names></name><name><surname>Kobayashi</surname> <given-names>Y</given-names></name><name><surname>Strausser</surname> <given-names>SA</given-names></name><name><surname>Ide</surname> <given-names>K</given-names></name><name><surname>Watwe</surname> <given-names>A</given-names></name><name><surname>Xu-Vanpala</surname> <given-names>S</given-names></name><name><surname>Privratsky</surname> <given-names>JR</given-names></name><name><surname>Crowley</surname> <given-names>SD</given-names></name><name><surname>Shinohara</surname> <given-names>ML</given-names></name><name><surname>Alman</surname> <given-names>BA</given-names></name><name><surname>Souma</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Yolk-sac-derived macrophages progressively expand in the mouse kidney with age</article-title><source>eLife</source><volume>9</volume><elocation-id>e51756</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.51756</pub-id><pub-id pub-id-type="pmid">32301704</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadaja</surname> <given-names>M</given-names></name><name><surname>Keyes</surname> <given-names>BE</given-names></name><name><surname>Lin</surname> <given-names>M</given-names></name><name><surname>Pasolli</surname> <given-names>HA</given-names></name><name><surname>Genander</surname> <given-names>M</given-names></name><name><surname>Polak</surname> <given-names>L</given-names></name><name><surname>Stokes</surname> <given-names>N</given-names></name><name><surname>Zheng</surname> <given-names>D</given-names></name><name><surname>Fuchs</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>SOX9: a stem cell transcriptional regulator of secreted niche signaling factors</article-title><source>Genes &amp; Development</source><volume>28</volume><fpage>328</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1101/gad.233247.113</pub-id><pub-id pub-id-type="pmid">24532713</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagan</surname> <given-names>VE</given-names></name><name><surname>Mao</surname> <given-names>G</given-names></name><name><surname>Qu</surname> <given-names>F</given-names></name><name><surname>Angeli</surname> <given-names>JP</given-names></name><name><surname>Doll</surname> <given-names>S</given-names></name><name><surname>Croix</surname> <given-names>CS</given-names></name><name><surname>Dar</surname> <given-names>HH</given-names></name><name><surname>Liu</surname> <given-names>B</given-names></name><name><surname>Tyurin</surname> <given-names>VA</given-names></name><name><surname>Ritov</surname> <given-names>VB</given-names></name><name><surname>Kapralov</surname> <given-names>AA</given-names></name><name><surname>Amoscato</surname> <given-names>AA</given-names></name><name><surname>Jiang</surname> <given-names>J</given-names></name><name><surname>Anthonymuthu</surname> <given-names>T</given-names></name><name><surname>Mohammadyani</surname> <given-names>D</given-names></name><name><surname>Yang</surname> <given-names>Q</given-names></name><name><surname>Proneth</surname> <given-names>B</given-names></name><name><surname>Klein-Seetharaman</surname> <given-names>J</given-names></name><name><surname>Watkins</surname> <given-names>S</given-names></name><name><surname>Bahar</surname> <given-names>I</given-names></name><name><surname>Greenberger</surname> <given-names>J</given-names></name><name><surname>Mallampalli</surname> <given-names>RK</given-names></name><name><surname>Stockwell</surname> <given-names>BR</given-names></name><name><surname>Tyurina</surname> <given-names>YY</given-names></name><name><surname>Conrad</surname> <given-names>M</given-names></name><name><surname>Bayır</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis</article-title><source>Nature Chemical Biology</source><volume>13</volume><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2238</pub-id><pub-id pub-id-type="pmid">27842066</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>HM</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name><name><surname>Reidy</surname> <given-names>K</given-names></name><name><surname>Han</surname> <given-names>SH</given-names></name><name><surname>Chinga</surname> <given-names>F</given-names></name><name><surname>Susztak</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sox9-Positive progenitor cells play a key role in renal tubule epithelial regeneration in mice</article-title><source>Cell Reports</source><volume>14</volume><fpage>861</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.12.071</pub-id><pub-id pub-id-type="pmid">26776520</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenny</surname> <given-names>EM</given-names></name><name><surname>Fidan</surname> <given-names>E</given-names></name><name><surname>Yang</surname> <given-names>Q</given-names></name><name><surname>Anthonymuthu</surname> <given-names>TS</given-names></name><name><surname>New</surname> <given-names>LA</given-names></name><name><surname>Meyer</surname> <given-names>EA</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Kochanek</surname> <given-names>PM</given-names></name><name><surname>Dixon</surname> <given-names>CE</given-names></name><name><surname>Kagan</surname> <given-names>VE</given-names></name><name><surname>Bayir</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ferroptosis contributes to neuronal death and functional outcome after traumatic brain injury</article-title><source>Critical Care Medicine</source><volume>47</volume><fpage>410</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000003555</pub-id><pub-id pub-id-type="pmid">30531185</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirita</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name><name><surname>Uchimura</surname> <given-names>K</given-names></name><name><surname>Wilson</surname> <given-names>PC</given-names></name><name><surname>Humphreys</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury</article-title><source>PNAS</source><volume>117</volume><fpage>15874</fpage><lpage>15883</lpage><pub-id pub-id-type="doi">10.1073/pnas.2005477117</pub-id><pub-id pub-id-type="pmid">32571916</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishi</surname> <given-names>S</given-names></name><name><surname>Brooks</surname> <given-names>CR</given-names></name><name><surname>Taguchi</surname> <given-names>K</given-names></name><name><surname>Ichimura</surname> <given-names>T</given-names></name><name><surname>Mori</surname> <given-names>Y</given-names></name><name><surname>Akinfolarin</surname> <given-names>A</given-names></name><name><surname>Gupta</surname> <given-names>N</given-names></name><name><surname>Galichon</surname> <given-names>P</given-names></name><name><surname>Elias</surname> <given-names>BC</given-names></name><name><surname>Suzuki</surname> <given-names>T</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Gewin</surname> <given-names>L</given-names></name><name><surname>Morizane</surname> <given-names>R</given-names></name><name><surname>Bonventre</surname> <given-names>JV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Proximal tubule ATR regulates DNA repair to prevent maladaptive renal injury responses</article-title><source>Journal of Clinical Investigation</source><volume>129</volume><fpage>4797</fpage><lpage>4816</lpage><pub-id pub-id-type="doi">10.1172/JCI122313</pub-id><pub-id pub-id-type="pmid">31589169</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname> <given-names>Y</given-names></name><name><surname>Tata</surname> <given-names>A</given-names></name><name><surname>Konkimalla</surname> <given-names>A</given-names></name><name><surname>Katsura</surname> <given-names>H</given-names></name><name><surname>Lee</surname> <given-names>RF</given-names></name><name><surname>Ou</surname> <given-names>J</given-names></name><name><surname>Banovich</surname> <given-names>NE</given-names></name><name><surname>Kropski</surname> <given-names>JA</given-names></name><name><surname>Tata</surname> <given-names>PR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis</article-title><source>Nature Cell Biology</source><volume>22</volume><fpage>934</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1038/s41556-020-0542-8</pub-id><pub-id pub-id-type="pmid">32661339</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuleshov</surname> <given-names>MV</given-names></name><name><surname>Jones</surname> <given-names>MR</given-names></name><name><surname>Rouillard</surname> <given-names>AD</given-names></name><name><surname>Fernandez</surname> <given-names>NF</given-names></name><name><surname>Duan</surname> <given-names>Q</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Koplev</surname> <given-names>S</given-names></name><name><surname>Jenkins</surname> <given-names>SL</given-names></name><name><surname>Jagodnik</surname> <given-names>KM</given-names></name><name><surname>Lachmann</surname> <given-names>A</given-names></name><name><surname>McDermott</surname> <given-names>MG</given-names></name><name><surname>Monteiro</surname> <given-names>CD</given-names></name><name><surname>Gundersen</surname> <given-names>GW</given-names></name><name><surname>Ma'ayan</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W90</fpage><lpage>W97</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Pang</surname> <given-names>P</given-names></name><name><surname>Krautzberger</surname> <given-names>AM</given-names></name><name><surname>Reginensi</surname> <given-names>A</given-names></name><name><surname>Akiyama</surname> <given-names>H</given-names></name><name><surname>Schedl</surname> <given-names>A</given-names></name><name><surname>Humphreys</surname> <given-names>BD</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sox9 activation highlights a cellular pathway of renal repair in the acutely injured mammalian kidney</article-title><source>Cell Reports</source><volume>12</volume><fpage>1325</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.07.034</pub-id><pub-id pub-id-type="pmid">26279573</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusaba</surname> <given-names>T</given-names></name><name><surname>Lalli</surname> <given-names>M</given-names></name><name><surname>Kramann</surname> <given-names>R</given-names></name><name><surname>Kobayashi</surname> <given-names>A</given-names></name><name><surname>Humphreys</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Differentiated kidney epithelial cells repair injured proximal tubule</article-title><source>PNAS</source><volume>111</volume><fpage>1527</fpage><lpage>1532</lpage><pub-id pub-id-type="doi">10.1073/pnas.1310653110</pub-id><pub-id pub-id-type="pmid">24127583</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Manno</surname> <given-names>G</given-names></name><name><surname>Soldatov</surname> <given-names>R</given-names></name><name><surname>Zeisel</surname> <given-names>A</given-names></name><name><surname>Braun</surname> <given-names>E</given-names></name><name><surname>Hochgerner</surname> <given-names>H</given-names></name><name><surname>Petukhov</surname> <given-names>V</given-names></name><name><surname>Lidschreiber</surname> <given-names>K</given-names></name><name><surname>Kastriti</surname> <given-names>ME</given-names></name><name><surname>Lönnerberg</surname> <given-names>P</given-names></name><name><surname>Furlan</surname> <given-names>A</given-names></name><name><surname>Fan</surname> <given-names>J</given-names></name><name><surname>Borm</surname> <given-names>LE</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>van Bruggen</surname> <given-names>D</given-names></name><name><surname>Guo</surname> <given-names>J</given-names></name><name><surname>He</surname> <given-names>X</given-names></name><name><surname>Barker</surname> <given-names>R</given-names></name><name><surname>Sundström</surname> <given-names>E</given-names></name><name><surname>Castelo-Branco</surname> <given-names>G</given-names></name><name><surname>Cramer</surname> <given-names>P</given-names></name><name><surname>Adameyko</surname> <given-names>I</given-names></name><name><surname>Linnarsson</surname> <given-names>S</given-names></name><name><surname>Kharchenko</surname> <given-names>PV</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RNA velocity of single cells</article-title><source>Nature</source><volume>560</volume><fpage>494</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0414-6</pub-id><pub-id pub-id-type="pmid">30089906</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledo</surname> <given-names>N</given-names></name><name><surname>Ko</surname> <given-names>YA</given-names></name><name><surname>Park</surname> <given-names>AS</given-names></name><name><surname>Kang</surname> <given-names>HM</given-names></name><name><surname>Han</surname> <given-names>SY</given-names></name><name><surname>Choi</surname> <given-names>P</given-names></name><name><surname>Susztak</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Functional genomic annotation of genetic risk loci highlights inflammation and epithelial biology networks in CKD</article-title><source>Journal of the American Society of Nephrology</source><volume>26</volume><fpage>692</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1681/ASN.2014010028</pub-id><pub-id pub-id-type="pmid">25231882</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legouis</surname> <given-names>D</given-names></name><name><surname>Ricksten</surname> <given-names>SE</given-names></name><name><surname>Faivre</surname> <given-names>A</given-names></name><name><surname>Verissimo</surname> <given-names>T</given-names></name><name><surname>Gariani</surname> <given-names>K</given-names></name><name><surname>Verney</surname> <given-names>C</given-names></name><name><surname>Galichon</surname> <given-names>P</given-names></name><name><surname>Berchtold</surname> <given-names>L</given-names></name><name><surname>Feraille</surname> <given-names>E</given-names></name><name><surname>Fernandez</surname> <given-names>M</given-names></name><name><surname>Placier</surname> <given-names>S</given-names></name><name><surname>Koppitch</surname> <given-names>K</given-names></name><name><surname>Hertig</surname> <given-names>A</given-names></name><name><surname>Martin</surname> <given-names>PY</given-names></name><name><surname>Naesens</surname> <given-names>M</given-names></name><name><surname>Pugin</surname> <given-names>J</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name><name><surname>Cippà</surname> <given-names>PE</given-names></name><name><surname>de Seigneux</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Altered proximal tubular cell glucose metabolism during acute kidney injury is associated with mortality</article-title><source>Nature Metabolism</source><volume>2</volume><fpage>732</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1038/s42255-020-0238-1</pub-id><pub-id pub-id-type="pmid">32694833</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewington</surname> <given-names>AJ</given-names></name><name><surname>Cerdá</surname> <given-names>J</given-names></name><name><surname>Mehta</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Raising awareness of acute kidney injury: a global perspective of a silent killer</article-title><source>Kidney International</source><volume>84</volume><fpage>457</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1038/ki.2013.153</pub-id><pub-id pub-id-type="pmid">23636171</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Feng</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Sun</surname> <given-names>R</given-names></name><name><surname>Tian</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Ning</surname> <given-names>S</given-names></name><name><surname>Yao</surname> <given-names>J</given-names></name><name><surname>Tian</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion</article-title><source>Cell Death &amp; Differentiation</source><volume>26</volume><fpage>2284</fpage><lpage>2299</lpage><pub-id pub-id-type="doi">10.1038/s41418-019-0299-4</pub-id><pub-id pub-id-type="pmid">30737476</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linkermann</surname> <given-names>A</given-names></name><name><surname>Skouta</surname> <given-names>R</given-names></name><name><surname>Himmerkus</surname> <given-names>N</given-names></name><name><surname>Mulay</surname> <given-names>SR</given-names></name><name><surname>Dewitz</surname> <given-names>C</given-names></name><name><surname>De Zen</surname> <given-names>F</given-names></name><name><surname>Prokai</surname> <given-names>A</given-names></name><name><surname>Zuchtriegel</surname> <given-names>G</given-names></name><name><surname>Krombach</surname> <given-names>F</given-names></name><name><surname>Welz</surname> <given-names>PS</given-names></name><name><surname>Weinlich</surname> <given-names>R</given-names></name><name><surname>Vanden Berghe</surname> <given-names>T</given-names></name><name><surname>Vandenabeele</surname> <given-names>P</given-names></name><name><surname>Pasparakis</surname> <given-names>M</given-names></name><name><surname>Bleich</surname> <given-names>M</given-names></name><name><surname>Weinberg</surname> <given-names>JM</given-names></name><name><surname>Reichel</surname> <given-names>CA</given-names></name><name><surname>Bräsen</surname> <given-names>JH</given-names></name><name><surname>Kunzendorf</surname> <given-names>U</given-names></name><name><surname>Anders</surname> <given-names>HJ</given-names></name><name><surname>Stockwell</surname> <given-names>BR</given-names></name><name><surname>Green</surname> <given-names>DR</given-names></name><name><surname>Krautwald</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Synchronized renal tubular cell death involves ferroptosis</article-title><source>PNAS</source><volume>111</volume><fpage>16836</fpage><lpage>16841</lpage><pub-id pub-id-type="doi">10.1073/pnas.1415518111</pub-id><pub-id pub-id-type="pmid">25385600</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Kumar</surname> <given-names>S</given-names></name><name><surname>Dolzhenko</surname> <given-names>E</given-names></name><name><surname>Alvarado</surname> <given-names>GF</given-names></name><name><surname>Guo</surname> <given-names>J</given-names></name><name><surname>Lu</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Dessing</surname> <given-names>MC</given-names></name><name><surname>Parvez</surname> <given-names>RK</given-names></name><name><surname>Cippà</surname> <given-names>PE</given-names></name><name><surname>Krautzberger</surname> <given-names>AM</given-names></name><name><surname>Saribekyan</surname> <given-names>G</given-names></name><name><surname>Smith</surname> <given-names>AD</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Molecular characterization of the transition from acute to chronic kidney injury following ischemia/reperfusion</article-title><source>JCI Insight</source><volume>2</volume><elocation-id>e94716</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.94716</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macosko</surname> <given-names>EZ</given-names></name><name><surname>Basu</surname> <given-names>A</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name><name><surname>Nemesh</surname> <given-names>J</given-names></name><name><surname>Shekhar</surname> <given-names>K</given-names></name><name><surname>Goldman</surname> <given-names>M</given-names></name><name><surname>Tirosh</surname> <given-names>I</given-names></name><name><surname>Bialas</surname> <given-names>AR</given-names></name><name><surname>Kamitaki</surname> <given-names>N</given-names></name><name><surname>Martersteck</surname> <given-names>EM</given-names></name><name><surname>Trombetta</surname> <given-names>JJ</given-names></name><name><surname>Weitz</surname> <given-names>DA</given-names></name><name><surname>Sanes</surname> <given-names>JR</given-names></name><name><surname>Shalek</surname> <given-names>AK</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>McCarroll</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Highly parallel Genome-wide expression profiling of individual cells using nanoliter droplets</article-title><source>Cell</source><volume>161</volume><fpage>1202</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.05.002</pub-id><pub-id pub-id-type="pmid">26000488</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madisen</surname> <given-names>L</given-names></name><name><surname>Zwingman</surname> <given-names>TA</given-names></name><name><surname>Sunkin</surname> <given-names>SM</given-names></name><name><surname>Oh</surname> <given-names>SW</given-names></name><name><surname>Zariwala</surname> <given-names>HA</given-names></name><name><surname>Gu</surname> <given-names>H</given-names></name><name><surname>Ng</surname> <given-names>LL</given-names></name><name><surname>Palmiter</surname> <given-names>RD</given-names></name><name><surname>Hawrylycz</surname> <given-names>MJ</given-names></name><name><surname>Jones</surname> <given-names>AR</given-names></name><name><surname>Lein</surname> <given-names>ES</given-names></name><name><surname>Zeng</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A robust and high-throughput cre reporting and characterization system for the whole mouse brain</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nn.2467</pub-id><pub-id pub-id-type="pmid">20023653</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mah</surname> <given-names>SP</given-names></name><name><surname>Saueressig</surname> <given-names>H</given-names></name><name><surname>Goulding</surname> <given-names>M</given-names></name><name><surname>Kintner</surname> <given-names>C</given-names></name><name><surname>Dressler</surname> <given-names>GR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Kidney development in cadherin-6 mutants: delayed mesenchyme-to-epithelial conversion and loss of nephrons</article-title><source>Developmental Biology</source><volume>223</volume><fpage>38</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1006/dbio.2000.9738</pub-id><pub-id pub-id-type="pmid">10864459</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malone</surname> <given-names>AF</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name><name><surname>Fronick</surname> <given-names>C</given-names></name><name><surname>Fulton</surname> <given-names>R</given-names></name><name><surname>Gaut</surname> <given-names>JP</given-names></name><name><surname>Humphreys</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Harnessing expressed single nucleotide variation and single cell RNA sequencing to define immune cell chimerism in the rejecting kidney transplant</article-title><source>Journal of the American Society of Nephrology</source><volume>31</volume><fpage>1977</fpage><lpage>1986</lpage><pub-id pub-id-type="doi">10.1681/ASN.2020030326</pub-id><pub-id pub-id-type="pmid">32669324</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marable</surname> <given-names>SS</given-names></name><name><surname>Chung</surname> <given-names>E</given-names></name><name><surname>Adam</surname> <given-names>M</given-names></name><name><surname>Potter</surname> <given-names>SS</given-names></name><name><surname>Park</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hnf4a deletion in the mouse kidney phenocopies fanconi renotubular syndrome</article-title><source>JCI Insight</source><volume>3</volume><elocation-id>e97497</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.97497</pub-id><pub-id pub-id-type="pmid">30046000</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marable</surname> <given-names>SS</given-names></name><name><surname>Chung</surname> <given-names>E</given-names></name><name><surname>Park</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hnf4a is required for the development of Cdh6-Expressing progenitors into proximal tubules in the mouse kidney</article-title><source>Journal of the American Society of Nephrology</source><volume>31</volume><fpage>2543</fpage><lpage>2558</lpage><pub-id pub-id-type="doi">10.1681/ASN.2020020184</pub-id><pub-id pub-id-type="pmid">32764140</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriwaki</surname> <given-names>K</given-names></name><name><surname>Balaji</surname> <given-names>S</given-names></name><name><surname>McQuade</surname> <given-names>T</given-names></name><name><surname>Malhotra</surname> <given-names>N</given-names></name><name><surname>Kang</surname> <given-names>J</given-names></name><name><surname>Chan</surname> <given-names>FK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair</article-title><source>Immunity</source><volume>41</volume><fpage>567</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.09.016</pub-id><pub-id pub-id-type="pmid">25367573</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriwaki</surname> <given-names>K</given-names></name><name><surname>Chan</surname> <given-names>FK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Necroptosis-independent signaling by the RIP kinases in inflammation</article-title><source>Cellular and Molecular Life Sciences</source><volume>73</volume><fpage>2325</fpage><lpage>2334</lpage><pub-id pub-id-type="doi">10.1007/s00018-016-2203-4</pub-id><pub-id pub-id-type="pmid">27048814</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname> <given-names>T</given-names></name><name><surname>Dewitz</surname> <given-names>C</given-names></name><name><surname>Schmitz</surname> <given-names>J</given-names></name><name><surname>Schröder</surname> <given-names>AS</given-names></name><name><surname>Bräsen</surname> <given-names>JH</given-names></name><name><surname>Stockwell</surname> <given-names>BR</given-names></name><name><surname>Murphy</surname> <given-names>JM</given-names></name><name><surname>Kunzendorf</surname> <given-names>U</given-names></name><name><surname>Krautwald</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure</article-title><source>Cellular and Molecular Life Sciences</source><volume>74</volume><fpage>3631</fpage><lpage>3645</lpage><pub-id pub-id-type="doi">10.1007/s00018-017-2547-4</pub-id><pub-id pub-id-type="pmid">28551825</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nezu</surname> <given-names>M</given-names></name><name><surname>Souma</surname> <given-names>T</given-names></name><name><surname>Yu</surname> <given-names>L</given-names></name><name><surname>Suzuki</surname> <given-names>T</given-names></name><name><surname>Saigusa</surname> <given-names>D</given-names></name><name><surname>Ito</surname> <given-names>S</given-names></name><name><surname>Suzuki</surname> <given-names>N</given-names></name><name><surname>Yamamoto</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression</article-title><source>Kidney International</source><volume>91</volume><fpage>387</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2016.08.023</pub-id><pub-id pub-id-type="pmid">27789056</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paragas</surname> <given-names>N</given-names></name><name><surname>Qiu</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Samstein</surname> <given-names>B</given-names></name><name><surname>Deng</surname> <given-names>SX</given-names></name><name><surname>Schmidt-Ott</surname> <given-names>KM</given-names></name><name><surname>Viltard</surname> <given-names>M</given-names></name><name><surname>Yu</surname> <given-names>W</given-names></name><name><surname>Forster</surname> <given-names>CS</given-names></name><name><surname>Gong</surname> <given-names>G</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Kulkarni</surname> <given-names>R</given-names></name><name><surname>Mori</surname> <given-names>K</given-names></name><name><surname>Kalandadze</surname> <given-names>A</given-names></name><name><surname>Ratner</surname> <given-names>AJ</given-names></name><name><surname>Devarajan</surname> <given-names>P</given-names></name><name><surname>Landry</surname> <given-names>DW</given-names></name><name><surname>D'Agati</surname> <given-names>V</given-names></name><name><surname>Lin</surname> <given-names>CS</given-names></name><name><surname>Barasch</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The ngal reporter mouse detects the response of the kidney to injury in real time</article-title><source>Nature Medicine</source><volume>17</volume><fpage>216</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1038/nm.2290</pub-id><pub-id pub-id-type="pmid">21240264</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>J</given-names></name><name><surname>Shrestha</surname> <given-names>R</given-names></name><name><surname>Qiu</surname> <given-names>C</given-names></name><name><surname>Kondo</surname> <given-names>A</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name><name><surname>Werth</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Barasch</surname> <given-names>J</given-names></name><name><surname>Suszták</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease</article-title><source>Science</source><volume>360</volume><fpage>758</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1126/science.aar2131</pub-id><pub-id pub-id-type="pmid">29622724</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ransick</surname> <given-names>A</given-names></name><name><surname>Lindström</surname> <given-names>NO</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Zhu</surname> <given-names>Q</given-names></name><name><surname>Guo</surname> <given-names>JJ</given-names></name><name><surname>Alvarado</surname> <given-names>GF</given-names></name><name><surname>Kim</surname> <given-names>AD</given-names></name><name><surname>Black</surname> <given-names>HG</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-Cell profiling reveals sex, lineage, and regional diversity in the mouse kidney</article-title><source>Developmental Cell</source><volume>51</volume><fpage>399</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.10.005</pub-id><pub-id pub-id-type="pmid">31689386</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reginensi</surname> <given-names>A</given-names></name><name><surname>Clarkson</surname> <given-names>M</given-names></name><name><surname>Neirijnck</surname> <given-names>Y</given-names></name><name><surname>Lu</surname> <given-names>B</given-names></name><name><surname>Ohyama</surname> <given-names>T</given-names></name><name><surname>Groves</surname> <given-names>AK</given-names></name><name><surname>Sock</surname> <given-names>E</given-names></name><name><surname>Wegner</surname> <given-names>M</given-names></name><name><surname>Costantini</surname> <given-names>F</given-names></name><name><surname>Chaboissier</surname> <given-names>M-C</given-names></name><name><surname>Schedl</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>SOX9 controls epithelial branching by activating RET effector genes during kidney development</article-title><source>Human Molecular Genetics</source><volume>20</volume><fpage>1143</fpage><lpage>1153</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddq558</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname> <given-names>J</given-names></name><name><surname>Rudemiller</surname> <given-names>NP</given-names></name><name><surname>Wen</surname> <given-names>Y</given-names></name><name><surname>Lu</surname> <given-names>X</given-names></name><name><surname>Privratsky</surname> <given-names>JR</given-names></name><name><surname>Crowley</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The transcription factor Twist1 in the distal nephron but not in macrophages propagates aristolochic acid nephropathy</article-title><source>Kidney International</source><volume>97</volume><fpage>119</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2019.07.016</pub-id><pub-id pub-id-type="pmid">31685313</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roche</surname> <given-names>KC</given-names></name><name><surname>Gracz</surname> <given-names>AD</given-names></name><name><surname>Liu</surname> <given-names>XF</given-names></name><name><surname>Newton</surname> <given-names>V</given-names></name><name><surname>Akiyama</surname> <given-names>H</given-names></name><name><surname>Magness</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SOX9 maintains reserve stem cells and preserves radioresistance in mouse small intestine</article-title><source>Gastroenterology</source><volume>149</volume><fpage>1553</fpage><lpage>1563</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2015.07.004</pub-id><pub-id pub-id-type="pmid">26170137</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudman-Melnick</surname> <given-names>V</given-names></name><name><surname>Adam</surname> <given-names>M</given-names></name><name><surname>Potter</surname> <given-names>A</given-names></name><name><surname>Chokshi</surname> <given-names>SM</given-names></name><name><surname>Ma</surname> <given-names>Q</given-names></name><name><surname>Drake</surname> <given-names>KA</given-names></name><name><surname>Schuh</surname> <given-names>MP</given-names></name><name><surname>Kofron</surname> <given-names>JM</given-names></name><name><surname>Devarajan</surname> <given-names>P</given-names></name><name><surname>Potter</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-Cell profiling of AKI in a murine model reveals novel transcriptional signatures, profibrotic phenotype, and Epithelial-to-Stromal crosstalk</article-title><source>Journal of the American Society of Nephrology</source><volume>31</volume><fpage>2793</fpage><lpage>2814</lpage><pub-id pub-id-type="doi">10.1681/ASN.2020010052</pub-id><pub-id pub-id-type="pmid">33115917</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname> <given-names>BJ</given-names></name><name><surname>Ferdinand</surname> <given-names>JR</given-names></name><name><surname>Young</surname> <given-names>MD</given-names></name><name><surname>Mitchell</surname> <given-names>TJ</given-names></name><name><surname>Loudon</surname> <given-names>KW</given-names></name><name><surname>Riding</surname> <given-names>AM</given-names></name><name><surname>Richoz</surname> <given-names>N</given-names></name><name><surname>Frazer</surname> <given-names>GL</given-names></name><name><surname>Staniforth</surname> <given-names>JUL</given-names></name><name><surname>Vieira Braga</surname> <given-names>FA</given-names></name><name><surname>Botting</surname> <given-names>RA</given-names></name><name><surname>Popescu</surname> <given-names>DM</given-names></name><name><surname>Vento-Tormo</surname> <given-names>R</given-names></name><name><surname>Stephenson</surname> <given-names>E</given-names></name><name><surname>Cagan</surname> <given-names>A</given-names></name><name><surname>Farndon</surname> <given-names>SJ</given-names></name><name><surname>Polanski</surname> <given-names>K</given-names></name><name><surname>Efremova</surname> <given-names>M</given-names></name><name><surname>Green</surname> <given-names>K</given-names></name><name><surname>Del Castillo Velasco-Herrera</surname> <given-names>M</given-names></name><name><surname>Guzzo</surname> <given-names>C</given-names></name><name><surname>Collord</surname> <given-names>G</given-names></name><name><surname>Mamanova</surname> <given-names>L</given-names></name><name><surname>Aho</surname> <given-names>T</given-names></name><name><surname>Armitage</surname> <given-names>JN</given-names></name><name><surname>Riddick</surname> <given-names>ACP</given-names></name><name><surname>Mushtaq</surname> <given-names>I</given-names></name><name><surname>Farrell</surname> <given-names>S</given-names></name><name><surname>Rampling</surname> <given-names>D</given-names></name><name><surname>Nicholson</surname> <given-names>J</given-names></name><name><surname>Filby</surname> <given-names>A</given-names></name><name><surname>Burge</surname> <given-names>J</given-names></name><name><surname>Lisgo</surname> <given-names>S</given-names></name><name><surname>Lindsay</surname> <given-names>S</given-names></name><name><surname>Bajenoff</surname> <given-names>M</given-names></name><name><surname>Warren</surname> <given-names>AY</given-names></name><name><surname>Stewart</surname> <given-names>GD</given-names></name><name><surname>Sebire</surname> <given-names>N</given-names></name><name><surname>Coleman</surname> <given-names>N</given-names></name><name><surname>Haniffa</surname> <given-names>M</given-names></name><name><surname>Teichmann</surname> <given-names>SA</given-names></name><name><surname>Behjati</surname> <given-names>S</given-names></name><name><surname>Clatworthy</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Spatiotemporal immune zonation of the human kidney</article-title><source>Science</source><volume>365</volume><fpage>1461</fpage><lpage>1466</lpage><pub-id pub-id-type="doi">10.1126/science.aat5031</pub-id><pub-id pub-id-type="pmid">31604275</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockwell</surname> <given-names>BR</given-names></name><name><surname>Friedmann Angeli</surname> <given-names>JP</given-names></name><name><surname>Bayir</surname> <given-names>H</given-names></name><name><surname>Bush</surname> <given-names>AI</given-names></name><name><surname>Conrad</surname> <given-names>M</given-names></name><name><surname>Dixon</surname> <given-names>SJ</given-names></name><name><surname>Fulda</surname> <given-names>S</given-names></name><name><surname>Gascón</surname> <given-names>S</given-names></name><name><surname>Hatzios</surname> <given-names>SK</given-names></name><name><surname>Kagan</surname> <given-names>VE</given-names></name><name><surname>Noel</surname> <given-names>K</given-names></name><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Linkermann</surname> <given-names>A</given-names></name><name><surname>Murphy</surname> <given-names>ME</given-names></name><name><surname>Overholtzer</surname> <given-names>M</given-names></name><name><surname>Oyagi</surname> <given-names>A</given-names></name><name><surname>Pagnussat</surname> <given-names>GC</given-names></name><name><surname>Park</surname> <given-names>J</given-names></name><name><surname>Ran</surname> <given-names>Q</given-names></name><name><surname>Rosenfeld</surname> <given-names>CS</given-names></name><name><surname>Salnikow</surname> <given-names>K</given-names></name><name><surname>Tang</surname> <given-names>D</given-names></name><name><surname>Torti</surname> <given-names>FM</given-names></name><name><surname>Torti</surname> <given-names>SV</given-names></name><name><surname>Toyokuni</surname> <given-names>S</given-names></name><name><surname>Woerpel</surname> <given-names>KA</given-names></name><name><surname>Zhang</surname> <given-names>DD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease</article-title><source>Cell</source><volume>171</volume><fpage>273</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.021</pub-id><pub-id pub-id-type="pmid">28985560</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strausser</surname> <given-names>SA</given-names></name><name><surname>Nakano</surname> <given-names>D</given-names></name><name><surname>Souma</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response</article-title><source>Current Opinion in Nephrology and Hypertension</source><volume>27</volume><fpage>314</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1097/MNH.0000000000000424</pub-id><pub-id pub-id-type="pmid">29702491</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strunz</surname> <given-names>M</given-names></name><name><surname>Simon</surname> <given-names>LM</given-names></name><name><surname>Ansari</surname> <given-names>M</given-names></name><name><surname>Kathiriya</surname> <given-names>JJ</given-names></name><name><surname>Angelidis</surname> <given-names>I</given-names></name><name><surname>Mayr</surname> <given-names>CH</given-names></name><name><surname>Tsidiridis</surname> <given-names>G</given-names></name><name><surname>Lange</surname> <given-names>M</given-names></name><name><surname>Mattner</surname> <given-names>LF</given-names></name><name><surname>Yee</surname> <given-names>M</given-names></name><name><surname>Ogar</surname> <given-names>P</given-names></name><name><surname>Sengupta</surname> <given-names>A</given-names></name><name><surname>Kukhtevich</surname> <given-names>I</given-names></name><name><surname>Schneider</surname> <given-names>R</given-names></name><name><surname>Zhao</surname> <given-names>Z</given-names></name><name><surname>Voss</surname> <given-names>C</given-names></name><name><surname>Stoeger</surname> <given-names>T</given-names></name><name><surname>Neumann</surname> <given-names>JHL</given-names></name><name><surname>Hilgendorff</surname> <given-names>A</given-names></name><name><surname>Behr</surname> <given-names>J</given-names></name><name><surname>O'Reilly</surname> <given-names>M</given-names></name><name><surname>Lehmann</surname> <given-names>M</given-names></name><name><surname>Burgstaller</surname> <given-names>G</given-names></name><name><surname>Königshoff</surname> <given-names>M</given-names></name><name><surname>Chapman</surname> <given-names>HA</given-names></name><name><surname>Theis</surname> <given-names>FJ</given-names></name><name><surname>Schiller</surname> <given-names>HB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>3559</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17358-3</pub-id><pub-id pub-id-type="pmid">32678092</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname> <given-names>T</given-names></name><name><surname>Butler</surname> <given-names>A</given-names></name><name><surname>Hoffman</surname> <given-names>P</given-names></name><name><surname>Hafemeister</surname> <given-names>C</given-names></name><name><surname>Papalexi</surname> <given-names>E</given-names></name><name><surname>Mauck</surname> <given-names>WM</given-names></name><name><surname>Hao</surname> <given-names>Y</given-names></name><name><surname>Stoeckius</surname> <given-names>M</given-names></name><name><surname>Smibert</surname> <given-names>P</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive integration of Single-Cell data</article-title><source>Cell</source><volume>177</volume><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tata</surname> <given-names>A</given-names></name><name><surname>Kobayashi</surname> <given-names>Y</given-names></name><name><surname>Chow</surname> <given-names>RD</given-names></name><name><surname>Tran</surname> <given-names>J</given-names></name><name><surname>Desai</surname> <given-names>A</given-names></name><name><surname>Massri</surname> <given-names>AJ</given-names></name><name><surname>McCord</surname> <given-names>TJ</given-names></name><name><surname>Gunn</surname> <given-names>MD</given-names></name><name><surname>Tata</surname> <given-names>PR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Myoepithelial cells of submucosal glands can function as reserve stem cells to regenerate airways after injury</article-title><source>Cell Stem Cell</source><volume>22</volume><fpage>668</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2018.03.018</pub-id><pub-id pub-id-type="pmid">29656943</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname> <given-names>N</given-names></name><name><surname>Tiwari</surname> <given-names>VK</given-names></name><name><surname>Waldmeier</surname> <given-names>L</given-names></name><name><surname>Balwierz</surname> <given-names>PJ</given-names></name><name><surname>Arnold</surname> <given-names>P</given-names></name><name><surname>Pachkov</surname> <given-names>M</given-names></name><name><surname>Meyer-Schaller</surname> <given-names>N</given-names></name><name><surname>Schübeler</surname> <given-names>D</given-names></name><name><surname>van Nimwegen</surname> <given-names>E</given-names></name><name><surname>Christofori</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming</article-title><source>Cancer Cell</source><volume>23</volume><fpage>768</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2013.04.020</pub-id><pub-id pub-id-type="pmid">23764001</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname> <given-names>C</given-names></name><name><surname>Cacchiarelli</surname> <given-names>D</given-names></name><name><surname>Grimsby</surname> <given-names>J</given-names></name><name><surname>Pokharel</surname> <given-names>P</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Morse</surname> <given-names>M</given-names></name><name><surname>Lennon</surname> <given-names>NJ</given-names></name><name><surname>Livak</surname> <given-names>KJ</given-names></name><name><surname>Mikkelsen</surname> <given-names>TS</given-names></name><name><surname>Rinn</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells</article-title><source>Nature Biotechnology</source><volume>32</volume><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1038/nbt.2859</pub-id><pub-id pub-id-type="pmid">24658644</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname> <given-names>SE</given-names></name><name><surname>Tyurina</surname> <given-names>YY</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>St Croix</surname> <given-names>CM</given-names></name><name><surname>Dar</surname> <given-names>HH</given-names></name><name><surname>Mao</surname> <given-names>G</given-names></name><name><surname>Tyurin</surname> <given-names>VA</given-names></name><name><surname>Anthonymuthu</surname> <given-names>TS</given-names></name><name><surname>Kapralov</surname> <given-names>AA</given-names></name><name><surname>Amoscato</surname> <given-names>AA</given-names></name><name><surname>Mikulska-Ruminska</surname> <given-names>K</given-names></name><name><surname>Shrivastava</surname> <given-names>IH</given-names></name><name><surname>Kenny</surname> <given-names>EM</given-names></name><name><surname>Yang</surname> <given-names>Q</given-names></name><name><surname>Rosenbaum</surname> <given-names>JC</given-names></name><name><surname>Sparvero</surname> <given-names>LJ</given-names></name><name><surname>Emlet</surname> <given-names>DR</given-names></name><name><surname>Wen</surname> <given-names>X</given-names></name><name><surname>Minami</surname> <given-names>Y</given-names></name><name><surname>Qu</surname> <given-names>F</given-names></name><name><surname>Watkins</surname> <given-names>SC</given-names></name><name><surname>Holman</surname> <given-names>TR</given-names></name><name><surname>VanDemark</surname> <given-names>AP</given-names></name><name><surname>Kellum</surname> <given-names>JA</given-names></name><name><surname>Bahar</surname> <given-names>I</given-names></name><name><surname>Bayır</surname> <given-names>H</given-names></name><name><surname>Kagan</surname> <given-names>VE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals</article-title><source>Cell</source><volume>171</volume><fpage>628</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.044</pub-id><pub-id pub-id-type="pmid">29053969</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>PC</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name><name><surname>Kirita</surname> <given-names>Y</given-names></name><name><surname>Uchimura</surname> <given-names>K</given-names></name><name><surname>Ledru</surname> <given-names>N</given-names></name><name><surname>Rennke</surname> <given-names>HG</given-names></name><name><surname>Welling</surname> <given-names>PA</given-names></name><name><surname>Waikar</surname> <given-names>SS</given-names></name><name><surname>Humphreys</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The single-cell transcriptomic landscape of early human diabetic nephropathy</article-title><source>PNAS</source><volume>116</volume><fpage>19619</fpage><lpage>19625</lpage><pub-id pub-id-type="doi">10.1073/pnas.1908706116</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witzgall</surname> <given-names>R</given-names></name><name><surname>Brown</surname> <given-names>D</given-names></name><name><surname>Schwarz</surname> <given-names>C</given-names></name><name><surname>Bonventre</surname> <given-names>JV</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Localization of proliferating cell nuclear antigen, Vimentin, c-Fos, and clusterin in the postischemic kidney evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells</article-title><source>Journal of Clinical Investigation</source><volume>93</volume><fpage>2175</fpage><lpage>2188</lpage><pub-id pub-id-type="doi">10.1172/JCI117214</pub-id><pub-id pub-id-type="pmid">7910173</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>WS</given-names></name><name><surname>SriRamaratnam</surname> <given-names>R</given-names></name><name><surname>Welsch</surname> <given-names>ME</given-names></name><name><surname>Shimada</surname> <given-names>K</given-names></name><name><surname>Skouta</surname> <given-names>R</given-names></name><name><surname>Viswanathan</surname> <given-names>VS</given-names></name><name><surname>Cheah</surname> <given-names>JH</given-names></name><name><surname>Clemons</surname> <given-names>PA</given-names></name><name><surname>Shamji</surname> <given-names>AF</given-names></name><name><surname>Clish</surname> <given-names>CB</given-names></name><name><surname>Brown</surname> <given-names>LM</given-names></name><name><surname>Girotti</surname> <given-names>AW</given-names></name><name><surname>Cornish</surname> <given-names>VW</given-names></name><name><surname>Schreiber</surname> <given-names>SL</given-names></name><name><surname>Stockwell</surname> <given-names>BR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Regulation of ferroptotic Cancer cell death by GPX4</article-title><source>Cell</source><volume>156</volume><fpage>317</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.12.010</pub-id><pub-id pub-id-type="pmid">24439385</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname> <given-names>SE</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Na</surname> <given-names>R</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Rios</surname> <given-names>C</given-names></name><name><surname>Van Remmen</surname> <given-names>H</given-names></name><name><surname>Richardson</surname> <given-names>A</given-names></name><name><surname>Ran</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain</article-title><source>Free Radical Biology and Medicine</source><volume>52</volume><fpage>1820</fpage><lpage>1827</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.02.043</pub-id><pub-id pub-id-type="pmid">22401858</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Kang</surname> <given-names>R</given-names></name><name><surname>Tang</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Identification of ACSL4 as a biomarker and contributor of ferroptosis</article-title><source>Biochemical and Biophysical Research Communications</source><volume>478</volume><fpage>1338</fpage><lpage>1343</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2016.08.124</pub-id><pub-id pub-id-type="pmid">27565726</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>Z</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Zhou</surname> <given-names>C</given-names></name><name><surname>Han</surname> <given-names>B</given-names></name><name><surname>Zhu</surname> <given-names>H</given-names></name><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Ma</surname> <given-names>Z</given-names></name><name><surname>Ming</surname> <given-names>Z</given-names></name><name><surname>Yao</surname> <given-names>Y</given-names></name><name><surname>Zeng</surname> <given-names>R</given-names></name><name><surname>Xu</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia-reperfusion injury</article-title><source>Cell Death &amp; Disease</source><volume>11</volume><elocation-id>629</elocation-id><pub-id pub-id-type="doi">10.1038/s41419-020-02871-6</pub-id><pub-id pub-id-type="pmid">32796819</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.68603.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Germino</surname><given-names>Gregory G</given-names></name><role>Reviewing Editor</role><aff><institution>National Institutes of Health</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Conrad</surname><given-names>Marcus</given-names> </name><role>Reviewer</role><aff><institution>Helmholtz Zentrum München</institution><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.03.23.436661">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.03.23.436661v1.full">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>In this study, Ide et al., present a comprehensive analysis of single cell transcriptomic changes in the kidney in response to mild and recoverable injury compared to severe and persistent injury after renal ischemia reperfusion in an effort to identify cellular pathways that promote maladaptive repair. They find that cellular pathways (Gpx4-glutathione) that prevent ferroptosis, a major pathway known to drive cell death in renal ischemia-reperfusion injury, are involved. This is further corroborated in an elegant genetic mouse model with mild ischemic stress-induced ablation of GPX4 and by pharmacologic inhibition of ferroptosis. These studies will be of significant interest both to those studying acute kidney injury and others interested in ischemic injury in other organ systems.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Ferroptotic stress promotes the accumulation of pro-inflammatory proximal tubular cells in maladaptive renal repair&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Mone Zaidi as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Marcus Conrad (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. Necessary experiments: Please test whether ferroptosis inhibitors administered in vivo blunt some of the dynamic changes/plasticity of proximal tubular cells or impair the overall damage in the genetic GPX4 null model (data presented in Figures3, 5, 7, 8). These studies were deemed necessary to corroborate the contribution of ferroptosis in the proposed model.</p><p>2. Please address the variability between the staining patterns for <italic>SOX9</italic>immunostaining and the <italic>Sox9</italic>-TdTomato reporter. For example, in Figure 2D/E, the number of <italic>SOX9</italic>+ cells (over DAPI+ cells) is only ~8% in the 30-minute IRI kidney at day 21 while in Figure 3B/C, the number of <italic>Sox9</italic>;TdTomato+ cells (over DAPI+ cells) is 60% in the cortex and 40% in the medulla in the 30-minute IRI kidney at day 21. Even in the 20-minute IRI kidney, the <italic>SOX9</italic>+ cells are close to 0% at day 21 (Figure 2E) but the <italic>Sox9</italic>;TdTomato+ cells are close to 20% in Figure 3C. We also ask that you discuss the limitations of using <italic>SOX9</italic> as a primary marker for maladaptive proximal tubular repair.</p><p>3. Please explain the variability of VCAM1 staining across figures. For example, in Figure S9B VCAM1 staining is almost completely negative in the contralateral control kidney while there is a fair amount of VCAM1 positive staining in Figure 2C and Figure 3D of the contralateral control kidney. Please also provide an explanation for VCAM1 expression in a subset of normal human kidney proximal tubule cells (Figure S11B).</p><p>4. Please discuss the limitations of using pseudo time and RNA velocity in RNA-Seq analysis to identify novel transitional cell states given that the results are imputed by mathematical modeling.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>– A major concern with these studies is the reliance on <italic>SOX9</italic>+ cells to represent DA-PT cells. Figures S5D and 5C demonstrate that less than 40% of the DA-PT cells express <italic>SOX9</italic>. <italic>SOX9</italic> is not specific to DA-PT cells either, as they are seen in both PT cells and DCT1 cells as well. Additionally, the scale of the dot plots should be 0-100, and not 0-40. Also, Figures 5 D and E do not differentiate between DCT1 and PTs and this should be clarified.</p><p>– When defining the initial DA-PT cell population, the authors should include data showing there is no upregulation of genes associated with the cellular death pathways.</p><p>– Did the authors observe the DA-PT phenotype after &quot;mild&quot; 20 minute uIRI? This is relevant since the authors show that <italic>SOX9</italic>+ cells appear after 20 minute uIRI.</p><p>– Figure 3E would suggest that only 25% of the <italic>SOX9</italic>+ cells were also VCAM1+. If only 40% of DA-PT cells were <italic>SOX9</italic>+, that would suggest that only 10% of DA-PT cells were <italic>SOX9</italic>+VCAM+, again questioning the validity of using <italic>SOX9</italic> for identifying DA-PT cells.</p><p>– How do the authors reconcile the link between ferroptosis and severe AKI when accumulation of MDA and ACSL4 seems to occur in only a minority of <italic>SOX9</italic>+ cells and is also seen in <italic>SOX9</italic>- cells?</p><p>– Figure 5 does not include comparison of sequencing results for the mild-injury. Are there differences in the gene expression of MDA and ACSL4 in the 20 minutes vs 30 minutes uIRI?</p><p>– Human data in Figure 6E is not particularly convincing that the &quot;DA-PT like&quot; cells are expressing <italic>SOX9</italic>, VCAM or CDH6. Expression looks very low and potentially higher in normal PT cells. Violin (with individual dots) or dot blots should be used to show the quantification of these data.</p><p>– The justification for the 22 minutes of ischemia for the studies with the cKO mice in Figures 7 and 8, should be provided.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Suggestions to authors:</p><p>– Title: &quot;Ferroptotic stress&quot; sounds rather awkward as the I/R stress is the trigger of ferroptosis in kidney tubular cells.</p><p>– Page 8: Would in vivo active ferroptosis inhibitors blunt some of the dynamic changes/plasticity of proximal tubular cells (Figures 3, 5)? Along the same line, would they also impair the overall damage in the genetic GPX4 null model? These studies would be extremely helpful to corroborate the contribution of &quot;ferroptosis&quot; in the proposed model.</p><p>– Did the author consider secondary forms of cell death including apoptosis and necroptosis in their model as a consequence of a highly proinflammatory milieu?</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>As one of the main strengths of this manuscript is the validation of the scRNA-Seq data analysis findings, it is important that the validations are clear. Some of the immunostaining are not consistent with expected findings (Lotus lectin staining) or are variable (VCAM1 and <italic>SOX9</italic>), described below.</p><p>1. Figure S6B Image is not consistent with LTL staining which should be apical staining of the brush border. The staining in the image appears cytoplasmic or reflects kidney autofluorescence.</p><p>2. <italic>SOX9</italic> staining appears to be variable and the abundance of <italic>SOX9</italic>+ cells differ between <italic>SOX9</italic>immunostaining and the <italic>Sox9</italic>-TdTm reporter. In Figure 5D/F, S9B <italic>SOX9</italic>immunostaining in the control kidney with zero or rare positive cells while <italic>Sox9</italic>-tdTomato have quite a few scattered throughout the kidney given the larger field presented at a lower magnification, as shown in Figure 3B-control kidney. Depending on the field chosen, the <italic>Sox9</italic>-TdTm+ cells could be as high as 5-6 per higher power field and as low as 0-2 (which is what Figure 3D presents). Is the overall pattern and frequency of <italic>SOX9</italic>+ immunostaining at a lower power field also consistent with the <italic>Sox9</italic>-TdTomato reporter image in Figure 3B?</p><p>Figure 3B control kidney image also does not support the sentence on page 12 line 11 stating that <italic>Sox9</italic>-CreERT2 activity is &quot;not induced&quot; in non-injured kidneys, as there are clearly <italic>Sox9</italic>-TdTm+ cells in Figure 3B in the control kidney, unless the <italic>Sox9</italic>-CreERT2 is leaky and some of the lineage traced cells are false positives, in which case interpretation of the experiments using the <italic>Sox9</italic>-CreERT2 may require some consideration of this possibility.</p><p>3. There is variability of the VCAM1 staining throughout the manuscript. Figure S9B contralateral control kidney is VCAM1 staining is almost completely negative, while there is a fair amount of VCAM1 positive staining in Figure 2C and Figure 3D of the contralateral control kidney, albeit the VCAM1+ cells appear interstitial. It is described in the text that VCAM1 is &quot;expressed weakly&quot; in macrophages and endothelial cells after injury, although some of these images in the manuscript suggest that VCAM1 is relatively strongly expressed at baseline, and further induced after injury in interstitial and/or endothelial cells. Of note, it is odd that VCAM1 expression is present in a subset of normal human kidney proximal tubule cells, specifically presented on the Dot plot in Figure S11B. Is there an explanation for this finding?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.68603.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. Necessary experiments: Please test whether ferroptosis inhibitors administered in vivo blunt some of the dynamic changes/plasticity of proximal tubular cells or impair the overall damage in the genetic GPX4 null model (data presented in Figures3, 5, 7, 8). These studies were deemed necessary to corroborate the contribution of ferroptosis in the proposed model.</p></disp-quote><p>Following the reviewer’s advice, we have performed a pharmacological inhibitor study using liproxstatin1 (a potent inhibitor of ferroptosis that scavenges lipid peroxides) in our genetic Gpx4 conditional deletion model (Sox9<sup>IRES-CreERT2</sup>; Gpx4 <sup>flox/flox</sup>). The new data summarized below strongly support our original notion that ferroptotic stress promotes the accumulation of pathologic proximal tubular cells in addition to ferroptotic cell death, thus preventing successful repair. Targeting ferroptotic stress in acute kidney injury holds the promise of preventing maladaptive repair and improving long-term renal outcomes.</p><p>1) Liproxstatin-1 potently prevented renal atrophy after IRI in the absence of <italic>Gpx4</italic> (Figure 9B).</p><p>2) In conditional knockout (cKO) mice after IRI, liproxstatin-1 mitigated overall damage compared to the vehicle control (Figure 9C and 9D). Liproxstatin-1-treated cKO kidneys show reduced expression of tubular injury markers (KIM-1 and KRT8) compared to vehicle-treated cKO kidneys after IRI. We observed that <italic>Sox9</italic>-lineage cells (tdTomato-positive) are positive for KIM1 in the vehicle cKO group, but largely negative in liproxstatin-1-treated cKO kidneys (Figure 9—figure supplement 2B). Moreover, the Sox9lineage cells express a high level of LTL-binding (a differentiated PT cell marker) in the liproxstatin-1treated cKO group, but not in the vehicle-treated cKO group (Figure 9—figure supplement 2C).</p><p>Please note that liproxstatin-1 and vehicle-treated animals underwent the same procedures; unilateral ischemia-reperfusion (ischemic time 22 min), tamoxifen treatment, and daily intraperitoneal injections of liproxstatin-1 or vehicle.</p><p>1) Liproxstatin-1 effectively reduced the accumulation of <italic>Sox9</italic>+Vcam1+ proximal tubular cells in postIRI cKO kidneys (Figure 9E and 9F). Liproxstatin-1 also reduced the expression of damage-associated proximal tubular cell markers (<italic>Sox9</italic>, Vcam1, and Cdh6) compared to the vehicle group in post-IRI kidneys (Figure 9G).</p><p>2) Liproxstatin-1 reduced tubular cell death (TUNEL staining, Figure 9H and 9I) in cKO post-IRI kidneys.</p><p>3) Liproxstatin-1 did not affect the efficacy of genetic targeting in cKO kidneys (Figure 9—figure supplement 1). As a control experiment, we employed lineage-tracing and GPX4 immunostaining to detect the genetic targeting efficacy of our mouse models treated with liproxstatin-1. We observed a similar level of <italic>Gpx4</italic> deletion both in liproxstatin1-treated and vehicle-treated groups after IRI (Figure 9—figure supplement 1, B and C). Moreover, liproxstatin-1 effectively reduced expression of ACSL4, a ferroptotic stress marker, in ischemia-reperfusion injured cKO kidneys (Figure 9—figure supplement 1D).</p><disp-quote content-type="editor-comment"><p>2. Please address the variability between the staining patterns for SOX9 immunostaining and the Sox9-TdTomato reporter. For example, in Figure 2D/E, the number of SOX9+ cells (over DAPI+ cells) is only ~8% in the 30-minute IRI kidney at day 21 while in Figure 3B/C, the number of Sox9;TdTomato+ cells (over DAPI+ cells) is 60% in the cortex and 40% in the medulla in the 30-minute IRI kidney at day 21. Even in the 20-minute IRI kidney, the SOX9+ cells are close to 0% at day 21 (Figure 2E) but the Sox9;TdTomato+ cells are close to 20% in Figure 3C. We also ask that you discuss the limitations of using SOX9 as a primary marker for maladaptive proximal tubular repair.</p></disp-quote><p>We thank the reviewers for this comment and apologize that our data presentation was not entirely clear. We employed a combination of genetic fate-mapping and immunostaining to dissect dynamic phenotypic alteration of proximal tubular cells. The <italic>Sox9<sup>IRES-CreERT2</sup>; Rosa26<sup>tdTomato</sup></italic> mouse line was used to permanently tag <italic>Sox9</italic>-lineage cells with tdTomato expression and thereby visualize the history of <italic>Sox9</italic> activation (Figure 3B and C). TdTomato expression accumulates during the course of injury and repair, but does not necessarily indicate ongoing <italic>Sox9</italic> expression at the time when the kidney tissue is analyzed. To detect this, we used immunostaining of <italic>SOX9</italic> (Figure 2 D and E). The “tdTomato positive SOX9-immunofluorescence (IF)-positive” cells thus represent cells with ongoing SOX9 activity, whereas “tdTomato-positive, SOX9IF negative” cells are those with a history of transient SOX9 expression that currently lack SOX9 activity. Combining these tools, we interpreted our results as follows: After mild ischemia-reperfusion (20 minischemia), <italic>SOX9</italic> is transiently induced, but the expression is diminished as cells return to their original state on day 21. However, severe ischemia induces persistent and ongoing SOX9 activation in some of the <italic>Sox9</italic>-lineage cells during the course of maladaptive repair.</p><p>We recognize the limitation of using <italic>SOX9</italic> alone as a primary marker for damage-associated PT cell state. In our case, we used a combination of markers to detect these pathological proximal tubular cells (ex. <italic>SOX9</italic>+VCAM1+ cells). This point is emphasized in our revised manuscript (page 7, line 25, page 8, line 10, and page 9, line 3).</p><disp-quote content-type="editor-comment"><p>3. Please explain the variability of VCAM1 staining across figures. For example, in Figure S9B VCAM1 staining is almost completely negative in the contralateral control kidney while there is a fair amount of VCAM1 positive staining in Figure 2C and Figure 3D of the contralateral control kidney. Please also provide an explanation for VCAM1 expression in a subset of normal human kidney proximal tubule cells (Figure S11B).</p></disp-quote><p>We thank the reviewers for carefully reviewing our manuscript. We observed VCAM1 expression in endothelial cells and macrophages in normal kidneys, but not in the tubular epithelial cells. VCAM1 is induced in proximal tubular cells after injury and serves as a marker of damage-associated PT cell state. We believe this inconsistency in the previous Figure S9 was due to the confocal imaging setting, which was slightly different when we captured these images. We have obtained new images, analyzed the data, and replaced the images for this figure (See Figure 2—figure supplement 1). The expression pattern of the new images is consistent with Figure 2C and 3D.</p><p>VCAM1 expressing human proximal tubular cells in the previous Figure S11B (current Figure 5—figure supplement 2) have been identified as a scattered cell population in human kidneys (PMID: 23124355). A recent report by Muto et al., investigated this unique subset of proximal tubular cells (PMID: 33850129). They used single-nucleus ATAC and RNA sequencing and identified that NFkB signaling is activated in this subset and promoting VCAM1 expression. The physiological and pathological roles of this subset of proximal tubular cells are still unclear and require further investigation.</p><disp-quote content-type="editor-comment"><p>4. Please discuss the limitations of using pseudo time and RNA velocity in RNA-Seq analysis to identify novel transitional cell states given that the results are imputed by mathematical modeling.</p></disp-quote><p>We agree with the reviewers. The results are imputed by mathematical modeling and require extensive validation, such as genetic fate-mapping combined with immunostaining. Following the reviewer’s advice, we included this discussion in our revised manuscript (Page 8, line 1 and 5).</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>– A major concern with these studies is the reliance on SOX9+ cells to represent DA-PT cells. Figures S5D and 5C demonstrate that less than 40% of the DA-PT cells express SOX9. SOX9 is not specific to DA-PT cells either, as they are seen in both PT cells and DCT1 cells as well. Additionally, the scale of the dot plots should be 0-100, and not 0-40. Also, Figures 5 D and E do not differentiate between DCT1 and PTs and this should be clarified.</p></disp-quote><p>Markers for DA-PT cell state: We thank the reviewer for raising this important point regarding the use of multiple markers to define DA-PT cells. We recognize the limitation of using <italic>SOX9</italic> alone as a marker of damage-associated PT cell state and performed a series of validation studies using multiple markers, including SOX9, VCAM1, and CDH6.</p><p>Dot plot Scale for Figure 5C: Single-cell and single-nucleus RNA sequencing has been implemented successfully in multiple disease processes and has identified heterogeneity of gene expressions. Many investigators use the default setting of Seurat for dot plot data representations with adjusted scale ranges (ex. Aviv Regev and Maria Lehtinen’s group, Figure 7, Cell 2021: 184, 3056-3074; PMID: 33932339). We would like to keep the current data representation as it is visually recognizable. However, we increased the font size of scales to highlight the heterogeneity.</p><p>Differentiation between DCT1 and PT: We agree with this reviewer on this point. Due to the limited antibody combinations, it is technically challenging to differentiate DCT1 and PT cells in Figure 5 at this time. Instead, we used our genetic <italic>Gpx4</italic> knockout mouse studies to show the functional importance of ferroptotic stress in regulating proximal tubular cell fate (i.e. accumulation of Vcam1+ cells. Vcam1 is not induced in DCT1 cells). Our data collectively support our notion that ferroptotic stress in DA-PT cells promotes the accumulation of this pathologic state, cell death, and drives the maladaptive renal repair.</p><disp-quote content-type="editor-comment"><p>– When defining the initial DA-PT cell population, the authors should include data showing there is no upregulation of genes associated with the cellular death pathways.</p></disp-quote><p>Following the reviewer’s suggestion, we analyzed the expression pattern of genes associated with necroptosis (<italic>Ripk3</italic> and <italic>Mlkl</italic>) and pyroptosis (<italic>caspase-1</italic> and <italic>Gsdmd</italic>). DA-PT cells do not have high expression levels of these genes (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>).</p><fig id="sa2fig1"><label>Author response image 1.</label><caption><title>UMAP plots showing genes associated with necroptosis and pyroptosis.</title><p>Blue arrowheads indicate DA-PT cells. These genes are not highly expressed in the DA-PT cell population.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-resp-fig1-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>– Did the authors observe the DA-PT phenotype after &quot;mild&quot; 20 minute uIRI? This is relevant since the authors show that SOX9+ cells appear after 20 minute uIRI.</p></disp-quote><p>We observed transient appearance of SOX9+VCAM1+ cells in the kidneys that underwent 20 min ischemia as shown in Figure 2—figure supplement 1B. However, these markers were negative in proximal tubular cells on day 21 (Figure 2—figure supplement 1B).</p><disp-quote content-type="editor-comment"><p>– Figure 3E would suggest that only 25% of the SOX9+ cells were also VCAM1+. If only 40% of DA-PT cells were SOX9+, that would suggest that only 10% of DA-PT cells were SOX9+VCAM+, again questioning the validity of using SOX9 for identifying DA-PT cells.</p></disp-quote><p>We apologize that our data presentation and description were not clear as they should be. We also agree with the reviewer that we need to use multiple markers to define the DA-PT cell state.</p><p>As described in the essential revision section (#2), the data of Figure 3E show the percentage of DA-PT cells over the <italic>Sox9</italic>-lineage cells (but not current SOX9-expressing cells on day 21 post-IRI). The tdTomatopositive cells are the cells with a “history” of <italic>Sox9</italic> expression. The number of tdTomato+ cells accumulates over the experimental time course. The expression of tdTomato does not indicate the current SOX9 expression nor DA-PT state at the time when the kidneys were harvested. Conversely, VCAM1immunopositivity indicates these cells are in a DA-PT state at the time of harvest.</p><disp-quote content-type="editor-comment"><p>– How do the authors reconcile the link between ferroptosis and severe AKI when accumulation of MDA and ACSL4 seems to occur in only a minority of SOX9+ cells and is also seen in SOX9- cells?</p></disp-quote><p>We would like to thank this reviewer again for raising this important question. <italic>Sox9</italic>-lineage cells have been identified as a critical cellular population for successful renal repair (PMID: 26279573 and 26776520). Therefore, we hypothesized that the damage to these cells has a high impact on failed renal repair. Indeed, genetic induction of ferroptotic stress selectively in these cells drove the maladaptive repair process (Figure 7: increased tubular injury, inflammation, and fibrosis). Moreover, our new data using a ferroptosis inhibitor demonstrate that we can prevent these pathologic changes induced by genetic deletion of <italic>Gpx4</italic> in ischemia-reperfusion-injured kidneys (Figure 9). Collectively, our data demonstrate the critical role of ferroptotic stress in SOX9+ cells in maladaptive repair process.</p><p>To answer the potential roles of ferroptotic stress in SOX9-negative tubular epithelial cells, we are currently generating a new mouse line and would like to address this intriguing question in future studies.</p><disp-quote content-type="editor-comment"><p>– Figure 5 does not include comparison of sequencing results for the mild-injury. Are there differences in the gene expression of MDA and ACSL4 in the 20 minutes vs 30 minutes uIRI?</p></disp-quote><p>We did not observe a statistically significant difference in gene expression for <italic>Acsl4</italic> between 20 min vs. 30 min on day 1 post-IRI (data not shown). However, we observed the difference at a protein level (<xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>), confirming the previous observation that ACSL4 protein expression serves as a quantitative marker of ferroptosis and ferroptotic stress (Cell Mol Life Sci 2017; PMID 28551825).</p><p>Malondialdehyde (MDA) is a reactive aldehyde and marker for lipid peroxidation, commonly quantified using immunostaining. Following the reviewers’ comments, we analyzed MDA expression by immunostaining. As expected, severe ischemia (30 min) showed higher MDA expression compared to 20 min mild ischemia.</p><fig id="sa2fig2"><label>Author response image 2.</label><caption><title>Immunostaining and quantification for malondialdehyde (MDA) and ACSL4.</title><p>The post-IRI kidneys harvested on 6-hrs and 1-day after ischemia were used to detect MDA and ACSL4, respectively. *P&lt;0.05 and ***P&lt;0.001 unpaired t-test. Scale bars, 50µm. Note tha 30-min ischemia induces more ferroptotic stress (MDA and ACSL4) in damaged kidneys compares to 20-min ischemia.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-resp-fig2-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>– Human data in Figure 6E is not particularly convincing that the &quot;DA-PT like&quot; cells are expressing SOX9, VCAM or CDH6. Expression looks very low and potentially higher in normal PT cells. Violin (with individual dots) or dot blots should be used to show the quantification of these data.</p></disp-quote><p>We thank the reviewers for this comment to improve our data visualization. Following the reviewer’s suggestion, we used dot plots to represent our data (Figure 6E). Our analyses showed that at least three cellular states exist in human proximal tubular cells after acute kidney injury (state1, 2, and 3). We observed a decreasing trend of differentiated PT cell markers from state 1 to state 3 and an increasing trend of damage-induced genes from state 1 to state 2 and state 3. State 3 has high damage-induced genes and low homeostatic differentiation markers, indicating that cells in state 3 are closely related to the mouse DA-PT cell state. We agree with this reviewer that a relatively small fraction of cells in state 3 (DA-PT-like) expresses <italic>SOX9</italic>, <italic>VCAM1</italic> and <italic>CDH6</italic>. This result could be species-specific or reflect the time of biopsy in these two AKI patients. The potential of species-specific transcriptional responses to AKI of various etiologies needs further investigation with a larger cohort of patients in the future.</p><disp-quote content-type="editor-comment"><p>– The justification for the 22 minutes of ischemia for the studies with the cKO mice in Figures 7 and 8, should be provided.</p></disp-quote><p>We found that an ischemic time of 22 min is the most reliable protocol to induce genetic deletion of <italic>Gpx4</italic> in <italic>Sox9<sup>IRESCREERT2</sup>; Gpx4<sup>flox/flox</sup></italic>. In this protocol, we found that the kidneys with control genotype (<italic>Gpx4<sup>flox/flox</sup></italic>) manifest a successful repair as in the 20 min ischemia protocol. Therefore, we used 22 min instead of 20 min for this mouse line. To minimize the effect of genetic background, we only used littermate controls to compare the phenotypic differences.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Suggestions to authors:</p><p>– Title: &quot;Ferroptotic stress&quot; sounds rather awkward as the I/R stress is the trigger of ferroptosis in kidney tubular cells.</p></disp-quote><p>We thank the reviewers for this comment. As summarized in the essential revision section (#1), we now show that a ferroptosis inhibitor, liproxstatin-1, effectively mitigates the accumulation of damage associated proximal tubular cells and cell death (ferroptosis) after IRI in the absence of <italic>Gpx4</italic> in <italic>Sox9</italic>-lineage cells. Our results emphasize the critical role of ferroptotic stress in dynamic phenotypic alterations of proximal tubular cells among the various stressors evoked by IRI. Therefore, we respectfully request to keep our title in its current form.</p><disp-quote content-type="editor-comment"><p>– Page 8: Would in vivo active ferroptosis inhibitors blunt some of the dynamic changes/plasticity of proximal tubular cells (Figures 3, 5)? Along the same line, would they also impair the overall damage in the genetic GPX4 null model? These studies would be extremely helpful to corroborate the contribution of &quot;ferroptosis&quot; in the proposed model.</p></disp-quote><p>We thank the reviewer for these insightful and clinically important comments. As summarized in the essential revision section (#1), we used liproxstatin-1 to treat our conditional knockout mice (<italic>Sox9<sup>IRESCreERT2</sup>; Gpx4 <sup>flox/flox</sup></italic>) that underwent unilateral IRI. While the vehicle and IRI-treated cKO kidneys showed maladaptive repair phenotype, liproxstatin-1 potently mitigated tubular injury and reduced the accumulation of pathologic proximal tubular cells (DA-PT cells, SOX9+VCAM1+) and cell death (ferroptosis). These data strongly support our initial notion that ferroptotic stress triggers both cell death and pathologic cellular changes in proximal tubular cells. We consider glutathione peroxidase 4 to be a central guardian for the proximal tubular cell fate.</p><disp-quote content-type="editor-comment"><p>– Did the author consider secondary forms of cell death including apoptosis and necroptosis in their model as a consequence of a highly proinflammatory milieu?</p></disp-quote><p>We thank this reviewer for raising this interesting question. It is highly likely that other types of regulated cell death are also induced in the hostile microenvironment of failed repair model. We would like to interrogate how multiple forms of regulated cell death may interact and contribute to failed renal repair in future studies.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>As one of the main strengths of this manuscript is the validation of the scRNA-Seq data analysis findings, it is important that the validations are clear. Some of the immunostaining are not consistent with expected findings (Lotus lectin staining) or are variable (VCAM1 and SOX9), described below.</p></disp-quote><p>We thank the reviewer for their positive comments on our extensive validation and carefully reviewing our manuscript.</p><disp-quote content-type="editor-comment"><p>1. Figure S6B Image is not consistent with LTL staining which should be apical staining of the brush border. The staining in the image appears cytoplasmic or reflects kidney autofluorescence.</p></disp-quote><p>We thank the reviewer for carefully reviewing our manuscript. We have retaken the images and re-analyzed the data accordingly (previous Figure S6B is renumbered to Figure 1—figure supplement 6B).</p><disp-quote content-type="editor-comment"><p>2. SOX9 staining appears to be variable and the abundance of SOX9+ cells differ between SOX9 immunostaining and the Sox9-TdTm reporter. In Figure 5D/F, S9B SOX9 immunostaining in the control kidney with zero or rare positive cells while Sox9-tdTomato have quite a few scattered throughout the kidney given the larger field presented at a lower magnification, as shown in Figure 3B-control kidney. Depending on the field chosen, the Sox9-TdTm+ cells could be as high as 5-6 per higher power field and as low as 0-2 (which is what Figure 3D presents). Is the overall pattern and frequency of SOX9+ immunostaining at a lower power field also consistent with the Sox9-TdTomato reporter image in Figure 3B?</p></disp-quote><p>We apologize that our data representation was not clear as it should be. As summarized in the essential revision section (#2), SOX9 immunostaining and <italic>Sox9</italic>-tdTomato-expression represent different cellular states. SOX9 immunostaining detects the ongoing SOX9 activity, but tdTomato expression identifies the history of <italic>Sox9</italic> activation. We observed rare SOX9-immunopositive cells in normal and contralateral kidneys, and we identified more <italic>Sox9</italic>-lineage cells in these conditions as the genetic fate-mapping system detects all the cells that expressed SOX9 during the experimental time course as a sum. Therefore, the tdTomato+ area (history of <italic>Sox9</italic> activity) is larger than the immunostained area (ongoing <italic>Sox9</italic> activity).</p><p>Additionally, we have added quantification of <italic>Sox9</italic>-lineage area of contralateral kidneys in new Figure 3C.</p><p>Regarding the overall pattern of SOX9+ cells, we observed a consistent expression pattern between immunostaining and lineage-mapping data. SOX9 expression is mostly confined to distal convoluted tubule both in lineage-reporter and immunostaining for control kidneys (<xref ref-type="fig" rid="sa2fig3">Author response image 3</xref>).</p><fig id="sa2fig3"><label>Author response image 3.</label><caption><title>Distal convoluted tubules express <italic>SOX9</italic> protein in uninjured kidneys.</title><p><italic>Sox9</italic>-lineage tagged uninjured kidneys were used to localize <italic>Sox9</italic>-lineage cells (tdTomato). Sodium chloride co-transporter (NCC, Slc12a3) is a marker for distal convoluted tubular cells. Insets: Individual fluorescent channels of dotted area are shown. Scale bar: 20 µm. Arrows: double-positive cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-68603-resp-fig3-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>Figure 3B control kidney image also does not support the sentence on page 12 line 11 stating that Sox9-CreERT2 activity is &quot;not induced&quot; in non-injured kidneys, as there are clearly Sox9-TdTm+ cells in Figure 3B in the control kidney, unless the Sox9-CreERT2 is leaky and some of the lineage traced cells are false positives, in which case interpretation of the experiments using the Sox9-CreERT2 may require some consideration of this possibility.</p></disp-quote><p>We agree with this reviewer that our description was not accurate. In control kidneys, <italic>Sox9</italic> is only expressed in a small subset of distal convoluted tubular cells (<xref ref-type="fig" rid="sa2fig3">Author response image 3</xref>) but not in proximal tubular cells. To more precisely describe this point, we rephrased “<italic>Sox9</italic>-CreERT2 activity is not induced in non-injured kidneys” to “<italic>Sox9</italic>-CreERT2 activity is not induced in non-injured proximal tubular cells” (Page 12, line 23).</p><disp-quote content-type="editor-comment"><p>3. There is variability of the VCAM1 staining throughout the manuscript. Figure S9B contralateral control kidney is VCAM1 staining is almost completely negative, while there is a fair amount of VCAM1 positive staining in Figure 2C and Figure 3D of the contralateral control kidney, albeit the VCAM1+ cells appear interstitial. It is described in the text that VCAM1 is &quot;expressed weakly&quot; in macrophages and endothelial cells after injury, although some of these images in the manuscript suggest that VCAM1 is relatively strongly expressed at baseline, and further induced after injury in interstitial and/or endothelial cells. Of note, it is odd that VCAM1 expression is present in a subset of normal human kidney proximal tubule cells, specifically presented on the Dot plot in Figure S11B. Is there an explanation for this finding?</p></disp-quote><p>We thank the reviewer for carefully reviewing our manuscript. As described in the essential revision section (#3), we have corrected the previous Figure S9B (current Figure 2—figure supplement 1). Regarding the previous Figure S11B (current Figure 5—figure supplement 2), The expression of VCAM1 in a subset of proximal tubular cells has been reported (J Pathol 2013, PMID: 23124355) and interrogated in detail recently (Nat Comm 2021, PMID; 33850129).</p></body></sub-article></article>